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1. INTRODUCTION 
Peptide hormones such as vasopressin and oxytocin which are 
found in hypothalamic and pituitary neuroendocrine cells of the central 
nervous system are known to have physiological roles in homeostasis. 
Recent advances in peptide sequencing and solid state peptide synthesis 
techniques have led to important developments in peptide neurobiology. 
Techniques have been developed which enable the measurement 
of minute amounts of specific peptides (radioimm~~oassay) and the visu-
alization, histologically and cytologically, of specific peptides within 
nervous tissue (immunohistochemistry). With the use of radioimmunoassay 
and immunohistochemistry many peptides once believed to be contained 
solely in hypothalamic or other neuroendocrine cells in the central ner-
VOUS system have now been found in neurons throughout the central and 
peripheral nervous systems. This has led to the suggestion that they 
may function as neurotransmitter or neuromodulatory agents. In the past 
ten years the number of peptides for which a neurotransmitter role has 
been proposed has grown from one (substance P) to at least twelve (see 
table 1) (Scharrer, 1977; Iversen, Nicoll and Vale, 1978; Hughes, 1978; 
Walker, 1978). 
In order to demonstrate that any of the neuropeptides are neuro-
transmitter substances, several criteria must be met. First, the pep-
tide under study must be contained within nerve terminals. In addition, 
it should also be contained within synaptic vesicles which are a char-
1 
Table l. The names and &~ino-acid sequence of some proposed peptide 2 
neurotransmitters, and some of their analogs (all sequences 
begin with N terminal). 
Peptide Sequence 
angiotensin 
S-endorphin 
)'-endorphin 
a-endorphin 
met-enkephalin 
leu-enkephalin 
gastrin 
LHRF 
neurotensin 
oxytocin 
somatostatin 
substance P 
substance P free acid 
substance P pentapeptidel 
TRF 
vasopressin 
VIP 
Asn-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-
Val-Tyr-Ser 
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-
Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Gly-Ala-Ile-
Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu-OH 
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-
Thr-Pro-Leu-Val-Thr-Leu 
Tyr-Gly-Gly-Phe-Net-Thr-Ser-Gly-Lys-Ser-Gln-
Thr-Pro-Leu-Val-Thr 
Tyr-Gly-Gly-Phe-Met 
Tyr-Gly-Gly-Phe-Leu 
Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-
Tyr-Gly-Trp-Met-Asp-Phe-NH2 
HSO 
pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 
Glu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Pro-Ile-Leu-OH 
eys-Tyr-Ile-Gly-Asn-Cys-Pro-Leu-Gly-NH2 
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-!1et 
Phe-Phe-Gly-Leu-Met-NH2 
pGlu-His-Pro-NH2 
Cys-Tyr-Phe-Glu(NH2)-Asp(NH2)-Cys-Pro-Lys-Gly-
NH2 
His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-~Jr-Thr­
Arg-Leu-Arg-Lys-Gly-Net-Ala-Val-Lys-Lys-Tyr-
Leu-Asn-Ser-Ile-Leu-Asn-NH2 
acteristic feature of the presynaptic nerve terminal. 3 A second crite-
rion which must be met is that the substance be released from the ter-
minal in response to a depolarization of the presynaptic neuron. This 
release must be dependent on the presence of extracellular calcium ions. 
The most common method by which the release of various putative trans-
mitters has been studied is by depolarizing the cells with a solution 
having a high concentration of potassium ions. 
The use of high potassium solutions to evoke release can be 
criti~ised for the following reasons: (a) Osmotic imbalances during 
the release period must be considered and corrected., (b) Viability of 
the preparation after such a powerful stimulus should be tested., (c) 
Reproducible release from the same preparation is usually not observed., 
(d) In addition to being calcium-dependent, the release of the proposed 
transmitter should be decreased by tetrodotoxin. Sensitivity of re-
lease to tetrodotoxin indicates that the depolarization and subsequent 
release can be ascribed to action potential generation. Techniques 
such as application of veratridine or electrical stimulation are less 
drastic than the use of high potassium solutions, and they affect 
neurons more specifically, thereby reducing the possibility of extra-
neous release from other types of cells in the preparation. 
The third criterionwhich must be met is the capability of the 
presynaptic neuron to synthesize the proposed transmitter; that is to 
say, the enzymes which are known to be necessary for synthesis of the 
transmitter must be present. The fourth requirement is that a process 
by which the transmitter is inactivated either pre- or post-synaptically 
4 
is present at the proposed synapse. Finally, the action of the neuro-
peptide on neuronal excitability and postsynaptic membrane properties 
must mimic the response to presynaptic nerve stimulation. This crite-
rion requires the use of electrophysiological techniques; this is the 
approach taken in the present study. 
Electrophysiological studies may be carried out in vivo or in 
vitro. There are advantages and disadvantages to each approach. Stud-
ies in vivo leave the anatomy intact and the neurons remain in. an en-
vironment which approximates normality; functional connections between 
different areas of the central and peripheral nervous sys·tems are intact. 
The actions of the peptides on the neuron can be studied in relation to 
the cell's responses to physiological as well as artificial stimuli. 
Neurons may even be studied in animals which are conscious and behaving 
normally. There are also certain limitations to i~ vivo recordings. 
The concentration of peptides near the cell being studied is difficult 
to quantitate when administered systemically or by local application, 
synaptic influences are sometimes not distinguishable from direct ac-
tions on the cell, metabolic and hormonal factors as well as the anes-
thetic used may interfere with peptide action, the neuronal effects seen 
after administration of the peptide may be secondary to blood pressure 
or respiratory changes, diffusional barriers may limit the use of some 
drugs, and investigation of the ionic mechanisms of any observed effects 
is rendered difficult. 
Studies of neurons in vitro eliminate most of the above problems; 
however, different problems arise. Studies of single neurons in vitro 
are limited to peripheral ganglia, brain slices, or immature neurons 
5 
grown in tissue culture. In each case, the isolated preparation is 
maintained in an artificial environment which approximates the condi-
tions in vivo. Even so, explanted adult neurons eventually lose via-
bility in vitro, and the rate at which they do this may limit the exper-
imental approach. The strongest criticism of in vitro techniques is 
that it is difficult to ascribe functional significance to the effects 
observed because the neurons are more or less removed from any normal 
physiological connections. Studies of peripheral ganglia, on the other 
hand, have demonstrated that those neurons recorded in vivo or in vitro 
have similar properties including membrane potential, input resistance 
and synaptic potentials (Skok, 1973). The loss of synaptic transmission 
in the autonomic ganglia after being maintained in vitro for 15-20 hr 
correlates well with the degradation of presynaptic terminals after sec-
tioning of the preganglionic fibers (Skok, 1973). It appears that stud-
ies of synaptic mechanisms in peripheral ganglia in vitro are not dif-
ferent from recordings made in vivo. Therefore, meaningful results from 
studies on synaptic mechanisms can be attained with isolated autonomic 
ganglia. 
The present investigation has utilized the in vitro approach to 
study the action of several endogenous neuropeptides and related sub-
stances on the electrical properties of single autonomic neurons. This 
approach was chosen over in vivo electrophysiological techniques for 
several reasons. Basic information such as, the direct effects that 
these peptides have on single neurons, the time course of action and 
the effective concentration range can be more readily obtained from in 
6 
vitro studies. A study of the physiological role of the neuropeptides 
is also possible with in vitro techniques using autonomic ganglia since 
many of the neuropeptides are contained in nerve terminals of these gan-
glia (see below) . The myenteric plexus of the guinea pig ileum is well-
suited to study the action of the various neuropeptides for reasons 
which will become apparent as each individual peptide is discussed. 
1.1. OPIATES AND ENDOGENOUS OPIOID PEPTIDES 
1.1.1. Opiate Binding Sites 
There is a large body of evidence which indicates that the 
actions of opiates and endogenous opioid peptides are mediated by a 
common receptor or group of receptors. Areas with high numbers of opi-
ate binding sites were found in the mesolirnbic syst~m of the brain; 
speci£ically the amygdala, hypothalamus, periaqueductal gray, head of 
the caudate nucleus and thalamus (Kuhar, Pert and Snyder, 1973; Pert, 
Kuhar and Snyder, 1975). Certain afferent systems were also shown to 
be rich in opiate binding sites including the dorsal horn of the spinal 
cord, the trigeminal nucleus and nuclei of the vagus nerve such as the 
nucleus tractus solitarius (Atweh and Kuhar, 1977). A presynaptic loca-
tion of these binding sites was inferred when dorsal root section re-
sulted in a 50% decrease in receptor binding in the dorsal spinal cord 
(LaMotte, Pert and Snyder, 1976). Similar inferences have been made 
from the finding that vagotomy leads to a marked reduction in autoradi-
ographic binding of opiates in the nucleus tractus solitarius and nu-
cleus a~iguus (Atweh, Murrin and Kuhar, 1978). 
Opiate receptor binding has also been studied in the myenteric 
plexus of the guinea pig ileum (Creese and Snyder, 1975). Several meth-
ods were used to study the opiate receptors in the ileum. The results 
indicate that the binding properties of receptors in the ileum are much 
the same as those in the central nervous system. First, the inhibition 
7 
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of H3-labeled naloxone binding was stereospecific; that is, the active 
(-)-isomers of three agonist.s were 10-1,000 times more effective in dis-
placing H3-naloxone binding than the corresponding (+)-isomers. Second, 
a series of opiates having dif;eering binding affinities in the rat brain 
were compared to the binding in the ileum. A significant correlation 
between the relative order of binding affinities was found between the 
two tissues. Finally, ~here was good correlation between the ability of 
agonists to inhibit the electrically induced contraction of the longitud-
inal muscle-myenteric plexus preparation and their affinities for the re-
ceptor in the ileum. 
Autoradiographic localization of opiate binding sites in the cen-
tral nervous system has proved useful in determining the pathways which 
contain opiate receptors. Unfortunately, no reliable autoradiographic 
studies on myenteric ganglia have been done. 
9 
1.1.2. Endogenous Opioid Peptides 
Studies on the distribution of opiate binding sites d~~onstrated 
that opiate binding was not associated with any one specific transmitter 
system {Kuhar, Pert and Snyder, 1973). The demonstration of stereospe-
cific opiate binding sites led to attempts to find endogenous opiate-
like substances in the brain. An endogenous ligand for the opiate re-
ceptor was isolated from brain tissue, purified, sequenced and synthe-
sized. {Hughes, Smith, Kosterlitz, Fothergill, Morgan al'ld Morris, 1975). 
This ligand was found to be a mixture of two pentapeptides which have 
been termed methionine-enkephalin (met-enkephalin) and leucine-enkepha-
lin (leu-enkephalin) (for structures see Table 1). The structure of 
met-enkephalin was sho>-m to be completely represented in the pituitary 
hormone S-lipotropin and this led to the discovery of a family of endo-
genous opioid peptides which inclued a-, S-and ~-endorphin (Table 1). 
The opiate-like activity of these peptides has been tested on 
peripheral, behavioral and opiate binding models of opiate action. Al-
though the peptides had potent opiate-like activity on isolated prepara-
tions such as the guinea pig ileum and mouse vas deferens, the opioid 
peptides had little significant opiate-like activity when administered 
systemically (Buscher, Hill, Romer, Cardinaux, Classe, Hauser and Pless, 
1976). Intracerebral administration of enkephalin resulted in transient 
antinociception which was reversed or prevented by the narcotic antagonist 
naloxone. The pentapeptides were found to be metabolically labile, thus 
accounting for their lack of effect when administered systemically (Miller, 
10 
Chang and CUatrecasas, 1977). The enkephalin molecule is metabolized 
rapidly by carboxypeptidases and also aminopeptidases (Hughes, Kosterlitz, 
McKnight, So sa, Lord and ivaterfie ld, 1978) • The rapid metabolism of en-
kephalin is consistent with a neurotransmitter role, but no specific in-
activating enzyme for enkephalin has been isolated yet. The most suscep-
tible region of the e~~ephalin molecule appears to be the amino terminus 
where aminopeptidases cleave the tyrosine from the enkephalin. Enkephalin 
analogs having a (D-Ala) residue in position two are metabolically stable 
(Pert, Pert, Chang and Fong, 1976). With this substitution, aminopepti-
dases are unable to cleave the tyrosine-D-alanine bond and the (D-Ala) 2 -
enkephalin analogs have potent and long-lasting analgesic activity in 
vivo (Pert et al., 1976). 
S-endorphin, the largest of the endogenous opioid peptides, was 
first isolated from pituitarJ extracts (Lee and Chung, 1976). The ques-
tion arose whether S-endorphin was the precursor of met-enkephalin. How-
ever, the difference in distribution of neurons which contain enkephalin-
like immunoreactivity argues against a precursor role for s·-endorphin 
(Rossier, Vargo, Minick, Ling, Bloom and Guillemin, 1977; Bloom, Batten-
berg, Rossier, Ling and Guillemin, 1978). A pituitary precursor of B--en-
dorphin itself, however, has been postulated (Guillemin, Vargo, Rossier, 
Minick, Ling, Rivier, Vale and Bloom, 1977). Antibodies to S-endorplun, 
8-lipotropin and corticotropin (ACTH) all crossreacted with a large pep-
tide (31,000 daltons) in extracts from a mouse pituitary tumor (Mains, 
Eipper and Ling, 1977). Tryptic digests of this 31,000 dalton peptide 
resulted in ACTH, 8-lipotropin, and other endorphin fragments. Further-
more, the concomitant release of S-endorphin and ACTH from the pituitary 
ll 
gland during acute stress or long-term adrenalectomy further supports a 
common precursor (Guillemin et al., 1977). However, the effects of 8-
endorphin released during acute stress have not as yet been determined. 
It seems clear, however, that 8-€ndorphin secreted by the pituitary into 
the blood does not result in changes in the levels of S-endorphin in the 
central nervous system (Rossier, French, Rivier, Ling, Guillemin and Bloom, 
1977). Since S-endorphin does not cross the blood brain barrier, it may 
be possible that it may have no action at all or it may have an action on 
peripheral opiate receptors. 
The synthesis of leu- and met-enkephalin has been studied in the 
rat brain and guinea pig myenteric plexus using (H 3) tyrosine (Hughes 
et al., 1978). There is a lag time of 1-2 hr after administration of the 
labeled tyrosine before labeled leu- or met-enkephalin is found. The 
synthesis of both peptides was blocked by cycloheximide or puromycin indi-
eating that the pathway is ribosomal. The classical synthetic pathway for 
proteins is by the ribosomes of the endoplasmic reticulum. Although it is 
possible that the enkephalins as pentapeptides are synthesized by the 
classical pathway, it seems more probable, in light of the lag time, that 
the pentapeptides are products of a pro-enkephalin molecule. 
Immunohistochemical localization of leu- and met-enkephalin indi-
cates that the amount of these peptides varies markedly in different areas 
of the central nervous system (Elde, Hokfelt, Johansson and Terenius, 1976; 
Simantov, Kuhar, Uhl and Snyder, 1977). In general, the amount of and lo-
cation in which the opioid peptides were found correlated with the density 
and localization of opiate receptor binding. There were some ~xceptions. 
12 
The central nucleus of the amygdala contained many immunoflourescent 
(enkephalin containing) fibers; however, the receptor binding was more 
evenly distributed in the amygdala (Simantov et al., 1977}. The ventral 
gray portion of the spinal cord has enkephalin containing fibers; how-
ever, there is little opiate receptor binding (Simantov et al. , 1977). 
The globus pallidus has the most enkephalin of any area in the brain; 
however, there are only moderate amounts of receptor binding (Kuhar et 
al., 1973; Elde et al., 1976; Simantov et al., 1977). These few quanti-
- -- -·-
tative differences in the distribution of enkephalin and density of opi-
ate receptors may represent limitations in the techniques used or may 
also suggest that the opioid peptides act by a mechanism independent of 
the opiate receptor in some areas. 
Subcellular fractionation studies indicate that most enkephalin 
is contained v1ithin the crude synaptosomal fraction of brain homogenates 
(Smith, Hughes, Kosterlitz and Sosa, 1976; Osborn, Holt and Herz, 1978}. 
A sizable (25%} amount of the recoverable enkephalin was also found in 
the crude microsomal (p3) fraction (Osborn et al., 1978). This fraction 
also contains a considerable density of opiate receptor binding sites; 
however, it was thought that the amount of enkephalin found in this frac-
tion was more than that which would be expected to be bound to the opi-
ate receptors. It was also not possible to account for the enkephalin 
in the microsomal fraction by contamination, since the supernatant con-
tained only small &~ounts of enkephalin. The localization of enkephalin 
in the microsomes may represent an early storage form of enkephalin. 
Experiments using incorporation of labeled tyrosine are required to test 
this hypothesis. Ultrastructural immunohistochemical studies may also 
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aid in demonstrating the relevance of the enkephalin found in the micro-
somal fractions. 
A calcium-dependent potassium evoked release of met- and leu-
enkephalin from slices of rat striatum has been demonstrated (Henderson, 
Hughes and Kosterlitz, 1978; Iversen, Iversen, Bloom, Vargo and Guillemin, 
1978; Osborn, Holt and Herz, 1978}. Release was also found to be evoked 
by veratridine and this release was blocked by tetrodotoxin, suggesting 
that the source of the enkephalin was neuronal (Henderson et al., 1978}. 
These. results satisfy one criterion which must be met before a neuro-
transmitter role can be assigned to the enkephalins. 
Leu- and met-enkephalin have been sho~m to be contained in the 
nerve terminals of the myenteric plexus using immunohistochemical (Elde 
et al., 1976} and biochemical methods (Hughes, Kosterlitz and Smith, 1977}. 
There is a limited amount of evidence which indicates that enkephalin is 
released by nerve stimulation from the myenteric plexus of the guinea pig 
ileum. The contractile response to nerve stimulation (at 0.1 Hz} of the 
longitudinal muscle-myenteric plexus preparation exhibits an inhibition 
following a 5 min period of stimulation at 10 Hz (Puig, Gascon, Craviso 
and Mussachio, 1977}. This inhibition in contractile response following 
the period of stimulation is also prevented by naloxone, and by theactive 
(-}-isomer of an opiate antagonist GPA-1943, but is not prevented by the 
inactive isomer GPA-1847. This. was taken as evidence indicating that 
nerve stimulation resulted in release of an endogenous opioid, possibly 
enkephalin. 
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Direct measurement of enkephalin released fro~ the guinea pig 
myenteric plexus by nerve stimulation has been reported in a single study 
(Schulz, vfuster, Simantov, Snyder and Herz, 1977). Tne amount of enke-
phalin released in these experiments was quite variable in the three 
tissues studied. others have also indicated that release of enkephalin 
from the myenteric plexus for direct measurement is unreliable and vari-
able (Hughes et al., 1978). Using cycloheximide to stop synthesis of 
enkephalin, the amount of enkephalin present in the myenteric plexus was 
compared between electrically stimulated and unstimulated tissues. A sig-
nificant reduction in the amount of enkephalin found in the stimulated 
preparations was taken as evidence for its release. The depletion of en-
kephalin from stimulated preparations was also blocked by treatment of the 
tissue with tetrodotoxin, indicating that the release was from stimulation 
of neurons. 
1.1.3. Actions of Opiates on Single Neurons In Vivo 
Single neuron studies on the action of morphine v1ere few prior 
to the description of stereospecific opiate binding sites (Pert and 
Snyder, 1973; Simon, Hiller and Edelman, 1973) • As the distribution of 
opiate binding sites was described, electrophysiological studies on sin-
gle cells were directed toward areas which were high in opiate bL~ding 
sites. 
The localization of receptor binding sites and knmvn physiolog-
ical pathways involved in pain perception aided the direction of electro-
physiological experiments. However, opiates have many effects on neu-
ronal tissue and it became important to demonstrate that the effects ob-
served were directly relevant to the spectrum of effects observed when 
pharmacological doses of opiates were given to normal animals including 
man. The relevance of electrophysiological studies on the action of nar-
cotic analgesics therefore required fulfillment of the following criteria. 
First, the action of the opiates on the cell being studied must be at a 
concentration comparable to that which reaches that site when a pharma-
cologically relevant dose of opiates is given to the whole animal. Sec-
ond, the action of the opiate agonists must be reversed by specific opi-
ate antagonists in appropriate concentrations. Third, the action of the 
opiates must be stereospecific; that is, the (-)-isomer must be more ac-
tive than the (+)-isomer of enantiomeric agonists. Likev;ise, the (-)-
isomer of the anantiomeric antagonists should produce a larger degree of 
antagonism than the (+)-isomer. 
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With in vivo experiments, it is often difficult to show that the 
action of an opiate is directly on the cell whose activity is being re-
corded. Systemic administration may result in any nwuber of indirect 
effects at distant sites. The alternative method of application of opi-
ates in such experiments is by iontophoresis. This limits any such in-
direct effects to sites near that of the recording. This advantage of 
iontophoresis over systemic administration is offset by the problem that 
with iontophoresis the local concentration of drug around the cell is 
unknown. A comparison between the effects on a given neuron produced by 
an analgesiC dose Of narcotiCS given systemically 1 and the effeCtS pro-
duced by iontophoretic application often results in a nuch clearer pic-
ture of the site and mechanism of opiate action. tJnfortunately, few 
studies in vivo have used both routes of administration. 
When administered either systemically or by iontophoresis, mor-
phine decreases the firing rate of most neurons whether they are spon-
taneously active or when they are induced to fire wit.lc nociceptive stim-
uli or excitatory agents such as glutamate. One site >.;here the action 
of morphine has been studied carefully is the locus coeruleus. Noxious 
stimuli transiently increased the firing rate of neurons of thatarea 
(Korf, Bunney and Aghajanian, 1974). This increase in firing rate and 
also the spontaneous firing rate were inhibited by morphine given sys-
temically (Korf, Bunney and Aghajanian, 1974) or iontophoretically (Bird 
and Kuhar, 1977). Other regions of the central nervous system where the 
inhibitory action of morphine has been studied by systemic as well as 
iontophoretic applications are the mesencephalic reticular formation 
(Haigler, 1976), sensorimotor cortex (Satoh, Zieglgansberger and Herz, 
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1976), spinal motor neurons (Zieglgansberger and Bayerl, 1976), and 
lamina IV and V cells from the spinal cord (Duggan, Hall and Headley, 
1977) . The action of morphine applied by iontophoresis in many other 
areas of the brain has been studied (Table 2) . 
Table 2. The action of opiates and opioid peptides studied in various 
locations in the central nervous system. 
abbreviat.:i,ons: H - opiates 
E - opioid peptides 
Ion - administered iontophoretically 
Sys - administered systemically 
t - firing rate increased 
i - (iring rate decreased 
t+ - variable effects 
x indicates reversal by naloxone 
Lateral Reti-
cular Fonnation 
Medulla 
NRGC and Pontis 
Cauda lis 
Locus Coeruleus 
Cerebellum 
Periaqueductal 
Gray 
Hypothalamus 
Thalamus 
Hippocampus 
Striatum 
(Caudate} 
Cortex 
+ + X 
+ 
X 
Reference 
Duggan, Hall and Headley, 
1976; 1977a; 1977b. 
Davies and Dray, 1978. 
Randic and Hiletic, 1978. 
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Zieglgansberger and Bayerl, 
1976. 
Davies and Dray_, 1976; 1978. 
Bradley, Briggs, Gayton and 
Lambert, 1976. 
Nicoll, Siggins, Ling, Bloom 
and Guillemin, 1977. 
x Hill, Pepper and Mitchell, 
2/8 1976. 
+ + at Gent and \iolstencroft, 1976. 
i 
trat 
! 
I 
at. 
I . fJUlnea 
ig 
lrat 
rat 
rat 
rat 
rat 
p:-at 
~at 
~at 
trat 
f-rat 
rat, cat 
+ + X 
+ 
H H X 
+ + X 
+ 
+ + X 
+ + X 
+ 
t 
"" 
X I 
HH X 
+ + X 
+ + X 
+ + X 
+ 
+ X 
+ + X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Scott-Young, Bird and Kuhar, 
1977. 
Guyenet and Aghajanian, 1977. 
Nicollet al., 1977. 
Fredrickson and Norris, 1976. 
Carette and Poulain, 1978. 
.. 
' 
Hill and Penper 1978 . 
Nicoll et al., 1977. 
Hill, Pepper and Mitchell, 
1976. 
Nicoll et al., 1977. 
Zieglgansberger, French, 
Siggins and Bloom, 1978. 
Nicoll et al. , 1977. 
Fredrickson and Norris, 1976. 
Nicoll et al. , 1977. 
Hill, Pepper and Mitchell, 
1976. 
Zieglgansberger, Fry, Herz, 
Moroder and Wunsch, 1976. 
Davies and Dray, 1978. 
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1.1.4. Actions of Opioid Peptides on Single Neurons In Vivo 
Electrophysiological studies of the enkephalins and S-endorphin 
on single neurons in the central nervous system showed that their effects 
were similar to those of morphine (Table 2} • The route of administra-
tion of the peptides has been limited to local applications by ionto-
phoresis or pressure injection. Due to the rapid metabolic degradation 
of the enkephalins, systemic application was unsuccessful. Development 
of stable analogs, however, has made systemic administration possible. 
A study of thalamic neurons demonstrated that iontophoretic as well as 
systemic administration of D-ala2 , D-leu5-enkephalin depressed the in-
crease in firing rate evoked by a noxious stimuli (Hill and Pepper, 
1978) . This depression was reversed by naloxone given either system-
ically or iontophoretically. The results obtained with the enkephalin 
analog were similar to those seen with morphine (Hill and Pepper, 1976} 
and enkephalin (Hill, Pepper and Mitchell, 1976). 
There is a generally good correlation between the density of 
opiate binding sites and the proportion of cells which are responsive 
to either morphine or the opioid peptides (Nicoll, Siggins, Ling, Bloom 
and Guillemin, 1977). It appears that morphine and the opioid peptides 
have the same action on nerve cells tested throughout the central ner-
vous system. That is to say, both morphine and the opioid peptides de-
crease firing whether it is spontaneous or evoked by physiological stim-
uli or excitatory amino acids. At the two sites where excitatory ef-
fects of morphine predominate, the opioid peptides also excite (Nicoll 
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et al., 1977). These sites are the pyramidal cells of the rat hippocam-
--
pus (Nicollet al., 1977) and the cat Renshaw cell (Davies and Dray, 
1978). There is now evidence that the excitation of hippocampal neurons 
is due to an inhibition of a tonically active inhibitory interneuron 
(Zieglgansberger, French, Siggins and Bloom, 1978). An inhibition of an 
inhibitory interneuron may explain the finding that a small proportion 
of cells are excited by iontophoretic application of morphine or enke-
phalin at other sites (brainstem, cortex, cerebellum, caudate nucleus) 
(Nicollet al., 1977). Similar considerations may explain the increase 
in firing of brainstem neurons evoked by morphine, enkephalin, acetyl-
choline and D,L-homocysteic acid, since the excitations produced by 
acetlycholine as well as morphine and enkephalin were blocked by nal-
oxone (Davies and Dray, 1978). 
In spontaneously active cells, the time course of effects pro-
duced by enkephalin administered iontophoretically was generally fast. 
Effects, whether excitatory or inhibitory, began soon after the onset of 
iontophoretic current (10-30 s) and the firing rate returned to con-
trol \vi thin 1 min after termination of the current. some Lamina IV and V 
cells in the spinal cord of cat are excited by noxious stimuli. Morphine 
and enkephalin block the increase in firing rate produced by noxious 
stimuli, but the time course of this effect is much longer than the in-
hibition of spontaneously firing cells (Duggan, Hall and Headley, 1977~). 
The time course of the inhibition produced by morphine ~Dd enkephalin on 
lamina IV and V cells was 30 min and 4-10 min, respectively. 
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In all previous studies, the release of enkephalin from the 
iontophoresis electrode has not been measured, and therefore the con-
centrations at the active site are unknown. The responses to iontophor-
etically applied enkephalin may be opiate receptor-mediated 
if they are blocked by the narcotic antagonist naloxone. However, sys-
temic administration of naloxone in a dose sufficient to block the usual 
pharmacological effects of morphine is more desirable. Because the con-
centrations of agonist and antagonist near the cell being studied are 
not known when both are applied by iontophoresis, antagonism by ionto-
phoretic administration of naloxone is of limited value. Indeed, ionto-
phoretic application of naloxone antagonises the inhibitions of neurons 
in the olfactory bulb of rat produced by o--aminobutyric acid (GABA) 
(Dingledine, Iversen and Breuker, 1978). In that study naloxone re-
versed the effect of morphine in only 2 of 14 cells tested. 
Another example of the difficulties inherent in iontophoretic 
administration of agonists and antagonists comes from the work of Dug-
gan, Hall and Headley (1976; 1977) on cat spinal cord. Iontophoretic 
application of an enkephalin analog near the cell bodies of lamina IV 
and V cells decreased both spontaneous firing and the increase in firing 
rate evoked by noxious or non-noxious stimulation. These effects were 
determined to be of limited significance for three reasons. First, the 
effects were not selective for either of the two sensory modalities tested 
whereas systemic application of morphine selectively blocked nociceptive 
responses. Second, other agents such as glycine and GA~A also blocked 
increases in firing rate produced by each sensory modality. Third, the 
inhibitions produced by enkephalin applied by iontophoresis near the 
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cell body were antagonized by iontophoretic administration o= naloxone 
but were not affected by intravenous administration of naloxone in doses 
up to 0.6 mg/kg. This dose of naloxone blocked the effect of systemi-
cally applied morphine and the effects of enkephalin when iontophoresed 
into the substantia gelatinosa. These experiments suggest that the con-
centration of enkephalin near the cell body was greater than that nee-
essary to cause blockade of noxious input and high enough to depress 
other modalities. On the other hand, iontophoresis of morphine and en-
kephalin into the substantia gelatinosa selectively depressed nocicep-
tive responses of lamina IV and V cells and this was reversed by low 
doses of naloxone given systemically (Duggan et al., l977a). 
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1.1.5. Actions of Opiates and Opioid Peptides on Single Neurons In Vitro 
In vitro studies have been carried out on peripheral morphine-
sensitive neurons of the myenteric plexus of the guinea pig ileum, and 
on spinal and dorsal root ganglion neurons maintained in culture, all of 
which have previously been shown to contain opiate receptors. 
In cultured dorsal root ganglion neurons two separate studies 
have indicated a possible presynaptic site of action for the opiates and 
opioid peptides (Crain, Peterson, Crain and Simmon, 1977; MacDonald and 
Nelson, 1978). A complex multi-unit potential was recorded in the dor-
sal horn area of fetal mouse spinal cord explants after electrically 
stimulating the attached dorsal root ganglion (Crain et ~., 1977). 
This potential was markedly diminished by morphine; the diminution was 
stereospecific and naloxone-reversible. The concentrations used in the 
bathing solution were comparable to those which are effective on the 
contractile response of the guinea pig ileum. Interestingly, the evoked 
dorsal cord potential was increased by low concentrations of naloxone 
alone which suggests that an inhibitory endogenous opioid system may 
have developed in these cultures. In the second study, simultaneous 
intracellular recordings from dorsal root ganglion cells and spinal cord 
cells in culture were made. Direct intracellular stimulation of the 
dorsal root ganglion cell resulted in a mono-synaptic depolarizing po-
tential recorded in the spinal cord cell (MacDonald and Nelson, 1978). 
The excitatory postsynaptic potential (e.p.s.p.) recorded in the spinal 
cord cell was depressed by iontophoretic application of etorphine in a 
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naloxone-reversible manner. The authors concluded that the depression 
of the e.p.s.p. was due to a decrease in quantal content of the e.p.s.p.: 
however, calculations of quanta! content and quantal size were done by 
assuming a Poisson distribution and these calculations may be erroneous 
since there is no evidence that a Poisson distribution of transmitter 
release occurs in this preparation. No evidence of any postsynaptic 
effects during application of etorphine were observed. 
In another experiment on cultured mouse spinal cord cells, leu-
enkep~alin was applied iontophoretically near the surface of spinal cord 
neurons (Barker, Neale, Smith and MacDonald, 1978) • Leu-enkephalin de-
creased the depolarization induced by iontophoretic application of gluta-
mate. This effect was partially reversed by iontophoretic application of 
naloxone in only some experiments and an opiate receptor-mediated effect 
may or may not :oe involved. The action of opiates on single myent.eric 
neurons has also been studied (see Section 1.3.3.). 
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1.1.6. The Significance of the Endogenous Opioid ?eptides 
The evidence concerning the location, release and actions of the 
endogenous opioid peptides strongly supports a neurotransmitter or neuro-
modulator role for these peptides. No functional opioid synapse, how-
ever, has been demonstrated. Also, naloxone has little or no action of 
its own when administered to normal human subjects. The endogenous opi-
oid system, however, has been proposed to mediate the analgesia produced 
by acupuncture in man (Mayer, Price and Rafii, 1977) cat ~~d mouse (Pom-
eranz, 1978) and by electrical stimulation of the periaqueductal gray in 
man (Akil, Watson, Berger and Barchas, 1978). Administration of naloxone 
was shown to partially reverse the analgesic effects caused by stimula-
tion produced analgesia in all species tested. The partial reversal, by 
naloxone, of stimulus produced analgesia (SPA) indicates at least part 
of the analgesic effect seen could be due to release of opioid peptides. 
The release of opioid peptides into cerebrospinal fluid follo~ing cen-
tral stimulation also indicates that an endogenous opioid system may 
play a role in SPA (Terenius, 1978). 
Several approaches have been used to study the nature of the 
antinociceptive effects of acupuncture (Mayer et al., 1977; Pomeranz, 
1978). First, the increase in firing rate of nociceptive spinal cord 
cells in lamina IV and V of cat produced by painful stimulatio~ was 
blocked by acupuncture in a naloxone-reversible manner (Pomeranz, 1978). 
Second, the latency of response to a noxious stimulus (heat) in awake 
mice was increased by acupuncture and this increase in late~cy was 
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blocked by prior treatment with naloxone (Pomeranz, 1978). Third, a 
strain of mice (CBXK) which had a deficit of opiate receptors was used 
to study acupuncture. This strain of mice showed no significant change 
in antinociceptive response after acupuncture (Pomeranz, 1978). Finally, 
naloxone antagonized the increase in pain threshold caused by acupunc-
ture in healthy humans (Mayer, et ~l·r 1977}. The most striking effect 
of the studies on acupuncture was the time course of effects. The on-
set and offset of analgesia produced by acupuncture were in the order of 
minutes to hours. 
It therefore appears that the antinociceptive responses,behav-
iorally and at a single cell level,to SPA and acupuncture are, at least 
in part, mediated by release of endogenous opioids. The site which may 
be involved in the release of the opioid has not yet been determined. 
It is of interest to note that hypophysectomy abolished the response to 
acupuncture in mice (Pomeranz, Cheng and Law, 1977). Since the pitui-
tary is known to contain large amounts of S-endorphin, it may be pos-
sible that release of S-endorphin from the pituitary is important in 
acupuncture analgesia. The metabolic stability of 8-endorphin may also 
account for the prolonged effects produced by acupuncture. 
1.2. NEUR0PEPTIDES 
1.2.1. Substance P 
1.2.1.1. General Background. Substance P, a hypotensive and 
smooth muscle stimulating agent was first extracted from brain and in-
testine by von Euler and Gaddum (1931). It was not Q~til 1970 that this 
peptide was isolated in a pure form (Chang and Leeman, 1970). The struc-
ture ~as determined to be an undecapeptide (Chang, Leeman and Niall, 1971) 
(Table 1) and it was subsequently synthesized (Tregear, Niall, Potts, 
Leeman and Chang, 1971). The availability of pure, synthetic substance 
P allowed the development of many avenues of research. A radioimmuno-
assay was developed wnicn allowed minute quantities to oe measured from 
gross tissue extracts (Powell, Leeman, Tregear, Niall and Potts, 1973). 
The distribution of substance P in the central nervous system has been 
studied by measuring the amount of substance P contained in discrete 
nuclei isolated by microdissection (Brownstein, Mroz, Kiaer, Palkovits 
and Leeman, 1976; Nakata, Kusuka, Seqawa, Yajima and Kitgawa, 1978). 
Regions in the central nervous system which contain high concentrations 
(>1.5 p mole/10 mg wet weight) are the hypothalamus, preoptic area and 
mesencephalon. The spinal cord contains somewhat less substance P. 
However, there is about twice as much substance P in the dorsal horn as 
in the ventral horn of the spinal cord. Using substance P labeled with 
tritium, a binding site for substance P has been deno::1strated in mem-
brane fragments from rabbit brain. This binding site has a dissocia-
tion constant (Kd) o= 2.7 nM and the order of binding affinities of a 
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series of analogs correlates well with their biological potencies (Nakata 
et al., 1978). The distribution of the substance P binding site also 
--
correlates well with the distribution of substance P in the central ner-
vous system of rabbit (Nakata et al., 1978). 
Immunohistochemical studies also became possible with the avail-
ability of pure substance P (Hokfelt, Kellerth, Nilsson and Pernow, 
1975) . Substance P-like immunoreactivity was found in the neuronal cell 
bodies and processes. The distribution of immunohistochemically identi-
fied substance p correlates well with the distribution determined by the 
extraction procedures described above. Although iwmw~ohistochemistry 
cannot be used quantitatively, the cellular and subcellular localiza-
tion is important in determining the physiological role of this peptide. 
Substance P was generally found in small unmyelinated fibers, often asso-
ciated with afferent nerve pathways (Hokfelt et al., 1975; Otsuka, Koni-
shi and Takahashi, 1975; Takahashi and Otsuka, 1975; Hokfelt, Elde, 
Johansson, Luft, Nilsson and Arimura, 1976; Chan-Pala'l and Palay, 1977; 
Hokfelt, Ljungdahl, Terenius, Elde and Nilsson, 1977). Substance P-like 
immunoreactivity has also been found in nerve terminals and varicosities 
of peripheral ganglia, including sympathetic ganglia, (Hokfelt, Elfvin, 
Schultzberg, Goldstein and Nilsson, 1977) and in the myenteric plexus 
(Nilsson, Larsson, Hakanson, Brodin, Pernow and Sundler, 1975; Hokfelt, 
Johansson, Kellerth, Ljungdahl, Nilsson, Nygards and Pernow, 1977). 
Ligation studies of the dorsal roots indicate that substance P is 
transported towards the spinal cord in nerve axons and may be involved 
in primary afferent transmission (Otsuka, Konishi, Takahashi and Sato, 
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1976; Otsuka and Konishi, 1976; Chan-Palay and Palay, 1977). Lesion stud-
ies using immunohistochemistry and extraction procedtues suggest that sub-
stance P is also involved in at least three other neuronal path·,.;ays: two 
are the projections to the substantia nigra from the globus pallidus and 
corpus striatum, and a third is the pathway from the hab€nula to the inter-
peduncular nuclei (Brownstein, Mroz, Tappaz and Leeman, 1977; Jessell, 
1978; Jessell, Emson, Paxinos and Cuello, 1978). Another short projection 
within the amygdala has also been described (Emson, Jessell, Paxinos and 
CUello, 1978). 
The subcellular localization of substance P has been studied in 
two ways. Cell fractionation of rat brain has shm·m t~1at substance P is 
located primarily in the synaptosomal fraction (Cuello, Jessell, Kanazm'la 
and Iversen, 1977). Electron microscopic immunohistochemistry of sub-
stance P in the amygdala and substantia gelatinosa demonstrated dense 
core vesicles which contained substance P-like immunoreactivity (~uello 
et al., 1977; Pelletier, LeClerc and Dupont, 1977). 
Substance P has been shown to be released fron synaptosomal prepar-
ations (Schenker, Mroz and Leeman, 1976), slices of hypothalamus (Iversen, 
Jessell and Kanazawa, 1976), trigeminal nucleus (Jessell a~d Iversen, 1977) 
and substantia nigra of the rat (Jessell, 1978) and isolated spinal cord of 
the rat (Otsuka and Konishi, 1976). These experiments all used high potas-
sium containing solutions to evoke the release; the release 'l·:as calcimn-
dependent. In addition, Otsuka and Konishi (1976) a~d Jessell (1978) ob-
served release of substance P with electrical stimulation and veratridine, 
respectively, Release of substance P in these preparations therefore 
appears to be specifically from nerves. 30 
Little is known of the synthesis of substance P. Likewise, no 
mechanism of inactivation of substance P has been described. Substance 
p was not found to be actively accumulated in rat b~ain slices from 
which it was released (Iversen, Jessell and Kanazawa, 1976). Substance 
p has been shown to be stable in the postmortem brain (Kanaza ... ra and 
Jessell, 1976) and in whole blood or plasma (Bury and ~·!ashford, 1977). 
If substance P is to satisfy all criteria for a neu~otransmi tter, dif-
fusion away from the receptor site may play an important role for the 
inactivation process. 
1.2.1.2. Actions on Single Neurons. Since t:-te synthesis of 
substance P,studies of the action on single neurons have proceeded rela-
tively quickly. Prior to this time, the effects of substance P (obtained 
from an extract of cattle intestine) on single neurons were inconsistent 
(Galindo, Krnjevic and Schwartz, 1967). This may be attributed to impur-
ities contained in the extract. Recent work has found substance P to be 
a weak depolarizing or excitatory agent on cells in several locations 
(Table 3). With the exception of Otsuka and Konishi's work on isolated 
spinal cord, all studies have been done in vivo using iontophoretic 
application of substance P. The most striking aspect of the effects 
produced by substance P was the extended time course of its action com-
pared to other excitatory agents such as glutamate. The onset and off-
set of the excitatory effect of substance P often occurred over a period 
of several minutes. The effects were variable and tended to decrease 
with repeated applications (Krnjevic and Morris, 1974; Henry, Krnjevic 
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Table 3. The action of substance P studied in various areas of the cen-
tral nervous system. 
Area SEJecies Ion Perfusion References 
Spinal Cord 
Lamina IV and v cat, rat t Henry, Krnjevic and Morris 
1975. 
Motor neurons frog t Konishi and Otsuka, 1974a. 
rat t Konishi and Otsuka, l974b. 
cat t Krnjevic, 1977. 
Renshaw cell cat, rat t Henry et al. , 1975. 
cat t Davies a..'1d Dray, 1977. 
cat t Belcher a..'1d Ryall, 1977. 
cat t Krnjevic and Lekic, 1977. 
cat t Ryall and Belcher, 1977. 
Cuneate cat t Krnjevic a'1d !•!orris, 1974. 
Locus coeruleus rat t Guyenet and Aghaj ani an, 
1977. 
Interpeduncular 
nucleus : ra::. t Sastry, 1978ai 1978b. 
-
Amygdala and I 
I rat Putamen t Le Gal La Salle and Ben-Ari 
1977. 
Substantia Nigra rat t Davies and Dray, 1978. 
Cortex rat, cat 
""' 
Henry et al., 1975. I 
rat t Sastry, 1978b. 
abbreviations: Ion - iontophoretic application 
Perfusion - superfusion of a known concentration 
on to an isolated preparation 
t - indicates that the predominate of 
substance P was excitatory 
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and Morris, 1975; Davies and Dray, 1976; Le Gal La Salle and Ben-Ari, 
1977; Sastry, 1978). Interpretation of in vivo studies on substance P 
is difficult for five reasons. First, in only two studies was the re-
lease of substance P from the iontophoresis electrode measured (Krnjevic 
and Morris, 1974; Belcher and Ryall, 1978). Second, specific antagonists 
for substance P are not available. Third, the effects of general anes-
thetics decrease the response of some cells to substance P (Sastry, 
1978b). Fourth, none of these studies included the iontophoresis of 
analogs of substance P. Fifth, stilistance P in iontophoretic electrodes 
has been reported to break down over a period of days (Gozlan, Le Gal 
La Salle, Michelot and Ben-Ari, 1977), even though the amount measured 
by radioimmunoassay decreased only slightly over extended periods of 
time (Krnjevic and Harris, 1974). This implies that breakdown in the 
iontophoresis electrode results in fragments which may be biologically 
less active but which are still immunologically reactive. 
Some of the above difficulties are removed in in vitro experi-
ments. In the isolated frog spinal cord preparation, bath application 
of known amounts of substance P caused a marked depolarization associ-
ated with an increase in conductance of spinal motor neurons (Konishi 
and Otsuka, 1974~). This depolarization was determined to be a direct 
action on the spinal motor neurons since it was still present in solu-
tions which contained low calcium and high magnesiQ~ ion concentrations; 
such solutions blocked the reflex activity induced in the dorsal root 
and recorded in the ventral root. The specificity of the depolarization 
produced by substance P was tested using a series of analogs. The po-
tency of the analogs was markedly decreased if any change was made at 
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the amino terminus of the molecule. Also, if more than five amino acid 
residues were removed from the carboxy terminal the potency was decreased 
(Otsuka and Konishi, 1977). The relative order of potency of these ana-
logs on spinal motor neurons corresponds reasonably well with the gut-
contracting and hypotensive activity (Otsuka and Konishi, 1977), as well 
as with their binding affinities (Nakata et al., 1978). The use of a 
series of structurally related analogs is important to demonstrate pas-
sible receptor interactions, since there are as yet no known substance 
P antagonists. If the relative order of potency of a series of analogs 
is the same for a number of biological responses and binding studies, 
then a receptor mediated effect is supported. A major difficulty in the 
interpretation of Otsuka's work is that the effective concentrations of 
substance P were 100-1,000 times higher than those effective in contract-
ing smooth muscle or reducing blood pressure. Indeed, a similar point 
may be raised with all the experiments using iontophoretic application, 
since the concentration around the cell is not known. 
Baclofen (8-(4-chlorophenyl)o-aminobutyric acid) (Lioresal) was 
found to antagonize the depolarization of spinal motor neurons produced 
by substance P (Saito, Konishi and Otsuka, 1975). However, baclofen 
also decreased the glutamate depolarization. At other synapses, antago-
nism of the substance P response by baclofen appears to be at least par-
tially non-specific (cat spinal motor neurons - Krnjevic, 1977; rat in-
terpeduncular neurons - Sastry, l978a). Systemic administration of bac-
lofen results in a decrease in synaptic transmission to spinal motor 
neurons and the cuneate nucleus, but the site of action of systemically-
applied baclofen seems to be both pre- and postsynaptic (Krnjevic, 1977). 
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A second discrepancy between the wo:tk vf Otsuka a..11d that of 
Krnjevic is the proposed mechanisms underlying the depolarization pro-
duced by substance P. Krnjevic reported a decrease in conductance in 
cat spinal motor neurons; the reversal potential for this action of sub-
stance P was more negative than the resting potential. Otsuka, on the 
other hand, found an increase in conductance with a reversal potential 
near zero. Krnjevic's results must be interpreted with caution because 
of the possible activation by substance P of cells \vhich have excitatory 
or inhibitory synapses on to the spinal motor neuron. Substance P may 
depolarize an interneuron which releases an excitatory tra11smitter on to 
the spinal motor neuron. In this case, substance P ana the excitatory 
transmitter may both depolarize the spinal motor neuron, but do so through 
different ionic mechanisms. 
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1.2.2. Neurotensin 
1.2.2.1. General Background. Neurotensin was isolated from 
bovine hypothalamus; it is a tridecapeptide (Table 1) (Carraway and Lee-
man, 1973; 1975 ~,b). When administered intravenously to rats neuroten-
sin has numerous actions including hypotension, increased vascular per-
meability, hyperglycemia and hyperg1ucagonemia. In mice and rats, an 
intracisternal injection of neurotensin decreases cold tolerance, in-
duces· hypothermia, and enhances the depressant effect of phenobarbital 
(Nemeroff, Bissette, Prange, Loosen, Barlow and Lipton, 1977). These 
actions are not seen \·lith systemic administration, which probably indi-
cates either an inability of this peptide to cross the blood brain bar-
rier or a relatively fast metabolism in the blood. 
The distribution of neurotensin in the central nervous system 
has been studied using radioimmunoassay and immunohistochemical methods 
(Uh1 and Snyder, 1976; Kobayashi, Brown and Vale, 1977; uTil, Kuhar and 
Snyder, 1977). Using immunohistochemistry, neuronal cell bodies and 
processes containing neurotensin were found in high density in the sub-
stantia gelatinosa, trigeminal nucleus, amygdala, anterior pituitary and 
hypothalamic nuclei. Subcellular fractionation studies indicated that 
the majority of the neurotensin was associated with a synaptosomal frac-
tion (Uhl and Snyder, 1976). Release of neurotensin from slices of hypo-
thalamus has been demonstrated; the release was evoked by a high potas-
sium solution and required the presence of extracellular calcium ions 
(Iversen, Ivsrs.=:n, Bloom, Douglas, Brown and Vale, 1978). 
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Il25_labeled neurotensin binds to membrane frag;c.ents from brain 
homogenates with a high affinity (Kd= 3-8 nM) and the density of binding 
sites is highest in regions containing large amounts of neurotensin 
(Lazarus, Bro>m and Perrin, 1977; Uhl, Bennett and Snyder, 1977). The 
binding affinity of a series of neurotensin analogs also correlates well 
with their rank order of potency tested on the hyperglycenic and hyper-
glucagonemic responses in rats (Uhl et al., 1977). The neurotensin bind-
ing sites may be taken to indicate that neurotensin acts on a specific 
receptor. 
The mechanisms by which neurotensin is synthesized, degraded, or 
removed from the extracellular space have not yet bee~ described. How-
ever, enzymic degradation of neurotensin was suggested by studies on ex-
tracts of brain and hypothalamus (Dupont and 1-!erand, 1978). 
1.2.2.2. Actions on Single Neurons. Some preliminary studies 
of the action of neurotensin on neurons in the cent?~al nervous system 
have been made. Neurons in several areaswhich have a relatively high density 
of binding sites and high levels of neurotensin were studied. These in-
elude frontal cortex, hippocampus, striatum and lateral thalamus (Ziegl-
gansberger, Siggins, Brown, Vale and Bloom, 1978) and laninas I-III of 
the spinal cord (Miletic and Randic, 1978). The predoninant effect pro-
duced by iontophoretic application in these areas 'das excitation which 
was slow in onset. This excitation long outlasted the period of appli-
cation. The locus coeruleus also contains neurotensin within cell bod-
ies and nerve terminals but iontophoresis of neurotensin on to these 
cells inhibits neuronal firing (Scott-Young, Uhl and ~uhar, 1978). The 
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results from this study differ also in the time course of the effects. 
The inhibition in firing rate and the return to control occurred rapidly 
after the onset and offset of iontophoretic current. 
Neurotensin causes a contraction of the guinea pig ileum which 
is blocked by tetrodotoxin, implying an excitatory action on myenteric 
neurons (Kitabgi and Freychet, 1978). A relaxation of other smooth 
muscle preparations has been found which was not affected by tetrodo-
toxin (Andersson, Rosell, Hjelmquist, Chang and Folkers, 1977). 
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1.2.3. Vasoactive Intestinal Polypeptide 
1.2.3.1. General Background. A second polypeptide first iso-
lated from the gut which has properties similar to those of substance P 
is vasoactive intestinal polypeptide (VIP) (Said and Mutt, 1970a). Ori-
ginally, the actions of VIP were thought to be confined to the gut since 
a single pass through the liver almost completely inactivates this pep-
tide (Said and Mutt, 1970£) . This 28-amino acid residue peptide (Table 
1) causes systemic vasodilation, hypotension, hyperglycemia, stimulates 
cardiac output and excites respiratory chemoreceptors (Mutt and Said, 
1974a). Recently, using radioimmunoassay and immunohistochemistry, VIP 
has been localized in neurons of peripheral ganglia and central nervous 
system (Larsson, Fahrenkrug, Schaffalitzky De Muckadell, Sundler, Hank-
anson and Rehfeld, 1976). A dense population of VIP-containing neurons 
was found in the gut (Larsson eta~., 1976; Larsson, 1977~,£; Fux, Hok-
felt, Said and Mutt, 1977) and in the mesenteric ganglia complex (Hok-
felt, Elfvin, Schulzberg, Fux, Said, Mutt and Goldstein, 1977). In the 
central nervous system, VIP-containing terminals were found in some 
hypothalamic nuclei, in parts of the amygdala and in the cortex (Fux et 
al., 1977). VIP has been shown to occur within neuronal granules of 120 
nm diameter by immunohistochemistry (Larsson, 1977~) and in the synapto-
somal fraction by subcellular fractionation studies (Gaichetti, Said, 
Reynolds and Koniges, 1977). Potassium-evoked release of VIP from a 
synaptosomal preparation by a calcium-dependent mechanism adds further 
evidence to support a neurotransmitter role for this peptide (Gaichetti 
et al., 1977). 
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1.2.3.2. Action on Single Neurons. Little work has been done 
on the actions of VIP on single neurons. Iontophoretic application of 
VIP on to cortical neurons results in an increase in firing rate (Phillis, 
Kirkpatrick and Said, 1978). VIP depolarizes the dorsal and ventral 
roots of toad spinal cord; however, very high concentrations of VIP 
(3-6 X 1o-6M) are required (Phillis et al., 1978). The high concentra-
tion used in this preparation contrasts with the lower doses required 
for other effects; for example, a dose of only 40 ng/kg increased femo-
ral arterial blood flow by 50% (Said and Mutt, 1970a) . 
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1.2.4. Somatostatin 
1.2.4.1. General Background. The hypothalamic peptide somato-
statin was first isolated, purified and synthesized in 1973 (Brazeau, 
Vale, Burgus, Ling, Butsher, Rivier and Guillemin, 1973). This cyclic 
tetradecapeptide has been shown to inhibit the release of growth hormone 
in both cultured pituitary cells and pentobarbital-treated rats (Brazeau 
et al., 1973). An inhibition of the release of other hormones by soma-
tosta.tin has also been reported (TSH - Siler, Yen, Vale and Guillemin, 
1974; insulin - Curry and Bennett, 1974; Curry and Bennett, 1976; gluca-
gon- Fujimoto and Esinck, 1976). More recently, somatostatin has been 
found by immunohistochemistry and radioimmunoassay at several sites in 
the central nervous system which are probably unrelated to hormone regu-
lation (Hokfelt, Efendic, Hellerstrom, Johansson, Luft and Arimura, 1975; 
Hokfelt, Elfvin, Elde, Schultzberg, Goldstein and Luft, 1977; Kobayashi, 
Brown and Vale, 1977). Extrahypothalamic areas which have high concen-
trations of somatostatin include the amygdala, nucleus accumbens, medulla, 
substantia gelatinosa, thalamus and hippocampus. Nerve terminals which 
contain somatostatin have been observed immunohistochemically in peri-
pheral ganglia including the myenteric plexus (Hokfelt et al., 1975; 
1976; Costa, Patel, Furness and Arimura, 1977). Immunocytochemical tech-
niques have localized this peptide to neuronal fibers and varicosities 
(Petrusz, Sar, Grossman and Kizer, 1977) and subcellular fractionation 
has indicated that it is concentrated in the synaptosomal fraction 
(Epelbaum, Brazeau, Tsang, Brawer and Martin, 1977). Release of somato-
statin from slices of hypothalamus and amygdala using high potassium 
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solutions by a calcium-dependent mechanism may imply tl"lat, in addition 
to its neuroendocrine function, somatostatin may act as a neurotrans-
mitter (Iversen, Iversen, Bloom, Douglas, Brown and '/ale, 1978). 
There is some evidence, from binding studies aDd behavioral ex-
periments, that the actions of somatostatin may be mediated by opiate 
receptors (Rezek, Havicek, Lebin, LaBella and Freisen, 1977; Pugsley 
and Lippmann, 1978). This evidence is weak because 1,000 times more 
somatostatin than opiates was needed to displace naloxone from its bind-
ing site. In fact, somatostatin binding compared Hith that of dextror-
phan (Pugsley and Lippmann, 1978). Large amounts of so~atostatin admin-
istered intracerebroventricularly resulted in slight a~tinociception 
which was only partially reversed by naloxone (Rezek et al., 1977). 
Somatostatin inhibited the contractile response of the longitudinal mus-
cle-myenteric plexus preparation to nerve stimulation; however, this 
effect of somatostatin was not reversed by the opiate antagonist, nalox-
one (Guillemin, 1976). 
In the frog isolated spinal cord, the action of somatostatin on 
the membrane potential of the ventral and dorsal roots has been studied 
using the sucrose gap technique (Padjen, 1977). Somatostatin hyperpolar-
ized the dorsal roots and this persisted in solutions ,,;here synaptic 
transmission was blocked using a calcium-free solution, and v1here propa-
gated activity was blocked by a local anesthetic. In this study, the 
endocrinologically inactive retro-somatostatin did not produce a hyper-
polarization. The hyperpolarization produced by somatostatin therefore 
appears to be a direct action on the dorsal roots; ho· ... ·ever, the concen-
tration required \vas l, 000 fold greater than that required to produce 
endocrine effects. 
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1.2.4.2. Actions on Single Neurons. Iontophoretic application 
of somatostatin inhibits neuronal firing in the cortex, hy~othalamus and 
cerebellum (Renaud, Martin and Brazeau, 1975) and in l&uina I-III of the 
spinal cord {Niletic, Kavacs and Randic, 1977). On the other hand, in 
slices of rat hippocampus, iontophoresis or pressure injection of soma-
tostatin resulted in depolarization and increased excitability of CAl 
and CA2 cells (Dodd and Kelly, 1978). 
There are no specific antagonists of somatostatin; somatostatin 
analogs have not been studied and there is no method b:/ which to corre-
late the concentrations which produce the endocrine effects with the 
amount of somatostatin which is applied iontophoretically. Moreover, the 
differences in responses to somatostatin seen among cells of the hippo-
campus and those elsewhere in the central nervous system \'lere much like 
those seen with morphine and enkephalin (see section 1.1.4.). The exci-
tation of pyramidal cells of the hippocampus by the opiates and opioid 
peptides has been shown to be a trans-synaptic action (Zieglgansberger 
et al., 1978). The opiates are thought to excite pyr~~idal cells by in-
hibiting an in'b.ibitory interneuron. The same type of disinhibition could 
explain the depolarization seen with iontophoretic application of somato-
statin in the hippocampus. 
l. 3 . THE MYENTERIC PLEXUS 
l. 3 . l. Anatomy 
The myenteric plexus is a complicated netv;ork of neurons which 
may be involved in the transmission of afferent and efferent impulses to 
and from the central nervous system as well as being involved in local 
reflex mechanisms (Schofield, 1968). In the guinea pig ileum, the plex-
us is a network of neurons arranged in ganglia which are laid out in a 
relatively structured manner. The ganglia of the plexus are situated in 
a roughly rectangular arrangement with interconnecting strands contain-
ing nerve processes running between the ganglia. The ganglia range from 
50-100 ym in width, are up to l ~~ in length and are l-3 cells thick. 
The entire ganglion is surrounded by a basal lamina which isolated the 
neurons from connective tissue and blood vessels (Gabella, 1972). Each 
ganglion contains from 20-200 nerve cells and about 2-3 times as many 
glial cells (Gabella, 1972). The extracellular space within the ganglia 
is limited by a dense neuropil of nervous and glial origin. 
The size of the ganglion cells vary from less than 10 ym to 35 
~in diameter (Gabella, 1972; Cook and Burnstock, 1976). Unlike sympa-
thetic and spinal ganglia, there are few nerve cell bodies which are sur-
rounded by satellite cells (Gabella, 1972; Cook and Burnstock, 1976). 
Using the electron microscope, up to nine types of ganglion cells were 
distinguished by their size, type of endoplasmic reticulu.ll, appearance 
and distribution of other cellular organelles and the relationship the 
neurons had with satellite cells and neuropil (Cook and Burnstock, 1976). 
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Extraganglionic neurons were present in the interconnecting strands be-
tween the ganglia. These cells were seen only occasionally, were unlike 
other nerve cell types seen in the ganglia and exhibited very few typical 
synaptic specializations (Cook and Burnstock, 1976). 
Several types of axons have also been described using the elec-
tron microscope (Gabella, 1972; Cook and Burnstock, 1976). Different 
types of axons were distinguished by the type of vesicles found near 
synaptic membrane specializations and included: small granular vesicles 
(40-60 nm), round agranular vesicles (40-60 nm), flattened agranular ves-
icles (20-40 nm), elongate structures (up to 350 nm long and 18-30 nm in 
diameter) and three types of large vesicles with granular cores (Gabella, 
1972; Cook and Burnstock, 1976). It was assumed that the small granula-
ted vesicles in nerve terminals contained noradrenaline, and the agranu-
lar vesicles which Here most frequently seen contained acetylcholine 
(Gabella, 1972). The presence of cholinergic and noradrenergic terminals 
in the myenteric plexus is well accepted. Electrophysiological evidence 
strongly supports the neurotransmitter role of acetylcholine and nora-
drenaline (see section 1.3.2.2.). 
The significance of the remaining types of axon profiles based on 
the type of vesicles found in the varicosities remains to be determined. 
Several endogenous agents have been proposed to function as neurotrans-
mitters in the myenteric plexus on the basis of their histochemical and 
cytochemical locations. The presence of nerve terminals and cell bodies 
in the myenteric plexus which can take up m1d synthesize 5-hydroxytrypta-
mine (5-HT) suggests that 5-HT may be another transmitter in the myenteric 
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plexus (Dreyfus, Bornstein and Gershon, 1977; Dreyfus, Sher~an and Ger-
s.hon, 1977). Electrophysiological evidence on the action and role of 
5-HT in the myenteric plexus is inconclusive (see sections 1.3.2.1. and 
1.3.2.2.). The myenteric plexus is also thought to have neurons which 
contain and release purine nucleotides (Burnstock, 1972). Hare recently, 
immunohistochemical studies have demonstrated the presence of the follow-
ing neuropeptides within nerve terminals of the myenteric plexus: enke-
phalin (leu and met), substance P, somatostatin and VIP (see appropriate 
sections for references). The location of the cell bodies of origin is 
not known with certainty. VIP-like and somatostatin-like irronunoreactiv-
ity have been observed in cell soma within the myenteric plexus such that 
at least a part of the VIP and somatostatin is intrL~sic to the gut. An 
extrinsic source of enkephalin, substance P and sonatostatin has been 
proposed, but experiments using agents to block axonal transport (colchi~ 
cine) to increase the content of immunoreactive substru>ces in the cell 
bodies have not been performed. 
The distribution of the neuropeptides within the gastrointestinal 
tract has not been studied, with the exception of enkephalin. A higher 
content of met- and leu-enkephalin was found in the duodenum than in 
other parts of the gastrointestinal tract (Hughes et al., 1977). The 
significance of this observation remains to be detemined. However, it 
is possible that regional variations in the content of one or more of 
the neuropeptides may account in part for some functional differences 
along the gastrointestinal tract. 
Histologically, the occurrence of a dense neuropil, the isolation 
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from blood vessels and connective tissu8, and the absence of extracellu-
lar space make the cells of the myenteric plexus more like those of the 
central nervous system than other autonomic ganglia (Gabella, 1972). 
Functionally, the myenteric plexus also appears to be somwhat different 
from other autonomic ganglia. The arrangement of neurons within the 
plexus confers preferential pathways of conduction in the aboral direc-
tion (Bayliss and Starling, 1899; Kosterlitz and ~ydon, 1971; Hirst and 
McKirdy, 1975; Yokoyama, Ozaki and Kajitsuka, 1977). The plexus also 
contains a neuronal type which is functionally distinct from those in 
autonomic ganglia (see below). 
1.3.2. Electrophysiology 
The development of techniques to study single myenteric neurons 
has been made by several groups. The early work utilized extracellular 
electrodes made of metal or glass (Yokoyama, 1966; Wood, 1970). More 
recently, intracellular recordings have been performed (Nishi and North, 
1973~; Hirst, Holman and Spence, 1974). There are marked differences in 
the results obtained by these two techniques. The most notable differ-
ence ~s that few spontaneously active cells were found with intracellu-
lar techniques, whereas ongoing spike activity was recorded using extra-
cellular electrodes. A description of the methods and results obtained 
with extracellular and intracellular electrodes is necessary before an 
understanding of these differences is possible. 
1.3.2.1. Extracellular Recording. The first recordings from 
single myenteric neurons were made by Yokoyama (1966) using extracellu-
lar electrodes. Subsequently, Wood (1970) and Ohkawa and Prosser (1972) 
described a series of different types of neuronal units in terms of 
their discharge patterns. The experimental methods used by ~vood, and 
Ohkawa and Prosser were similar. Both used the isolated jejunum from 
cat and metal or metal-filled electrodes having tip diameters of 1-25 ~­
The myenteric ganglia were stained with methylene blue for visualiza-
tion. They described similar types of activity. There were three types 
of neuronal discharge patterns: (1) mechanosensitive; (2) single spike; 
(3) burst. Mechanosensitive neurons were stimulated by distortion of 
the ganglion produced by a glass probe or an electrode having a large 
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tip diameter. Single spike neurons fired at lov; frec;:uencies (0 .1-2 Hz) 
with no consistent firing pattern. Burst type neuro~s periodically dis-
charged a flurry of action potentials followed by periods of silence. 
Attempts to record activity which was evoked by electrical stimulation 
were not successful (Ohkawa and Prosser, 1972~,£). The same types of 
discharge patterns were found in the guinea pig ileun using a similar 
experimental design (Wood, 1973). 
When a glass suction electrode (30-100 ~) was used to record 
activity, only the single spike and burst units were found (Sate, Taka-
yanagi and Takagi, 1973). This type of electrode enabled evoked acti-
vity to be recorded (Dingledine and Goldstein, 1976; Yokoyama, Ozaki 
and Kajitsuka, 1977). There was also a large difference in the ratio of 
burst units to single spike units encountered when using the different 
types of electrodes. vlith metal electrodes, burst U..Dits were found five 
times more frequently than single spike units (l·lood, 1970); with glass 
suction electrodes, burst units were found only occasionally (Sate et 
al., 1973; Dingledine and Goldstein, 1976). 
Dingledine, Goldstein and Kendig (1974) were the first workers 
to ensure that the unit firing was not secondary to local muscle move-
ment. They isolated 1-3 ganglia using small pins. All previous studies 
had used methylene blue to visualize the ganglia whereas Dingledine et 
al. (1974) transilluminated the ganglia and eliminated the need for 
staining. Methylene blue has been shown to block synaptic transmission 
in sympathetic ganglia at the concentrations used for staining and, at 
somewhat higher concentrations, it causes irreversible changes in the 
49 
firing patterns in the cat myenteric plexus (Nozdrachev, Gnetov, Kacha-
lov and Fedorova, 1977). It is likely that methylene blue, at the con-
centrations used for extracellular recording in the myenteric plexus, 
raay have changed the sensitivity of the neurons to some agents. 
Neuronal spikes have been reported to be 3-5 ms in duration. 
The waveform was usually biphasic and sometimes triphasic (Wood, 1975). 
Biphasic spikes were considered to originate at or near the soma and tri-
phasic spikes to be from a propagated potential coming toward, passing 
under. and moving away from the electrode. However, extracellular poten-
tials recorded with point microelectrodes may vary considerably in wave-
form. One important consideration is the time constant of the recording 
system. As the coupling time constant decreases, the waveform tends to 
change to a differentiated type of waveform (DeValois and Pease, 1973). 
It is common to use amplifiers capable of increasing or decreasing the 
coupling time constant in order to attenuate extraneous slow potentials 
and line noise which would interfere with spike discrimination. Evalu-
ation of extracellular potential waveform under these conditions is dif-
ficult. The waveform of extracellular spikes may also vary with the 
position of the electrode. As an extracellular electrode is advanced 
towards a cell in the central nervous system, it is common for the wave-
form to change (Towe, 1973). Simultaneous recording of intracellular 
and extracellular spikes has shown marked differences in extracellular 
waveform when recording from axons, initial segment and soma-dendritic 
spikes in a given cell (Svaetichin, 1958). Similar considerations must 
be given to the proximity of the cell being recorded to the electrode in 
the myenteric plexus. The precise site of recording in the myenteric 
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plexus has not previously been described. No mentio~ has been made of 
spontaneous activity recorded in the interconnecting stra~ds between 
ganglia, although evoked activity from electrical stimulation has been 
demonstrated (Dingledine and Goldstein, 1976; Yokoy&~a et al., 1977). 
The sensitivity of the three types of units to various trans-
mitters and to drugs is different. Mechanoreceptive and burst type 
units were relatively insensitive to most drugs, whereas single spike 
units exhibited marked sensitivity to many agents. All neuronal acti-
vity was abolished by tetrodotoxin or local anesthetics, but not by 
manganese (Sato et al., 1973; Sato, Takayanagi and Takagi, 1974). Sin-
gle spike units were excited by 5-hydroxytryptamine (5-HT), sodi~~ pi-
crate, caerulein, acetylcholine, nicotine and pentagas~rin. These exci-
tations were blocked by morphine as well as by the relev~t, more speci-
fic antagonist (Sato et al., 1973). The firing rate of single spike 
units was decreased by a-adrenergic agonists and morphine. A detailed 
study on the action of morphine on single unit firing in the myenteric 
plexus was reported by Dingledine and Goldstein (1975, 1976) (see sec-
tion 1. 3. 3 • ) • 
1.3.2.2. Intracellular Recording Studies. Intracellular re-
cording from myenteric neurons has been accomplished by two groups (Nishi 
and North, 1973~; Hirst et al., 1974). Similar methods ;.;ere used by each 
group. Direct visualization of individual neurons was necessary to allaH 
careful placement of the electrode because the myenteric neurons were 
highly sensitive to mechanical damage. The use of high resist~ce (> 
60 Mm electrodes was also required for stable recordings. The use of 
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electrodes of lower resistance led to slow depolarization of the cells 
which was attributed to severe mechanical damage. 
The results obtained by Nishi and North (l973a) and Hirst et al., 
(1974) were essentially the same. Two types of myenteric neurons were 
distinguished with intracellular recordings. The first type (Type I, 
Nishi and North, 1973~; S cell, Hirst, et al., 1974) gave multiple spikes 
with a depolarizing current, received synaptic input which was blocked by 
nicotinic antagonists and had properties similar to other peripheral 
gangl;i.on cells. The second type (Type II, Nishi and North, 1973~; AH 
cell, Hirst et al., 1974) was less excitable, received no synaptic input 
and had a slow after-hyperpolarization follmving the action potential 
evoked by direct or antidromic stimulation. A third type of cell was 
also impaled which was inexcitable, had a high resting membrane poten-
tial and a low input impedance. This type of cell was considered to be 
a glial cell. Occasional spontaneous neuronal activity was observed; 
however, spontaneously active cells were probably damaged by the isola-
tion of the ganglia. No evidence of any pacemaker activity was described 
in any neurons of the myenteric plexus. 
The sensitivity of the bvo types of neurons to pharmacological 
stimuli (acetylcholine, 5-HT, morphine) appear to be quite different. 
Iontophoretic application of acetylcholine to type I cells produce a 
rapid depolarization \•7hich was blocked by nicotinic antagonists (North 
and Nishi, 1973~). Application of acetylcholine to type II cells pro-
duced either no effect or a slow depolarization whic:C, Has blocked by 
muscarinic antagonists (North, unpublished results). 
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TI1e results obtained when studying the actio~ of 5-HT and nora-
drenaline with intracellular electrodes are different th~~ when studied 
using extracellular electrodes. Noradrenaline L~hibited firing of my-
enteric neurons recorded extracellularly (Sato et al., 1973). The pre-
dominant action of 5-HT on the firing rate of myenteric neurons recorded 
with extracellular electrodes \'las an increase in firing rate (Dingledine 
and Goldstein, 1975). 5-hydroxytryptamine produced variable results on 
the membrane properties of type I cells, but had a prominent action re-
ducing the size of the e.p.s.p. This is due to a presynaptic effect, 
decreasing acetylcholine release (North and Henderson, 1975). Similar 
presynaptic effects of noradrenaline have been found (Nishi and North, 
1973b) . Stimulation of sympathetic nerves to the gut also decreases ace-
tylcholine release without altering membrane properties of the myenteric 
neurons (Hirst and I·lcKirdy, 1974). The predominant effect that 5-HT has 
on the type II cell is a slow hyperpolarization with a fall in input re-
sistance (North and Henderson, 1975}. 
One of the primary differences between results obtained with 
intracellular and extracellular recording tec~niques in the guinea pig 
myenteric plexus was the lack of spontaneous activity recorded using in-
tracellular electrodes, whereas spontaneous neuronal firing was recorded 
with extracellular electrodes. The high sensitivity of myenteric neurons 
to mechanical damage seems inconsistent with the use of very large sue-
tion electrodes for extracellular recordings. h1ere are similarities, 
however, for the single spike unit and the burst units in some ways cor-
respond to the intracellular type I and type II cells, respectively. 
First, the type I cell is more excitable and, if it corresponds to a 
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single spike unit, this may account for the high frequency of single 
spike units encountered with a suction electrode. Second, the type I 
cell is sensitive to acetylcholine through a nicotinic receptor and 
single spike units are also excited by nicotine. Third, type II cells 
were insensitive to many pharmacological stimulants as ;·;ere the burst 
units encountered with extracellular electrodes (Sato et al., 1974; 
Dingledine and Goldstein, 1976; Nishi and North, 1973~; North, 1973). 
1.3.3. Actions of Opiates, Opioids and Neuropeptides 
in the Guinea Pig Hyenteric Plexus 
l. 3. 3 .l. Using the Longitudinal Huscle-I-!yenteric Plexus Prepar-
ation. Electrical stimulation of the nerves in the longitudinal muscle-
myenteric plexus preparation induces release of acet:?lcholine ;...;hich acts 
on the longitudinal muscle to cause a contraction. Tne nerve-mediated 
contraction of the longitudinal muscle is depressed by narcotic analge-
sics ·due to their inhibition of release of acetylcholine from the myen-
teric plexus neurons (Schaumann, 1957; Paton, 1957). Tnis decrease in 
acetylcholine output produced by narcotics is blocked by narcotic anta-
gonis·ts in a competitive manner (Kosterlitz and 1\'att, 1968). The rank 
order of potency of a series of narcotic agonists in depressing L~e 
nerve-mediated contraction of the guinea pig ileum correlates well with 
the analgesic potency of these agonists in man (Kosterlitz and Water-
field, 1975). There is also a good correlation between the affinity of 
opiate binding sites in the myenteric plexus and in the rat brain to a 
series of agonists and antagonists (Creese and Snyder, 1975). The de-
pression of acetylcholine output and the binding of narcotics to opiate 
receptors in the myenteric plexus are stereospecific as are the analge-
sic effects of these compounds (Kosterlitz and Haterfield, 1975). Fin-
ally, as with the central effects of opiates, cross-tolerance develops 
between different narcotic agonists (Goldstein and Schultz, 1973) and 
enkephalin, in the myenteric plexus (Waterfield, Hug~es and Kosterlitz, 
1976). The neurons of the myenteric plexus therefore appear to have 
opiate receptors which are much like those in the central nervous system 
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which mediate analgesia. 
Tne nerve-mediated contraction of the longitudinal muscle is also 
depressed by somatostatin and this is not through an interaction with an 
opiate receptor (see section 1.2.4.). The action of substance P on the 
nerve-mediated contractile response of the longitudinal muscle is dif-
ficult to assess because substance P contracts the longitudinal muscle 
by a direct action of the smooth muscle. Neurotensin, on the other hand, 
causes a contraction of the longitudinal muscle which is blocked by 
tetrodotoxin, suggesting an excitatory effect on myenteric neurons. 
Since many of the neuropeptides are present in the myenteric plexus and 
have been found indirectly to change the excitability of myenteric neu-
rons, this preparation may be useful to study the action of the neuro-
peptides at a single neuron level. 
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1.~.3.2. Using Extracellular Recording. There have been several 
electrophysiological studies on the actions of opiates on neurons con-
tained in the myenteric plexus. The first demonstration of an effect of 
morphine on single myenteric neurons was made by Sato and colleagues 
(Sato et al., 1973). In this study, only one concentration was used and 
this was very high (10 ~\:1) compared to the concentration \vhich is effec-
tive in inhibiting the contractile response of the longitudinal muscle 
(ED50~100 nM). Subsequently, studies by Dingledine and Goldstein demon-
strated that the inhibition of unit firing produced by morphine was dose-· 
dependent in the same concentration range as that \vhich is effective in 
inhibiting the release of acetylcholine (Dingledine, Goldstein and Ken-
dig, 1974; Dingledine and Goldstein, 1975; 1976). The inhibition of 
firing was stereospecific; that is, dextrorphan was without effect (in 
the concentrations tested), whereas the active isomer, levorphanol, was 
effective. Naloxone reversed or prevented the action of opiate agonists. 
Morphine also blocked the effects of a number of excitatory agents such 
as 5-HT, sodium picrate, caerulein, pentagastrin and acetylcholine (Sato, 
Takayanagi and Takagi, 1974), which suggests that it is acting directly 
on the neuron whose activity is being recorded. In fact, strong evidence 
for such a direct action on the neuron under study was provided by the 
experiments of Dingledine and Goldstein (1976) in which morphine was 
shown to be equally effective when synaptic transmission had been com-
pletely blocked by omission of calcium ions from the bathing solution. 
These studies asstL.lled that the neuronal spikes which '.·Jere being recorded 
were made from the cell soma; however, there \vas no clear evidence for 
this assumption. The effects of pentagastrin and caerulein on myenteric 
neurons has previously been studied. Both these peptides caused an in-
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crease in neuronal firing (Sato et al., 1973). Neither of these peptides 
was studied in detail and there are no other studies on the action of 
various peptides on single neurons in the myenteric plexus. 
1.3.3.3. Using Intracellular Recording. Using intracellular 
recordings from myenteric neurons, it has been found that morphine pro-
duced a hyperpolarization of the cell soma which \·las sometimes associated 
with an increase in conductance (North, 1976; North and Tonini, 1977). 
This hyperpolarization was stereospecific and blocked by naloxone. How-
ever,. the ionic mechanism involved has not been determined. Both type I 
and type II cells appear to be sensitive to morphine; however, the pro-
portion of type I cells which were affected was r:mch greater than that 
of type II cells. l'li th type II cells, it was com.llon for the effect of 
morphine to become smaller during the application or ',.;i th repeated ex-
posures, whereas type I cells more often gave reproducible responses 
(North and Tonini, 1977). The population of cells in 'tlhich a hyperpolar-
ization was found was much smaller than the proportion of cells \vhich 
were found to be sensitive with extracellular recordings. 
Studies using intracellular recording to test the action of opi-
oid peptides and other neuropeptides have not yet been done. 
1.6. SPECIFIC AIMS 
The first aim of the present study was to define the origin and 
nature of the neuronal activity recorded with extracellular electrodes 
in order to explain better the differences between results obtained with 
extracellular and intracellular techniques in the myenteric plexus. This 
part of the study included: (a) a study of spike waveforms of spontan-
eous and evoked activity; (b) determination of the locations from which 
spontaneous activity can be recorded (on the ganglia, on the strands of 
nerve processes which connect the ganglia and on the smooth nuscle); (c) 
the study of the sensitivity of spontaneous and evoked activity to tetro-
dotoxin and local anesthetics; (d) a general survey a= t~e types of 
firing patterns; (e) an investigation of the changes i~ firing induced 
by solutions of varying ionic composition. 
The second aim of this study was to investigate t:-te action of 
opiates on single myenteric neurons. This included: (a) testing the 
sensitivity to opiates of units displaying different types of discharge 
patterns; (b) confirming that the inhibition of firing is mediated via 
opiate receptors by antagonizing the effect of opiates \•li th naloxone; 
(c) examining the action of morphine in solutions with high ~~d low po-
tassium ion concentration and low chloride ion concentration to deter-
mine the ionic mechanism of action. 
The third aim of the present work was to study t~e action of 
several endogenous neuropeptides including leu- and net-e~ke:;:;halin, s-
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endorphin, somatostatin, substance P, neurotensin a~~ VIP on the firing 
rate of myenteric neurons. These peptides, \-lith t::,e exception of neuro-
tens in, have all been shown to be contained \·li thin neurons of the plexus. 
The effect that each of these peptides has on the firing rate of myen-
teric neurons, the time course of effects and the concentration range in 
which they are effective were studied. In addition, \·lhere applicable, 
antagonists of each peptide \.;ere studied to determine the specificity of 
the action of the peptide. For peptides for which there are no avail-
able specific antagonists, the effect of several peptides or peptide an-
alogs·were studied on a single unit in order to dete~ne the specificity 
of the effect. Finally, the action of each peptide '.vas studied in a 
solution which contained no calcium ions in order to eliminate possible 
trans-synaptic influences. The purpose of these experiments is to help 
substantiate or refute the hypothesis that the presence of the neuropep-
tides in the myenteric plexus may indicate that they act as neurotrans-
mitters or neuromodulators at this site. 
2. METHODS 
2.1. PREPARATION OF TISSue 
Hale guinea pigs (300-500 g) were stunned and bled from the neck. 
A portion of ileum 10-15 em long excluding the section 5 em in the oral 
direction from the ileocecal junction was removed and the luminal con-
tents were gently washed out with Krebs solution. The ileum was then 
placed in Krebs solution at room temperature. The longitudinal muscle 
myenteric plexus preparation was prepared as originally described by 
Ambache (1954) and modified for electrophysiological recording by Nishi 
and North (1973a) . A short piece of ileum (1-2 en) was slipped on to a 
glass rod such that the longitudinal muscle myenteric plexus preparation 
could be separated from the ileum. Small pieces of cotton soaked with 
Krebs solution were used to gently stroke the ileQ~ in order to tease the 
longitudinal muscle away from the circular muscle. The longitudinal mus-
cle with the myenteric plexus adherent was first separated from the cir-
cular muscle along each side of the mesenteric border and then peeled 
around to the anti-mesenteric side of the ileum. The longitudinal muscle 
myenteric plexus preparation was then removed from the anti-mesenteric 
side of the ileum and placed in a shallow tissue bath. The longitudinal 
muscle was pinned out as a flat sheet with the myenteric ganglia upper-
most. Ganglia were visualized with a dissecting microscope (10-60 x) 
using transmitted light. Ganglia were considered suitable for electro-
physiological experiments if they were free of large amounts of circular 
muscle and if they contained few or no large cells which stood out clearly 
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within the ganglion. Attempts to record from ganglia ·.-ihich did not meet 
the above requirements were usually futile. The area surrounding 10-15 
suitable ganglia was immobilized with several pins (tQ~gsten wire 25 ~ 
in diameter cut into l mm lengths) and the remaining portion.of the tis-
sue was cut and removed from the bath. When agents which had a direct 
excitatory effect on the smooth muscle were to be used, single ganglia 
were surrounded by several pins and thus rendered immobile. 
The tissue bath used was similar to that described by Nishi and 
North-(1973a). A rectangular hole the size of a coverslip (24 X 40 mm) 
was cut from a piece of plexiglass (40 X 80 X 1 mm) . A coverslip was 
then glued to the bottom of the bath and the trough was filled with Syl-
gard 184 Encapsulating resin (Dow Corning) . This clear resin can be 
transilluminated and is soft enough to allow the use of fine pins to fix 
the preparation. The Sylgard was then surrounded by a layer of caulk 
(2 mm high) . The caulk enclosed the bath and enabled the indifferent 
electrodes and perfusion tubes to be fixed to the bath. The bath volume 
was always less than 1 ml. 
2. 2. EXTRACELLULAR RECORDING 
A glass suction electrode having a tip diameter of 30-90 ~ was 
used for extracellular recording. The suction electrode was prepared by 
breaking back a longer electrode having a small tip diameter, andviewing 
the broken tip microscopically. Only electrodes with tips >vhich were 
flat, smooth and of proper size were selected for recording. Attemptsto 
use smaller glass electrodes or tungsten electrodes (tip diameter 5-10 
~) for recording were not successful. The recording electrodes were 
filled with Krebs solution and had a resistance of 500-1,000 kJ. The 
electrode was tightly connected by a piece of tubing to a syringe (5 or 
10 ml) . The electrode was placed on the tissue and suction >·las applied 
by manually wi thdra>ving the syringe plunger. Tne amount of suction re-
quired for successful recording varied from cell to cell; usually it was 
sufficient to allow the electrode to be raised 5-10 l.tTl •.vi thout dislodging 
it from the tissue. When the electrode had been placed on the tissueand 
suction applied, the resistance of the electrode typically increased by 
200-500 k~. This sealing resistance presumably reduced the extracellular 
shunting of current through the Y~ebs solution and increased the size of 
the recorded signal. Attempts to record neuronal activity vli thout sue-
tion were not successful. A chlorided silver wire ,,.,as inserted into the 
recording electrode, reaching almost to its tip. This wire led directly 
to the input of a differential AC coupled preamplifier (DC R.. , 10 Wl) . 
l.n 
The indifferent electrode had a tip diameter of 70-150 ~· and its tip 
was placed in the bath close to the site of recording. A chlorided sil-
ver wire, at a distant part of the bath, was used to ground thepreparation. 
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Potentials were amplified (1,000 X) and dis?layed on an oscillo-
scope (Tetronix 502A). Spike waveform of spontaneous and evoked paten-
tials were studied from photographs of oscilloscope traces. The coupling 
time constant was l s in those experiments in which spike \'laveform was 
studied, but in other experiments the coupling tiine constant was decreased 
to 2 ms. With a time constant of 2 ms, the spike amplitude was attenuated 
and somewhat differentiated. However, this was necessary to obtain a suf-
ficiently stable base line to use a window discriminator (Nentor Spike 
Analyzer). The output of the window discriminator was recorded either on 
chart· paper or counted with a rate analyzer (Frederick-Haer). Histograms 
were constructed of the number of action potentials in a given time 
interval (usually 10 s and up to l min) either by ha.'1d from the chart 
record or directly from the output of the rate analyzer. 
In some experiments, a third glass electrode ,,,i th a t.ip diameter 
of 20-40 ~ was used for electrical stimulation. The stimuli used were 
pulses of 100-500 ~s duration. Single pulses or short trains of pulses 
at frequencies up to 10 Hz were used. The tip of this stimulating elec-
trode was placed so that it just made contact with the preparation, either 
on the ganglion surface or on the interconnecting strands. 
t 
2.3. PERFUSION OF THE TISSUE k~D APPLICATIO~ OF DRUGS 
Krebs solution continuously perfused the tissue at a rate of 
2-4 ml/min, maintained by a peristaltic pump. The conposition of the 
Krebs solution is given in Table 4. The solution vras warmed in a heat-
ing jacket before it entered the bath such that the bath temperaturewas 
maintained at 35-37°C. Drugs were added to the bath by changing the per-
fusing solution to one which differed only in the content of the drug. 
There· was a delay time of about l min between the time '.vhen the drug 
solution was changed and when the drug entered the bath. All figures 
are drawn such that the periodsof drug applications correspond to the 
times when solutions were changed, without subtracting the delay time. 
All glassware that came in contact with peptide solutions \·ras pretreated 
with a siliconizing compound called sigma-coat (Si~a) to limit the bind-
ing of the peptides to the surface of the glass. Solutions of different 
ion concentrations were always kept isosmotic by changing the concentra-
tion of NaCl in the Krebs. The content of ions in these solutions is 
given in Table 4. 
Drug and p.:!ptide solutions were prepared fresh daily from stock 
solutions. Stock solutions were kept frozen for later use. Peptides 
were checked for stability by comparing the response of a single cell to 
the same concentration of two peptide solutions. One solution was fresh-
ly prepared from solid and the other had been made from a stock solution 
which had been used for periods up to several weeks. All the peptide 
solutions appeared to be stable for periods up to several weeks if the 
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stock solution was kept cool or frozen. The peptides and drugs used in 
this study are listed in Table 5. 
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Table 4. The content of salts (mM) in the various Krebs solutions 
used. 
Krebs Solutions 
+ + ++ High ++ Salt Normal Low C1 High K Low K Ca Free Ca 
(10 mM) (12 mM) (1 mH) ( 0 rnH) 
Na isethionate 118 
NaCl 118 110.7 121.7 120.75 106.75 
KCl 4.7 4.7 12 1 4.7 4.7 
CaC12 2.5 2.5 2.5 2.5 0 10 
MgS04 
1.2 1.2 1.2 1.2 1.2 1.2 
NaH2Po4 1.2 1.2 1.2 1.2 1.2 1.2 
Glucose 11 11 11 11 11 11 
NaHC0 3 
25 25 25 25 25 25 
* EGTA 1.0 
* ethylene-bis-(oxyethylene nitrilo) tetraacetic acid 
Table 5. The peptides and drugs used in the present study ·.·rith the 
source(s) of each. 
Drug Source 
normorphine 
sulfamate or HCl 
mor hine sulnhate 
enkephalin, base 
or HCl 
met-
leu-
Dr. E.L. :t-1ay 
Mallinckrodt 
Penninsula, Miles, Dr. B.A. :1organ 
S-endorphin Penninsula 
substance P (1-11) Penninsula, Beckman 
substance P (7-11) Penninsula 
substance P free acid Penninsula 
neurotensin Penninsula, Sigma 
somatost:atin Penninsula, Sigrr,a, Beckman 
VIP Calbiochem 
naloxone HCl Endo Laboratories 
hyocine HCl Sigma 
hexru~ethonium HBr Sigma 
baclofen (acid) Dr. H.K. Proudfit 
lidocaine ICN·K&K Laboratories 
tetrodotoxin Sank yo 
Sigma :ropranalol HCl 
phenoxy benz amine Smith, Kline and French 
Mr-2266, Mr-2267 Dr. H. Merz, Boehringer Ingelheim 
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3. RESULTS 
3 .1. EXTRACELLULAR RECORDING 
3.1.1. Spontaneous Activity 
Recordings were made from more than 500 units in tissues removed 
from 190 guinea pigs. A unit was considered to represent the activity of 
a single cell on the basis of the uniformity of the spike a~plitude, wave-
form and duration. Neuronal action potentials were clearly distinguish-
able from smooth muscle action potentials by their different a~plitudes 
and durations (Fig. 1). Smooth muscle action potentials were readily 
recorded when the recording electrode was placed on the muscle away from 
a myenteric ganglion. Neuronal activity was only recorded when the elec-
trode was placed on the surface of a ganglion. Neuronal action potentials 
were blocked by tetrodotoxin (1 lJM, n=6) or lidocaine (1 m:·l, n=2, Fig. 2) , 
whereas smooth muscle action potentials were unaffected by either drug. 
The waveform of spontaneous neuronal activity was usually mono-
phasic, spike duration being 2-5 ms. If the coupling time constant of 
the recording system was decreased, the spike amplitude was reduced and 
the waveform became biphasic (Fig. 3}. During the action potential, the 
recording electrode usually became negative with respect to the indiffer-
ent electrode, although spikes of opposite polarity were occasionally ob-
served. No sponteneous neuronal activity could be recorded from the 
strands of nerve processes connecting the ganglia within the plexus, al-
though electrically evoked activity was readily recorded from these sites 
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Figure 1. Comparison of neuronal and smooth muscle action potentials 
recorded with extracellular suction electrodes. (a) Differ-
ent traces from the smooth muscle. Calibration: Horizontal, 
20 ms; Vertical, 1 and 2, 100 ~V; 3, 200 ~V. (b) Neuronal 
spik~s at the same sweep speed. Calibration: Horizontal, 
20 ms; Vertical, 50 ~V. Coupling time constant in (a) and 
, (b) was' 1 s. 
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Figure 2. Inhibition of firing of a myenteric neuron by lid~caine. 
Ordinate: spike frequency (bin width - 10 s). Abscissa: 
time. The solid bar indicates the period during which the 
bathing solution was changed to one containing lidocaine 
(1 ~) . Lidocaine (1 mM) depressed neuronal firing in a 
reversible manner. 
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Figure 3. Spike waveform recorded with extracellular electrodes from 
myenteric neurons. (a) Coupling time constant 2 ms. 1-3, 
typical spikes recorded from three myenteric neurons with 
different electrodes. 4, three different waveforms were re-
corded with ~single electrode in the same position. 5, the 
same as 4 but spikes were recorded at a slow sweep speed. 
,Calibration: HQrizontal (1) 2 ms; (2,3) 10 ms; (4) 20 ms; 
(5) 2 s. Vertical (1) 100 f.JV; (2-5) 200 ]JV. (b) Coupling 
time constant 1 s. Typical monophasic spike waveforms re-
corded from three different myenteric neurons. Calibration: 
Horizontal 5 ms. Vertical (1,2) 100 lJV; (3) 50 1JV. 
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(see section 3.1.2.). The strands contain few cell bodies (Gabella, 
1972). No neuronal activity was recorded with metal electrodes, glass 
suction electrodes with a tip difu~eter less than 30 ~~ or with electrodes 
without suction. 
In agreement \'lith previous studies, two basic types of firing 
patterns were found. The first, and most common type (90%), had a dis-
charge pattern that was irregular with a mean rate of l-3 Hz. The wave-
form was monophasic (depending on the time constant .of the recording sys-
tem) ~nd had a spike amplitude which ranged from 50-300 ~V (Fig. 3). 
This type of unit \·las the most likely to continue firing and often lasted 
for periods of up to 4-5 hr. The firing rate of this type of unit was 
5-10 Hz soon after placement of the suction electrode on to the ganglion, 
but declined to l-3 Hz within a few minutes. The firing rate usually 
declined steadily throughout the period of recording, although some units 
maintained the same firing rate for periods of 4-5 hr. Neurons which 
stopped firing within the first few minutes of recording exhibited one of 
two distinct patterns of firing. The first pattern was marked by a de-
clining frequency associated with a steady increase in spike amplitude. 
When more suction was applied to the electrode, or if the electrode was 
removed and reapplied to the same point, the unit began to fire again. 
Units which ceased firing in this manner could usually be reexcited by 
changing the perfusing solution to one which contained no calcium ions 
or addition of an excitatory substance (see sections 3.1.3. and 3.4.2.). 
The second pattern began with a sudden flurry of action potentials assoc-
iated with decreasing spike amplitude and increasing spike duration. The 
neuron would continue to fire at high frequency until the spikeamplitude 
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decreased into the background noise. This second disc~arge pattern was 
probably due to mechanical cell damage leading to depolarization. Such 
cells sometimes appeared to recover; that is to say, after a period of 
l0-15 min a unit would begin to fire again. However, this unit would 
also begin to fire at a high frequency with the same result as described 
previously. On rare occasions, such a pattern of firing would continue 
for periods of up to 1 hr, with a decreasing frequency a~d number of 
spikes in each burst. This may correspond to the burst Q~it described 
in the experiments of Wood (1973). 
A second distinct type of unit made up a sw~ll proportion (10%) 
of the recordings. These units were of large amplitude (150-400 ~V} and 
had a very regular low frequency discharge (0 .1-1 Hz) . This type of unit 
was less likely to continue firing for extended periods of time and usu-
ally the onset and offset of firing was very abrupt wit~ little change in 
the firing frequency during the periods which it was active. Units of 
this type were generally less sensitive to most agents and it seems like-
ly that they correspond to the small population of morp~ine-insensitive, 
larger amplitude units described by Dingledine and Goldstein (1976). 
These units may correspond to the type II cell found with intracellular 
electrodes and further evidence for this is presented :below. 
A series of experiments was done to test whether polarizing cur-
rents could alter the firing rate of spontaneously active myenteric neu-
rons. While recording from a spontaneously active unit, a stimulating 
electrode was placed very close to the recording electrode a~d contin-
uous current (anodal or cathodal) was passed through this electrode. 
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When an anodal current was passed through the stimulating electrode, the 
firing rate of the neuron being recorded was decreased markedly. When a 
cathodal current was being passed through the stimulating electrode, an 
increase in the firing rate was observed. The changes in firing rate 
produced by anodal and cathodal currents usually lasted throughout the 
period during which current was passed, although there was some accomo-
dation observed during the passage of cathodal current. These results 
indicate that the firing rate of the neurons under study was sensitive 
to the effects of polarizing currents. 
3.1.2. Evoked Activity 
A series of experiments was done in which the nerve processes 
and cell bodies were stimulated, while recordings \vere made from the 
ganglia or along the strands of nerve processes \'lhich connect the gang-
lia. When an electrical stimulus was applied to the surface of theplexus 
at a distance of 100-1,000 ~ from the site of recording, two different 
types of responses were observed. The first type \vas a potential change 
which·was of short latency, sometimes coming directly (1-3 ms) after the 
stimulus artifact (Figs. 4, 5, 6). This potential \vas observed whether 
recording from the ganglia or from the nerve processes in the connecting 
strands between the ganglia. The amplitude of this potential was graded 
with the intensity of the stimulus, and follmved the stimulation at fre-
quencies of 10 Hz (Fig. 5). This potential was not blocked by hexameth-
onium (100 ]..lH) but was blocked reversibly by lidocaine (300 ]..lN and l mM, 
Fig. 6). 
The second type of electrically evoked potential closely resem-
bled, in waveform, the spontaneous neuronal spike recorded at the same 
site. This second type of evoked potential was observed only when re-
cordings were made from the surface of ganglia, not from the intercon-
necting strands. These potentials (from l-3 following a single stimulus) 
were all or nothing spikes which occurred with a latency that was rela-
tively constant for an individual experiment but which varied (from 10-
30 ms) among cells (Fig. 4). It is thought that these spikes arise from 
direct electrical stimulation of the cell or one of its processes or from 
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Figure 4. Response of myenteric neurons to focal stimulation of the 
ganglion with single pulses, and the effect of hexa.,.·nethonium. 
Each illustration is a single sweep. Stimulation frequency 
was 0.1 Hz. (a) A single pulse was follmved by a small, short 
latencq response and a longer latency response conprising two 
. 
spikes which were all or nothing and the individual spikes had 
a'waveform similar to the spontaneous potential. (b) 2 min 
after beginning perfusion with hexamethonium (100 ~~). The 
short latency response was still present. However, the long 
ratency all or nothing potential was blocked. (c) 4 min after 
the hexamethonium had been washed from the bath. Calibration: 
Horizontal 10 ms. Vertical 200 ~V. 
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Figure 5. Electrically evoked activity recorded from a myenteric gang-
lion. Each recording is the last sweep of an oscilloscopy 
trace following a 10 s train of pulses at the indicated freq-
uency. The evoked activity was of short latency (l-2 ms) and 
foll?wed a stimulation frequency of at least 10 Hz. At high 
stimulus frequencies, the activity tended to fractionate, 
·indicating the activity was a compound response. calibra-
tion: Horizontal 1 ms. Vertical 100 ~V. 
101-iz...,..V~~ 
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_1100)JV 
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Figure 6a. Electrically evoked activity recorded from a myenteric gang-
lion. Calibrat.ion: Horizontal l ms. Vertical 100 f..!V. 
Each recording is a single sweep. Stimulation frequency 0.1 
Hz. (l) control. (2) 2 min after changing to a solution 
whi~h contained lidocaine (l nM) . 
after washing out the lidocaine. 
(3 and 4) l and 5 min 
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Figure 6b. Electrically evoked activity recorded from the strailds of 
nerve processes connecting the ganglia. Calibration: Hori-
zontal l ms. Vertical 100 ~V. The stimulation frequency 
was 0.1 Hz and each recording is a single S'tleep. (l) con-
trol. A typ~cal waveform of activity recorded fro~ the 
interconnecting strands consisting of a short latency com-
.pound response~ (2-4) 1, 2 and 2.5 min after changing to a 
solution which contained lidocaine (300 mM). (5) 4 min after 
the solution containing lidocaine had been replaced with a 
normal Krebs solution. 
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synaptic excitation of the cell. It was possible to distinguish synap-
tically evoked potentials from directly evoked potentials as follmvs: 
(l) some of the evoked spikes followed at high frequencies ofstimulation 
(up to 10 Hz) with only a small increase in latency. These were not 
affected by hexamethonium (100 UM) and were considered to be directly 
evoked spikes. (2) Other potentials were reversibly blocked by perfus-
ing the tissues with hexamethonium (100 UM, Fig. 4). These spikes dis-
appeared when the frequency of stimulation was increased above 1 Hz: 
this observation supports the interpretation that th.ese are synaptically 
drive~ spikes, because the e.p.s.p.'s recorded intracellularly from myen-
teric neurons decline in amplitude when they are evoked at frequencies 
above 1 Hz (Nishi and North, l973a). 
The effect of repetitive electrical stimulation on the rate of 
spontaneously firing cells was studied (n=l5). A stimulating electrode 
was placed close (< 20 ~) to the recording electrode and a train of pul-
ses at 10 Hz for 10-60 s was applied. In a Krebs solution which did not 
contain acetylcholine receptor antagonists, this stimulation often re-
sulted in movement of the muscle which dislodged the electrode from the 
ganglion and an increase in firing rate was always observed. ~~en hexa-
methonium (100 ~M) and hyoscine (1 ~M) were added to the perfusing solu-
tion, muscle movement was eliminated; however, an increase in firing 
rate usually followed the period of stimulation. The firing rate in-
creased to about 10 Hz and lasted from 30 to 90 s following termination 
of the stimulation. An electrically evoked inhibition in firing was 
rarely observed (2 of 15 trials) . 
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3.1.3. Effects of Solutions of Varying Ionic Composition 
3.1.3.1. Lm.; Potassium. The effects of a solution containing 
a low concentration of potassium (l mM) was tested on 8 units. This 
solution reversibly decreased the spontaneous firing of only l unit and 
reversibly increased the firing rate in 5 units. The increase in firing 
frequency was preceded by a transient slowing (30-60 s) in 4 of these 
units (Fig. 7). The increase in firing rate was usually not maintained 
throughout the period during which the low potassiQ~ solution was per-
fusing the tissue. This increase in firing rate produced by a low potas-
sium solution, although unexpected, may be explained in terms of the ef-
fect that such a solution has on the sodium-potassium pump (Na-K pwnp). 
Under these conditions, when the cell is actively firing, the Na-K pump 
may be important in maintaining the membrane potential. By decreasiLg 
extracellular potassium, the pump is inhibited, which may lead to a de-
polarization and an increase in firing rate. This possibility is sup-
ported by experiments with the Na-K, ATPase inhibitor, ouabain. The ac-
tion of ouabain (1 ~.!H) on the firing rate was tested on 7 units and at 
least a twofold increase in firing rate was found in 3 units. 
3.1.3.2. High Potassium Solution. The effects of a solution 
containing high potassium ion concentration (12 m:1) ,,·as tested on 7 units. 
The firing rate of 3 of these was increased and the firing rate of 3 
others was decreased. The increase in firing rate induced by the high 
Figure 7. The effect of a low potassiQm (1 ~1) solution on firing rate 
of a typical myenteric neuron. Ordinate: firing rate (bin 
width - 30 s). Abscissa: time. During the periods indi-
cated by the filled and open bars, the bathing solution con-
taine~ normorphine (300 nM, NM) and 1 ~~ potassium, respec-
tively. The unit showed a typical decline in firing rate 
with time. NormGrphine (300 nM) caused an inhibition in fir-
ing rate. The solution containing low potassium increased 
the firing rate and normorphine prevented the increase in 
firing rate produced by the low potassium solution. Subseq-
uent application of low potassium solution increased the fir-
ing rate even though spontaneous firing had decreased to a 
very low level. 
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potassium solution was not maintained throughout the period during which 
it perfused the tissue and in 2 units vms biphasic; that is to say, a 
transient increase in firing rate was followed by a decrease in firing. 
The firing rate remained depressed for several minutes after the perfus-
ing solution had been replaced with Krebs solution containing normal potas-
sium (4.7 mM) ion concentration (Fig. 8). A high potassium solution would 
be expected to depolarize the neurons. With this depolarization, an in-
crease in firing might be expected. The decrease in spike frequency ob-
served in some units and the biphasic response of the firL~g rate (increase 
and th~n decrease) observed in others may be a result of a depolarization 
beyond the threshold level. 
3.1.3.3. Low Chloride. The effect of a solution containing low 
chloride ion concentration (10 ~~) was tested on the firing rate of 12 
myenteric neurons. In 11 of these, a small increase in firing rate which 
was slow in onset and offset was produced (Fig. 9). It appears that 
myenteric neurons are much less sensitive to changes in chloride ion con-
centrations than potassium ions. A small (5 mV) depolarization is pro-
duced in myenteric neurons in lov; chloride solutions recorded with intra-
cellular electrodes (North, unpublishe~ results) . This small depolari-
zation is consistent with the increase in firing rate observed in the 
present study. 
3.1.3.4. Calcium Free. Calcium-free solutions containing EGTA 
(l roM) always markedly increased the firing rate of myenteric neurons 
(Fig. 10, n=26). Neurons which had ceased to fire action potentials in 
association with an increasing spike amplitude were often induced to fire 
Figure 8. The effect of a high (12 nM) potassium solution on the firing 
rate of two myenteric neurons. Ordinate: spike frequency 
(bin width - 30 s). Abscissa: time. During the periods 
marked by the open and closed bars, the bathing solution was 
chan~ed to orre containing a high potassium (12 nM) and nor-
morphine (NM, 300 nM), respectively. (a) Application of a 
'high potassium solution produced a small depression in firing 
rate but did not alter the inhibition caused by normorphine. 
(b) Application of a high potassium solution produced a large 
increase in firing rate followed by a prolonged depression in 
firing which returned slowly upon washing the high potassium 
solution from the bath. 
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Figure 9. The effect of low chloride (10 nM) solution on the firing 
rate of a typical myenteric neuron. Ordinate: spike freq-
uency (bin width- 30 s). Abscissa: time. During the per-
iods denoted by the open and closed bars, a low chloride sol-
ution.(lO nM, ~sethionate substitution) and normorphine (NM, 
300 nM) perfused the tissue, respectively. A solution con-
~aining low chloride caused a modest increase in firing rate. 
The inhibition in firing rate produced by normorphine (300 
nM) appeared to be somewhat smaller in a low chloride solu-
tion on this neuron. 
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by changing to a solution which was calcium-free (?i;. 13). Similarly, 
when recording the firing rate of a single unit, cells ·.·::-1ich had been 
silent (not firing) prior to changing to the calci~-free solution, be-
gan to fire and interfered with the unit under study. 
It was also noted that if the preparation Has first perfused 
with calcium-free solution and then recordings were made, it was much 
easier to record neuronal activity. This contrasted · . .;i th the inability 
to record smooth muscle action potentials in calciuu-free solutions. 
3.1.3.5. High calcium. A solution contair.ing high calcium ion 
concentration (10 ml-1) was tested on 10 myenteric neuro:-:cs. In every case, 
this solution markedly depressed the firing rate (?igs. 10, 22), with a 
time course Hhich was abrupt upon entry of the solu~io" into the bath 
and which returned upon changing the perfusing solutio~ back to a Krebs 
solution containing normal calcium (2.5 ml-1). 
Figure 10. The effect of high calcium (10 mM) and calci~~-free solutions 
on the firing rate of a myenteric neuron. Ordinate: spike 
frequency (bin width - 15 s). Abscissa: time. 7!e solid 
bar indicates the period of time during which the bathing 
solution contained 10 mM calcium solution and the open bar 
indicates the periods when a calcium-free solution \>7as pre-
sent. The hign calcium solution caused a marked inhibition 
of cell firing. The calcium-free solution caused a marked 
excitation which became larger with longer periods of expo-
sure to the solution. This graded increase in firing rate 
probably indicates incomplete removal of calci~~ fro~ the 
bath. 
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3.2. THE ACTION OF OPIATES 
Normorphine was used in the majority of the exoeriments because 
its onset and offset of action is more rapid than that of morphine 
(Kosterlitz, Lord and Watt, 1972). The results are taken from 58 units 
recorded from tissues taken from 33 animals. Normorphine (100-1,000 ru~) 
reduced the firing rate of 90% of the units tested. ~1e onset of the 
inhibition produced by normorphine was relatively fast (within 10-20 s 
after·the entry of the normorphine into the bath). T.1e inhibition in fir-
ing was rapidly reversed by washing the tissue with drug-free Krebs. 
Occasionally, a short lasting rebound increase in firi~g rate was ob-
served upon washing out the normorphine. The inhibition in firing pro-
duced by morphine, however, was slower in onset and re:::;uired a longer 
period of time for the firing rate to return to co:1 trol ivhen 'dashing out 
the drug (Fig. 17) . In cells which were sensitive, r.or:::1orphine (l J.ll'1) 
completely inhibited firing (n=lO) and, in 31 of 37 experiments, normor-
phine (300 nM) reduced the firing rate to less than 75% of its control 
(Fig. 11) . 
The inhibition in firing rate produced by noE1.orphine was antag-
onized by a 3-10 fold lower concentration of naloxone. The inhibition 
was reversed by addition of naloxone during the period · . .;hen normorphine 
was in the bath and prior treatment of the tissue wi tn naloxone prevented 
the normorphine-induced inhibition (Fig. ll). Tnese findings are essen-
tially the same as those reported in detail by Dingledine a~d Goldstein 
(1975, 1976). 
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Figure 11. Effect of normorphine on firing of two myenteric neurons and 
the reversal of this inhibition by naloxone. Ordinate: 
spike frequency (bin width-60s). Abscissa: ti::1e. Dur-
ing the periods indicated by the closed and diagonal hatched 
bars, the bathing solution was changed to one which contained 
normorphine (NM, 300 nM) and naloxone (Nal, 30 :n.:·:) , respec-
·tively~ (a) The firing rate of this myenteric neuro~ stead-
ily declined throughout the experiment. The de?ression in 
firing rate produced by normorphine (300 nM) •;.;as co:-:l;?letely 
·reversed by a tenfold lower concentration of naloxone (30 
nM) . This reversal was not due to tachyphylaxis to the ef-
fect of normorphine since the inhibition produced by a sub-
sequent application lasted throughout the perioC: -;,.;hich it 
was in the bath. (b) The firing rate of this U.'1i t ·,:as main-
tained throughout the experiment. 
Figure 11. Effect of normorphine on firing of two myenteric neurons and 
the reversal of this inhibition by naloxone. Ordinate: 
spike frequency (bin width-60s). Abscissa: ti~. Dur-
ing the periods indicated by the closed and diagonal hatched 
bars,. the bat-hing solution was changed to one which contained 
normorphine (NM, 300 nM) and naloxone (Nal, 30 p_:.n, respec-
'tively. (a) Th~ firing rate of this myenteric neuron stead-
ily declined throughout the experiment. The de?ression in 
firing rate produced by normorphine (300 n!-1) was co:::~pletely 
·reversed by a tenfold lower concentration of naloxone (30 
nM) . This reversal was not due to tachyphylaxis to the ef-
fect of normorphine since the inhibition produced by a sub-
sequent application lasted throughout the period >·ihich it 
was in the bath. (b) The firing rate of this U.'1it '..:as main-
tained throughout the experiment. 
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During the inhibition produced by normor?~ine (1 J-!2·1), the firing 
rate of these neurons was increased by passing a steady cathodal current 
through a stimulating electrode close to the recording site. Tnis obser-
vation is compatible with a hyperpolarizing action of normorphine on the 
cell membrane which has subsequently been demonstrated by intracellular 
recording (North and Tonini, 1977). 
The inhibition in firing rate produced by normorphine (300 nM) 
was not altered when the tissue was perfused \~ith solutions containing 
1 ~~ (n=4) or 12 mM (n=S) potassiTh~ ion concentrations (Figs. 7, 8). 
The action of normorphine (300 nr-1) was tested on 5 units in the presence 
of a solution containing 10 mM chloride ion concentration. In 3 of these 
units, the inhibition of firing produced by nor:norp'hine \~as unchanged 
from control and, in 2 others, the inhibition in firing appeared to be 
reduced (Fig. 9). 
3.3. THE ACTION OF OPIOID PEPTIDES 
These results are based on 192 neurons recorded from tissues 
taken from 67 animals. 
3.3.1. Met-Enkephalin 
Application of met-enkepha1in (1-300 nM) inhibited the firing of 
77 of 96 neurons (Table 6). For a given neuron, the degree of inhibition 
of firing was dependent on the concentration of enkep~alin in the bath 
(Fig. 12). Met-enkepha1in at a concentration of 100 n2·! \'las sufficient 
to reduce the firing rate to 10% or less of the control rate in 90% of 
sensitive neurons. Lo~tier concentrations of met-enkep::alin caused marked 
inhibitions in many cells (Fig. 12). 
The onset of inhibition of firing and the return to control was 
within 10-15 s of the arrival and washout of met-enkephalin. There was 
a rebound increase in firing rate following the washout of enkephalin in 
40% of cells tested (Figs. 17a, 14). The inhibition in firing was usu-
ally maintained throughout the period that met-enkephalin was in thebath. 
Likewise, the degree of inhibition was reproducible with repeated appli-
cations of the same concentration at intervals of 2 min (Fig. 13). With 
concentrations of met-enkephalin (< 10 nM), the firing rate occasionally 
(~ 15%) returned to control levels during the presence of enkephalin. 
In such cells, the application of a higher concentration (30 or 100 nM) 
caused a greater degree of inhibition and this lasted throughout the 
period of application. 
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Table 6. The effect of different concentrations of met-enkephalin, leu-
enkephalin and B-endorphin in inhibiting the firing rate of 
myenteric neurons. Inhibition of firing indicates that the 
spike frequency fell to less than 75% of its control value dur-
ing the period of drug application and recovered to the origi-
nal control value following washout. The proportion of neurons 
which were inhibited by low concentrations of the peptides is 
artificially high, because low concentrations (met-enkephalin 
30 nM or less, leu-enkephalin 100 nH or less) were only tested 
when the unit was found to be sensitive to a higher concentra-
tion. 
Drug I Concentration Number of Units I t:u.sber of Units (nM) Tested rn::ibited 
met-enkephalin 1 1 1 
3 7 6 
10 I 20 13 30 I 38 ! 30 
100 I 23 
I 20 I 300 I 7 7 
I I I I i 
1eu-enkepha1in 10 I 1 I 0 I I 30 I 12 11 
100 73 I 54 I 300 21 13 
1000 1 l 
B-endorphin I 1 5 0 
I 
3 8 2 
10 3 2 
30 13 8 
100 25 16 
300 7 7 
1000 2 0 
Figure 12. Inhibition of spike frequency by met-enkephalin in a concen-
tration-dependent manner. Ordinate: spike frequency (10 s 
epochs). Abscissa: time. The solid bars indicate the per-
iods during which rnet-enkephalin was included in the bathing 
solution at the indicated concentration (n?-1) . In this cell, 
3 nM rnet-enkephalin was without effect and a te~fold higher 
concentration completely suppressed the firing. 
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Figure 13. Repeated applications of met-enkephalin on a singlemyenteric 
neuron. Ordinate: spike frequency (bin width - 15 s). 
Abscissa: time. Met-enkephalin (lOO nN) decreased the fir-
ing rate in a reproducible manner during each of five appli-
catiqns with ~arying durations of exposure (1, 2, 3 and 10 
min) . 
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In comparing the inhibition produced by morp::.ine a..Dd normorphine 
with that produced by met-enkephalin, two differences beca..~e apparent. 
First, met-enkephalin produced the same degree of inhibition at atenfold 
lower concentration than that of morphine or normorphine (Fig. 17). Sec-
ond, the time course of the inhibition produced by enkephalin was usually 
much faster than that produced by morphine and it was also slightly faster 
than the inhibition produced by normorphine (Fig. 17a). The frequency 
with which a rebound excitation was observed with the washout of enkeph-
alin was also much higher than that observed for normorphine (Fig. 17a). 
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3.3.2. Leu-Enkephalin 
Leu-enkephalin (10-300 nH) inhibited the firing of 79 of 108 
neurons tested (Table 6). The time course of the inribition produced by 
leu-enkephalin was similar to that of an equieffective concentration of 
met-enkephalin. In 90% of sensitive neurons, leu-enkef-halin (300 nH) 
reduced the firing rate by at least 90%. On a given neuron, the degree 
of inhibition produced by leu-enkephalin was dependent on the concentra-
tion in the bath. A 3-5 times higher concentration of leu-enkephalin 
was usually required to produce the same degree of inhibition as a given 
concentration of met-enkephalin (Fig. 14, n==l2) . As ·.,·i th met-enkephalin, 
the washout of leu-enkephalin "~i!as after: associated \•rit:-. a marked rebound 
increase in the firing rate. 
Figure 14. Inhibition of spike frequency by met- and leu-enkephalin. 
Ordinate: spike frequency (bin width - 30 s). Abscissa: 
time. In this cell, leu-enkephalin (100 nN, leu) had no 
effect whereas the same concentration of met-enkephalin 
(160 nM, met) caused almost a complete inhibition in firing. 
A five fold higher concentration of leu-enkephalin ( 500 n!·l) 
produced an inh,ibition in firing; rate which was sirular to 
that caused by met-enkephalin (100 nM) . Note that the inhi-
bition of firing by met-enkephalin remained present through-
out a 20 min period of exposure. 
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3.3.3. S-Endorphin 
S-endorphin (1-1,000 nM) inhibited the firing of 35 of 54 neu-
rons (Table 6). The time course of the effects produced by 3-endorphin 
was similar to that of the enkephalins. The rebound increase in firing 
rate with the washout of S-endorphin was very small and seen only occas-
ionally. The effect of S-endorphin was dependent on the concentration 
applied (Fig. 15). The most sensitive units were inhibited at a concen-
tration of 3 nM (Fig. 16). It was usually necessa0; to use a 3-10 fold 
higher concentration of S-endorphin to equal a response to a given con-
centration of met-enkephalin (Fig. 17c). In most units, the inhibition 
in firing produced by S-endorphin was equal or slightly s:-:caller than that 
caused by an equal concentration of leu-enkephalin (Fig. 25a). 
Figure 15. Concentration-related inhibition in firing of a single neu-
ron by S-endorphin. Ordinate: spike frequency (bin '.vidth -
10 s). Abscissa: time. Solid bars indicate the periods 
during which the bathing solution was changed to one which 
contained S-e_ndorphin in the concentration indicated (nN) . 
S-endorphin caused an inhibition in firing whic~~ \vas related 
~o the concentrqtion in the bath. 
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Figure 16. Inhibition in firing rate by B-endorphin and reversal of 
this inhibition by naloxone. Ordinate: spike frequency 
'(bin width - 10 s). Abscissa: time. During t~e periods 
denoted by the solid bars and diagonal hatched bar, the 
bathing solution was changed to one which contained S-endor-
. 
phin and naloxone, respectively. The numbers above and be-
low the.bars indicate the concentration (nM). S-endorphin 
(30 nM) caused a marked decrease in firing rate vmich was 
completely reversed by naloxone (10 nM) . Subsequent appli-
. cation of B-endorphin (3 nM) produced increasing amounts of 
inhibition of firing rate. The loss of effect of the first 
application of 3 nM S-endorphin may be due to tachyphylaxis 
following the larger concentration, or due to residual ef-
fects of naloxone. 
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Figure 17. A comparison of the effects produced by met-enkep~alin, S-
endorphin, morphine and normorphine on three myenteric neu-
rons. (a) Ordinate: spike frequency (bin \vidth - 30 s). 
Abscissa: time. During the periods indicated, the perfus-
ing solution was changed to one which contained morphine 
(M, 300 nM, vertically hatched bar) met-enkephalin (met-E, 
,30 nM, ·open bar{ or normorphine (NM, 300 nH, solid bar) . 
The time course of the inhibition produced by morphine \-las 
much longer than that caused by enkephalin or no~orphine . 
. About the same degree of inhibition in firing rate \'laS pro-
duced by met-enkephalin at a tenfold lower concentration as 
was produced by morphine and normorphine. A marked rebound 
increase in firing was also produced by washout o:=. enkep~alin. 
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Figure 17b. Ordinate: spike frequency (bin width- 15 s). rlbscissa: 
time. The inhibition in firing rate produced by ::-.et-enke-
phalin ( 30 n?-1) was exactly the same as the inhibition by 
morphine (300 nM) . 
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Figure 17c. Inhibition of spike frequency by met-enkephalin a~d 3-endor-
phin. Ordinate: spike frequency (10 s epochs). Abscissa: 
time. The solid and stippled bars indicate the periods dur-
ing which the bathing solution contained met-enkephalin and 
B-en.dorphin .at the concentration indicated (n:·!) . Het-enke-
phalin (30 nM) produced a marked inhibition in firing rate 
.whereas the in~tial application of the same concentration 
of B-endorphin only caused a transient inhibition which was 
not repeatable. A higher concentration of 3-endorphin (100 
nM) was required to cause the same amount of inhibition as 
met-enkephalin (30 nM). 
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3.3.4. The Effect of Calcium-Free Solutions 
on the Action of Opioid Peptides 
104 
The action of met-enkephalin (n=l5) and leu-enkephalin (n=6) were 
both unchanged in solutions which were calciQ~-free (?ig. 18). Even per-
fusion of the tissue with a calcium-free solution for periods of more 
than 1 hr did not change the action of the enkephalins on sensitive units. 
If the preparation was perfused with calcium-free solutions before record-
ings were made, the proportion of neurons which were not sensitive to en-
kephalin increased to about 50% of those tested. Sinilar results have 
been reported for the action of morphine in calci~~-free solutions 
(DL~gledL~e and Goldstein, 1976). 
Figure 18. Extracellular recordings from two myenteric neurons. Ordi-
nate: spike frequency (30 s epochs). Abscissa: time. 
During the periods indicated by the solid bars, the bathing 
solution was changed to one which contained met-enkephalin; 
. 
the numbers ~ndicate the concentration in nH. (a) The hori-
zontally hatched bar indicates the period during which the 
,bathing solutiop was changed to a calcium-free solution 
which also contained EGTA (1 mM). The initial firing rate 
of this unit was low, but met-enkephalin (10 n11) caused a 
. small inhibition in firing. The firing rate increased mark-
edly when the bathing solution was changed to a calcium-free 
solution. Enkephalin, however, still produced a marked in-
hibition in firing rate. (b) The open bar indicates that 
the bathing solution was calcium-free and included EGTA 
(1 ~1). The tissue had been perfused with the calcium-free 
solution for 70 min prior to this experiment. Het-enkepha-
lin caused a marked inhibition in firing rate of this cell. 
When the bathing solution was changed to one containing a 
normal calcium concentration, the firing rate of this unit 
decreased markedly and the effects of enkephalin could not 
be reliably assessed. 
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3.3.5. Antagonists 
Naloxone (100 nM- 1 ~) usually did not affect neuronal firing, 
but caused an excitation in approximately 15% of neurons tested (n;30). 
This increase was usually small (< 2 x control) and s~ort-lived (30-90 s) 
and only rarely persisted throughout the period of application. P~ in-
crease in firing rate was also evoked by both the active (levorotatory 
Mr-2266) and inactive (dextrorotatory Mr-2267) isomers of the benzomo~han 
antag~nist 5,9-diethyl-2-(3-furyl-methyl)-2'-hydroxy-6,7-benzonorphan 
hydrochloride (Fig. 19, n=6). The active and inactive isomers were equal-
ly effective in producing an increase in firing rate; ~~erefore, it seems 
unlikely that this effect is due to antagonism at t~e O:"'iate recer,tor of 
an endogenously released opioid. 
Naloxone (3-30 nH) reversed or prevented the action of the enke-
phalins and S-endorphin (Figs. 16, 20, 25). Antagonis::n v1as considered 
to be adequate when the inhibitory action was reversed by at least 90%. 
The mean ratio (dose of enkephalin) I (dose of naloxone) at \vhich antago-
nism was observed for met-enkephalin was approximately 9:1 ('l'able 7). 
Antagonism was also observed with Mr-2266 but not wit[-, ~·~r-2267 (Figs. 19, 
21, n;4). 
The specificity of the action of naloxone to reverse opioid pep-
tides was tested by examining its ability to reverse t:Ce inhibition of 
the firing of myenteric neurons produced by high calciu:::: solutions (10 
nH) (Fig. 22) or somatostatin (10-100 nH) (Fig. 25). :'::\·en at high con-
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Table 7. The antagonism of the inhibitory action of endorphins by nalo-
Drug 
xone. Antagonism is indicated when concurrent application of 
naloxone completely (>90%) prevented or reversed the inhibitory 
action of the agonist. Concentrations of agonists \.;ere: met-
enkephalin (30- 300 nH), leu-enkephalin (100- 300 nH), B-
endorphin (100 - 300 nM) . Concentrations of naloxone were 1 -
100 times lower than those of the agonists. In the case of 
met-enkephalin, the mean ratio agonist concentration: antago-
nist concentration \vas 8. 7:1 when antagonisn was observed (n= 
15) and 14:1 when antagonism was not observed (n=B). 
Nwnber of units 
tested 
Number of units 
in which antagon-
ism was observed 
met-enkephalin 23 15 
leu-enkephalin 9 7 
B-endorphin 5 4 
Figure 19. Prevention of the effect of met-enkephalin by benzomorphan 
antagonist. Ordinate: (bin width - 10 s). P~scissa: time. 
The solid bar indicates the period during >,;hich the perfus-
ing solution contained met-enkephalin (300 nH) . During the 
peri~ds indioated by the diagonally hatched bars,the solu-
tion contained either the inactive (Mr-2267) or the active 
, (Mr-226'6) isomel!' of the benzomorphan antagonist. Both the 
active and inactive isomers caused an increase in the firing 
rate of this neuron. During the period which the inactive 
·isomer (Mr-2267, 100 nM) was being perfused, met-enkephalin 
(300 nM) caused a complete inhibition of firing. In the 
presence of the active isomer (Mr-2266) met-enkephalin (300 
nH) produced only a slight decrease in firing rate. 
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Figure 20. Inhibition in firing produced by met-enkephalin: reversal 
and prevention of the inhibition by naloxone. Ordinate: 
spike frequency (bin width - 30 s). Abscissa: +-' -.J.me. Dur-
ing. the periods denoted by the solid and diagonally hatched 
bars, the pe:t;"fusing solution was changed to one which con-
tained met-enkephalin (100 nM) and naloxone (10 nH), respec-
.tively. Met-eQkephalin produced a nearly complete inhibi-
tion in firing rate of this unit. Reversal and prevention 
of the inhibition in firing rate produced by enkephalin was 
.obtained with a tenfold lower concentration of naloxone. 
The inhibition in firing rate during subsequent application 
of enkephalin was not as large as previous application~ prob-
ably because of the continued presence of naloxone. 
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Figure 21. Inhibition of firing rate by B-endorphin and the reversal of 
this inhibition by a benzomorphan antagonist. Ordinate: 
spike frequency (bin width- 10 s). Abscissa: +-' ~1me. The 
solid bars indicate the periods during which the bathing 
sol~tion contained B-endorphin in the indicated concentration 
(nM). The inactive (+) isomer of the benzomorphan antago-
nist {Mr-2267,'30 nM) and the active (-) isomer (:-Ir-2266, 
30 ni1) of the benzomorphan antagonists '~rere perfused during 
the periods indicated. B..,.endorphin ( 300 ni·:) co:-:1pletely 
·stopped the firing of this unit. Pretreatment of the tissue 
with the inactive isomer (Mr-2267) failed to alter the inhi-
bition produced by B-endorphin whereas pretreat:::~ent with the 
active isomer (Mr-2266) completely blocked the inhibition in 
firing caused by B-endorphin. 
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Figure 22. Inhibition in spike frequency of a myenteric neuron ·,;i th a 
high calciu.rn solution. Ordinate: spike frequer:.c:.: (biYl 
·width- 10 s). Abscissa: time. During the periods indi-
cated by the solid bars, the bathing solution was c~an;ed to 
one which contained a high calcium (10 mH), and the diagonal 
·hatched bar indicates the period in which the perfusing solu-
tion cqntained naloxone (300 nM). The high calci~~ solution 
produced an inhibition in firing rate which was not affected 
by prior treatment with naloxone even at a high concentra-
tion. 
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centrations (300 nM), naloxone did not alter the inhibi~ion produced by 
these agents. 
Alpha-receptor antagonists have been shmvn to reverse the inhi-
bition of the firing of myenteric neurons produced by noradrenaline 
(Sato et al. 1 1973). The inhibition in firing rate produced by met-
enkephalin was not effected by phenoxybenzamine (n=4) 1 nor was the effect 
of met-enkephalin blocked by the B-receptor antagonist propranolol (10 
~"1 1 n=2). 
3.4. NEUROPEPTIDES 
3.4.1. Somatostatin 
These results are based on recordings made fro::~ 7'J units from 25 
animals. Somatostatin (100 nM - 1 ~) inhibited the firing of up to 80% 
of myenteric neurons tested. This effect was depend~<t on the concentra-
tion of somatostatin applied (Fig. 23). The firing of the ~ost sensitive 
units was inhibited by a concentration of 300 pM and 50% of the units 
'"ere inhibited by somatostatin (30 nM) (Table 8). The inilibition of fir-
ing caused by somatostatin occurred within 15 s of the arrival of the soma-
tostatin, reversed equally quickly and usually persisted throughout the 
perio::'l of application (::''iss. 23, 25). Higher co:~cer:tr.c:.·~io!1s of somatosta-
tin sometimes caused a depression of firing which passed off during the 
continued presence of the peptide. The loss of effect during the applica-
tion was observed in 42% of units tested with a concentrc.tion of 300 nM, 
23% of units with 100 nH, 8% of units with 30 nH and in 19% of units with 
10 nM. In cells in which the inhibition in firing rate passed off during 
the presence of somatostatin, the response to somatostatin, even at higher 
concentrations, disappeared if the interval between applications was less 
than 9 min. However, repeated applications of the same concentration of 
somatostatin at intervals of at least 9 min produced sL~ilar inhibitions 
(Fig. 24). 
Somatostatin also produced an inhibition in the firing rate in cal-
cium-free solutions. The inhibition in firing produced by somatostatin was 
not altered by phenoxybenzar:1ine (l ~' Fig. 24, n=2) or by naloxone (100 n!-1, 
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Table 8. The number of neurons in which firing \·:as in'r.ibi ted b:l various 
concentrations of somatostatin. Inhibitio:1 indicates that the 
firing rate fell to 75% of the control rate. 
Concentration Ntunber of Units 
nM ~ested I inhibited excited I 
0.3 9 1 0 
1 10 1 0 
3 10 2 0 
10 16 I 4 1 
30 52 26 2 
100 30 24 0 
300 12 11 0 
1000 3 2 0 
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Fig. 25, n=l2). Propranolol (10 ~1) did block the inhibitio:1 produced by 
somatostatin in l of 5 experiments. 
The effects of enkephalin and somatostatin were compared on 51 
units. Six were unaffected by either peptide (enkephalin in concentra-
tions up to 300 nH, somatostatin in concentrations up to 100 n..:.l) • Ten 
units were inhibited by enkephalin but not by somatostatin (up to 100 
n:t-1). Nine units were inhibited by somatostatin but not enkephalin (up 
to 300 nM). The other 26 units were inhibited by both somatostatin and 
enkepbalin. In those units where a sufficient number of different con-
centrations of each peptide were applied, an equal in~ibition of firing 
was produced by somatostatin and enkephalin at about equimolar concentra-
tions. The existence of cells which respond to somatostatin and not to 
enkephalin (Fig. 23) is strong evidence to support the hypothesis t.hat~ 
somatostatin and enkephalin do not act via a corruno:1 receptor. 
Figure 23. Inhibition of spike firing by somatostatin. Ordinate: spike 
frequency (10 s epochs). Abscissa: time. Tne entire ex-
periment was carried out in a solution which was calcium-
free and contained EGTA (1 mM) . During the period indicated 
by t~e stipp~ed bars, the bathing solution contained somato-
statin in the indicated concentrations (nH) . Tne horizon-
.tally hatched bar indicates the period during which leu-
enkephalin (300 nH) was included in the bathing solution. 
Somatostatin produced a concentration-dependent inhibition 
. in spike frequency. The lowest concentration of somatosta-
tin (0. 3 nM) appeared to increase the firing rate. Hm.;ever, 
this was not repeatable (not shown). Leu-enkephalin (300 
nM) was without effect on this cell. 
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Figure 24. Inhibition by sonatostatin of the firin(] of bvo r:-::,•enteric neu-
rons. Ordinate: spike frequency (10 s epochs). ~bscissa: 
time. (a) During the periods marked by the solid bars, the 
bathing solution v1as changed to one which contained so:aatosta-
tin · (100 nH). The open bar denotes the period during which 
the perfusing solution contained phenoxybenzarnine (POB, 1 f.Ji·!). 
~omatostatin (10? nM) caused an inhibition in firing rate 
which was not maintained throughout the period during ,,.,hich 
somatostatin was in the bath. The inhibition was reproducible 
?n each of six applications and was still present in solutions 
which contained phenoxybenzamine (1 ~1). (b) The perfusing 
solution throughout this experiment, and for one hour pre-
vious to this experiment, was calcium-free and co::1tained EGTA 
(l rr,:.;). During the periods marked by the solid :Oars, leu-
enkephalin (LE, 300 nM) was contained in the bathi::1g solution. 
The diagonal hatched bars represent the periods ;·:hen the bath-
ing solution contained somatostatin (S, 100 or 300 n:.:). Soma-
tostatin (lOO and 300 nM) and leu-enkephalin (300 n~·l) inhibi-
ted firing of this myenteric neuron. The inhibition caused 
by somatostatin did not last throughout the period of its 
application. The inhibition by leu-enkephalin ~as maintained 
throughout the period of application. 
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Figure 25. Inhibition of spike firing by opioid peptides ae1d so:nat.osta-
tin, and the sensitivity of these inhibitio~s t.o naloxone. 
Ordinate: spike frequency (30 s epochs). Abscissa: time. 
During the periods indicated by the solid bars, the bathing 
solution contained somatostatin (S), leu-enkephalin (LE) and 
B-endorphin (BE) , in the concentrations indicated (n:·n . The 
perfusing soluti<;?n contained naloxone (lOO n:·l) during the 
period denoted by the diagonally hatched bar. (a) Somato-
statin (lOO n~1), leu-enkephalin (100 nM) and 3-er..dorphin 
.(100 nM) all caused a marked inhibition in firing rate of 
this unit. Only somatostatin produced the sa~e 6egree of in-
hibition in the presence of naloxone. (b) ~~other ~~it in 
which the inhibition produced by somatostatin at lo-.-;er con-
centrations (30 nH) was not effected by high co~centration 
of naloxone. (c) A final unit in which the inhibition pro-
duced by a low concentration of somatostatin (10 n:·:) was not 
effected by a tenfold higher concentration of naloxone (100 
nM). 
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3.4.2. Substance P 
Extracellular recordings were made from 204 units in tissues 
from 74 animals. Substance P was found to cause a marked increase in 
the firing rate in up to 80% of neurons. The increase in firing rate 
was abrupt upon entry of the peptide into the tissue bath (10-15 s) and 
the firing rate returned to control soon ('.vithin 30-60 s) after ;..;ashing 
the peptide from the bath. Substance P ( 1 nl·1) caused a clear excitation, 
at least doubling the firing rate, in about 50% of the cells tested 
(Table 9). Higher concentrations resulted in a greater proportion of 
cells being excited; up to where 80% of the units tested were foQDd to 
be sensitive (Table 9). Excitation of the smooth muscle by substance P 
limited the use of concentrations greater than 30 n;·l, and it is possible 
that the increase in firing rate with higher concentrations may have 
been secondary to muscle movements near the recording site or it may have 
been due to increased synaptic activity secondary to violent muscle move-
ment away from the recording site. These difficulties ;·:ere minimized by 
the use of lov;er concentrations of substance P and the careful pinning 
of single ganglia. 
The proportion of cells excited by low concentration (300 pl-'1) 
was less tha.'l the proportion of cells excited by higher concentrations 
(up to 30 nM). This change in proportion of cells excited by increasing 
concentrations implied a dose-related effect. The response of single 
cells to substance P was also dose-related, but. nbsolut:e sensi ti vi ties 
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Table 9. The effect of different concentratio~s of substance P 1 sub-
stance P pentapeptide and substance P free acid on the firing 
of myenteric neurons. An increase in firing '.-las determined if 
the firing frequency at least doubled in the presence of sub-
stance P or either analog. About 80% of the units tested were 
sensitive to substance P (10 n~1), no effects Viere seen with 
substance P free acid below a concentration of 100 n:•r and few 
cells were sensitive to substance P pentapeptide below a con-
centration of 30 nM. 
D.rug Concentration Number of Number Number 
(nM) Units Tested Excited Inhibited 
substance p 0.1 l l 0 
(l-11) 0.3 15 4 0 
l 81 42 1 
3 134 80 3 
10 25 21 0 
30 4 4 0 
300 2 2 0 
substance p l 1 l 0 
(7-ll) 10 6 l 0 
30 6 5 0 
100 3 2 0 
substance p 3 6 0 0 
free acid 10 4 0 0 
30 2 0 0 
100 7 4 0 
300 5 3 0 
600 1 1 0 
1000 2 l 0 
3000 1 1 0 
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varied among units (Figs. 26, 27, 31). The responses obscrvec tore-
peated applications of the same concentratio!1 of su:!Jsta::~.ce I' '\·.'ere of 
three types. First, the amplitude of the excitation decreased \vi th sec-
ond or subsequent applications (Figs. 26a, 27, 31). Second, the excita-
tory effect remained the same (Pigs. 28, 29, 30). Thirc, the excitatory 
effect became greater (Fig. 36c). The proportion of units shm·;ing these 
different types of responses to repeated applications ·..:as 60%, 30% and 
10%, respectively. 
Prolonged applications (up to 15 min) of substance P also yielded 
variable results: most units maintained an increased firing rate through-
out the period of application, but in other units the firing rate returned 
to the control rate b-2fore the peptide was washed fro.:-n ':.he bath. The de-
crease i;-; respo:-,se ·"o.j ~cepresent desensitization, bu::. ce_:::olarization block 
or other change in the condition of the cell cannot be detected using 
extracellular recording. 
Substance P produced a dose-dependent increase in firing rate of 
myenteric neurons in solutions which contained no calcilL-:t and EGTA (1 m:r-.1) 
(Fig. 27). In cells which were sensitive to substance Pin normal Krebs 
solution, an equivalent excitation could be produced by a lo·,.,·er concentra-
tion of substance P v;hen the neuron \·Jas in a calch4T•-free solution (Table 
10). This may be due to the depolarizing effect of the calciTh~-free solu-
tions (Nishi and North, 1973a). The proportion of cells which were found 
to be sensitive to substance P was decreased to 40% of those tested in cal-
cium-free solutions (Table 10); similar results were obtained ~·:ith :morpLine 
and enkephalin (see above). Substance P caused an excit;o.':.ion in solutions 
which contained cobalt chloride (l mM, n=3). 
Figure 26. Excitation by substance P of tvro myenteric: neurc::-:s. Ordinate: 
spike frequency (10 s epochs). Abscissa: tL~e. 7'e solid 
bars indicate the period during which substance P (SP, con-
centrations indicated in nH) was contained within ';:he bathing 
solution. (~) Increasing concentrations of subs~ance P from 
1-10 nH produced graded increases in firing rate of thisunit. 
,A second application of substance P in the same concentra-
tion range resulted in somewhat smaller responses. (b) The 
vertical hatched bar indicates the period during ·.-·hich the 
.bathing solution contained substance P free acid (SPFA, 100 
nH) . Substance P caused a concentration-dependent increase 
in firing of this unit. The substance P free acid a~alogwas 
about 33 times less potent than substance P on t~is unit. 
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Table 10. The effect of substance P in different concen~rations on the 
firing rate of myenteric neurons in a solutio:1 which was cal-
cium-free and contained EGTA (1 mH). An increase in firing 
rate was determined if the firing rate at least doutlled in 
the presence of substance P. About 50% of the cells tested 
were sensitive to substance P (300 p:'l) in calciu.rn-free solu-
tions. At the same concentration of substance P (300 pM) in 
calcium-containing Krebs, less than 30% of the units were sen-
si tive. At higher concentrations (1-10 n~l) , the number of sen-
sitive units in calcium-free solutions Has only 40% of those 
tested as c~~pared to 60% of units tested in calcilli~-contain-
ing Krebs. 
Drug Concentration Number of i\Jl.L:"tbe r Number 
(n!-1) Units Tested Excited I!ihibited 
substance p 0.1 2 0 0 
0.3 13 7 1 
1 23 lG 0 
3 9 4 1 
10 5 1 0 
Figure 27. Increase in firing rate produced by substance P on a myen-
teric neuron in calcium-free solution. Ordinate: spike 
frequency ( 2 s epochs). Abscissa: time. The tissue was 
continuously bathed in a solution which was calciQ~-free and 
cont~ined EGTA (1 m}1) • The open bars indicate the periods 
during which the bathing solution contained subst~~ce P (0.3-
,l nM, SP). Substance P (300 pM) caused a marked excitation 
of this unit. Repeated applications of the same concentra-
tion of substance P resulted in decreasing responses. 
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Substance P was equally effective in the presence of hexameth-
onium (100 flM, Fig. 28, n=l2) . This concentration of hexa.-nethoniurn 
blocks the fast e.p.s.p. of myenteric neurons (Nishi a.r;d North, 1973~). 
The excitation produced by substance P was not altered by naloxone at a 
concentration (300 nl-1, Fig. 30, n=l2) which was su£ficient to block the 
action of morphine or enkephalin (:Fig. 29, Table 7). Substance P pro-
duced an inhibition in 4 units. This inhibition Has not prevented by 
naloxone (300 nH) in the one cell on which it >·las tested. 
The increase in firing rate produced by substa.'lce P was not al-
tered by baclofen (5 f.llll, n=S) (Fig. 30) or baclofen (50 f.L'l, n=9). In two 
other experiments, the excitation produced by substance P was partially 
and reversibly blocked by baclofen (50 ~~) . 
The actions of two substance P analogs, substance P pentapeptide 
(penta-substance P) (l-100 n~1) and substance P free acid (3-3 ,000 nN) 
(Table 9) were studied on 9 and 17 units, respectively. Both analogs 
markedly increased the firing rate of myenteric neuro:1s ivith a time course 
which '\vas similar to that of substance P. Such excitations were observed 
only in units which were also excited by substance P. The response to 
repeated applications of the two analogs was similar to that observed 
with repeated applications of substance P. Penta-substance P (10 nM) 
produced an increase in the firing rate in 1 of 6 cells, whereas penta-
substance P (30 nM) increased the firing rate in 5 of 6 cells tested 
(Table 9) . No effects of substance P free acid i·rere observed at a con-
centration below 100 nl'-1, and above this concentratio:1, the proportion of 
units which were excited was about the same as for substance P. Substance 
Figure 28. The effec-t of acetylcholine antagonists on the response to sub-
stance P of a myenteric neuron. Ordinate: spike frequency 
(10 s epochs). Abscissa: time. Both upper and lower rec-
ords are taken from the same neuron, but they are separated 
in t~me by 30-min. During the periods indicated by the solid 
bars, the perfusing solution was changed to one v1hich con-
tained substance P (SP, 10 nM). The cholinergic antagonists, 
hexemethonium (C-6, 100 }.!M) and hyoscine (Scop. 1 lJl·l) were 
included in the bathing solution during the period marked by 
·the horizontally hatched bar. The cholinergic antagonists 
did not alter the excitation of this myenteric neuron by sub-
stance P, even after continuous exposure to the antagonists 
for 30 min (lower record). 
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Figure 29. Increase in spike frequency by substance P and lack of effect 
by naloxone. Ordinate: spike frequency (10 s epochs). Ab-
scissa: time. The solid bars indicate the periods during 
which the perfusing solution was changed to one containing 
substance P ~n the given concentrations (nH). During the 
period denoted by the diagonally hatched bar, naloxone (300 
nM) was· includeq in the bathing solution. Substance Pcaused 
a marked increase in firing rate which was not affected by 
naloxone. 
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Figure 30. Lack of effect of baclofen on the increase in firi~g ~ate 
produced by substance P on a myenteric neuron. Ordi::-1at.e: 
spike frequency (10 s epochs). Abscissa: time. L~e solid 
bars represent the periods during which the bathing solutio~ 
was changed t.o one which contained substance P (SP, 1 n;·!) and 
the diagonally hatched bar indicates the period when baclofen 
.( 5 1£1) · was inc],uded in the bathing solution. Substance P 
(l nN) produced an increase in firing rate of this unit -,.,rhich 
\'laS not affected by baclofen. 
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P free acid produced a concentration-dependent increase in spike fre-
quency (Fig. 31). 
In order to obtain an equal response on a single unit to a. given 
concentration of substance P, a 10-30 fold higher concentration of penta-
substance P and a 100-600 fold higher concentration of substance P free 
acid was required (Fig. 31) . The proportions of cells -,.;hich were ex-
cited by these peptides may be taken as an approximation of relative po-
tency. About 50% of the cells tested with substai1ce P (1 nH) produced 
~, inGrease in firing rate. In order for 50% of the cells to be affected 
by penta-substance P and substance P free acid, concentrations of 10-30 
nH and 100 nH were required, respectively. Thus, the relative potency 
of the two substance P analogs to substance P has been tested in two 
ways: first, by testing different concentrations of each peptide on a 
single unit. and second, by determining the concentration of each peptide 
which causes an increase in firing rate in 50% of the units tested. 
Figure 31. The effects of substance P and h'lo analogs on two different 
myenteric neurons. Ordinate: spike frequency {10 s epochs). 
Abscissa: time. The solid, horizontally hatched and verti-
cally hatched bars indicate the periods during which the per-
fusin~ soluti9n was changed to substance P, substance P 
pentapeptide (PSP) and substance P free ncid (SPFA) , respe=-
tively. · (a) Sub$tance P produced a concentration-dependent 
increase in firing rate. On this cell, a concentration of 
30 nM substance P pentapeptide produced about ,the same in-
crease in firing rate as did 1 nM substance P. A 300 fold 
greater concentration of substance P free acid was required 
to equal the substance P (1 nM) response on this unit. (b) 
Substance P (1 nH) produced a reproducible increase in firing 
rate in this neurc.n. About a 100 fold larger concentration 
of substance P free acid and a tenfold larger concentration 
of substance P pentapeptide were required to equal the sub-
stance P response. 
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3.4.3. Neurotensin 
Neurotensin was tested on 54 units in pre9arations fro~ 37 ani-
mals. Neurotensin (1-300 nM) increased the firing rate in about 50% of 
those cells tested. For a given unit, the increase in firing was concen-
tration-dependent (Fig. 32); however, the sensitivity among units varied 
considerably. Even at higher concentrations (> 10 ~~) only about half 
of the cells tested were sensitive to neurotensin (Table 11). Little or 
no smooth muscle movement was observed by microscopic examination dur-
ing the application of neurotensin and this permitted the use of higher 
concentrations. The action of neurotensin directly on the snooth muscle 
has been reported to be inhibitory (Kitabji and Freychelt, 1978). 'The 
excitation of myenteric neuro!l.s produced by neurotensin ha.d a time course 
similar to that observed with substance P. The increase in firing rate 
usually lasted throughout the period of application (up to 15 min) and 
the effect produced by a given concentration of neurotensin \vas repro-
ducible on the same unit (Fig. 33): in this respect, the excitations 
produced by neurotensin differ somewhat from those produced by substance 
P. The increase in firing rate produced by neurotensin was not altered 
by solutions containing hexamethonium (100 l-ll-1) and hyoscine (l l.ll'l, n=6) . 
Neurotensin excited neurons in solutions which were calcilli11-free. 
The proportion of cells which were sensitive to neurotensin was the same 
in a calcium-free solution as in solutions with normal concentrations of 
calcium (Table 11) . This suggests that neurotensin is affecting a some-
what different population of cells from those which were sensitive to 
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substance P or enkephalin. Further evidence for this was found in stud-
ies on the action of several peptides on the sane cell (see section 
3.4.5.). 
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Table 11. The effect of neurotensin at different concentrations o~ th8 
Drug 
neurotensin 
firing rate of myen 1:eric neurons in normal Krebs, and in sol·-
utions whic~ were calcium-free (+EGTA 1 m1·1). A.T'l increase in 
firing rate indicates that the firing fre~~ency at least dou-
bled in the presence of neurotensin. The proportion of units 
sensitive to neurotensin did not change vlhen studied in sol-
utions which were calcium-free. 
Concentration Number of 
(nM) Units Tested 
0.1 6 
NUITLl:>er 
Excited 
Nmnber 
Inhibited 
(in normal Krebs) 0.3 1 
3 
1 
17 
0 
0 
1 29 0 
3 13 7 0 
_LI --~~~~-------r-----2~~-----+~----l-2431----~----~~ 
- ~~~ I 1 ~ I ~ 
neurotensin I I I' 
(in Ca-free Krebs) I ~ _L 21 ~ ~ 
10 - ~-____1. ______ 2 ____ ~ _____ 0 ____ __ 
Figure 32. Effect of neurotensin on the firing rate of a m:,renteric neu-
ron. Ordinate: spike frequency (10 s epochs). Abscissa: 
time. During the periods indicated by the solid bars, the 
bathing solution contained neurotensin in the indicated con-
centration (QM) • A concentration-dependent increase in fir-
ing rate was produced by neurotensin at concentrations rang-
,ing from 0.3-lO,nM. 
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Figure 33. Effect. of long applications of ncurotensin on the firing 
rate of a myenteric neuron. Ordinate: spike frequency (10 
s epochs). Abscissa: time. The solid bars indicate the 
periods dl!ring which the perfusing solution contained neuro-
tensin (l nH).. Neurotensin (l nM) produced an increase in 
firing rate which was maintained throughout the period of 
application (up,to 16 minutes). 
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3.4.4. VIP 
The action of VIP (1 pH - 10 nM) was studied on 78 units in tis-
sues from 24 animals. An increase in firing rate was found in 35% of 
the cells studied (Table 12}. The time course of action of VIP was sim-
ilar to that of substance P and neurotensin. The increase in firing fre-
quency was dependent on the concentration (Fig. 34). Repeated applica-
tions of the same concentration of VIP usually resul.ted in progressively 
declining responses (Fig. 35). The effective concentrations of VIP were 
very low: 4 neurons were excited by 1 pM. It is possible that e. higher 
proportion of neurons \·lOuld have been affected by VIP in concentrAticns 
greater than 10 ru"1. The use of concentrations greater than 10 nH was 
not attempted for the follm·;ing reason. One co:TU'Tl.ercially available 
source of VIP (Calbiochem} contains VIP in 100 ng quantities lyophiled 
from 1 ml of a solution containing 0.2% bovine serum albunin (BSA). 
Solutions of VIP exceeding 10 nM therefore contained significant amounts 
of BSA. In control expermients, the tissue was perfused with a Krebs 
solution containing BSA (up to 0.2 g/1): this did not alter neuronal 
firing (n=6) • 
The action of VIP on myenteric neurons was present when the tis-
sue had been bathed i.n calcium-free solutions (Table 12, Fig. 36) and in 
solutions "'hich cc•ntained cobalt chloride (1 m!l). 
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Table 12. The effect of different concentrations c.f VIP on the firing 
rate of single myenteric neurons in nor:c:Jal and in calcium-
free Krebs. An increase in firing rate v:as determined if the 
firing frequency increased to at least 50% over control. The 
proportion of units sensitive to VIP '.·Jas about 45% at concen-
trations up to 1 nM. Some units were sensitive to concentra-
tions as lm-1 as 1 pH. 
VIP I Concentration Number of Nu1nber ! Number 
Units Tested Excited Inhibi ted 
VIP I 1 pM 15 I 4 1 (in I1orma1 Krebs) 3 pM 4 2 0 
I 
10 pM 35 
I 
10 I 0 
30 pM 6 4 I 0 
100 pM 13 3 
I 
0 ! 300 pM 14 3 0 
I 1 nH 29 13 I 0 10 nH 5 5 I 0 ! -
VIP 1 pM 19 4 
(in Ca-free Krebs) 3 pM 1 1 
0 
0 
0 10 p~·! 12 6 
100 H l 0 0 --------------------!----~~~~----~------~------~----~--~----~-----
Figure 34. Effect of VIP on the fix·ing rate of a myenteric neuron. 
Ordinate: spike frequency (10 s epochs). Abscissa: time. 
During the periods indicated by the solid bars, the bathing 
solution contained VIP in the concentration indicated (pH) • 
VIP (~0 pM) ca~sed a marked increase in firing rate of this 
unit, whereas 3 pM VIP caused only a small increase and l pM 
\\•as without effect. 
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Figure 35. Effect of repeated applications of VIP on the firing rate of 
a myenteric neuron. Ordinate: spike frequency (lo s epochs). 
Abscissa: time. During the periods indicated by the solid 
bars, the bathing solution contained VIP (300 p~!). Applica-
tion of VIP caused a modest increase in firing rate which 
became less apparent with repeated exposure and almost dis-
appeared durir.g a longer exposure. 
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3.4.5. Effects of Excitatory Neuropeptides on the Same Cell 
Substance P (1-10 n...'vl) , neurotensin (1-100 nM) and \liP (l pM-1 nH) 
>-Tere studied on each of 53 units. The effects of substance P and neuro-
tensin were initially tested at a concentration of 1 nM and the starting 
concentration of VIP was usually 10 pM. If an increase in firing rate 
was observed with at least one of the peptides, at the initial concentra-
tion, then a higher concentration (up to 100 times the initial ccncentra·-
tion)·of the other peptide or peptides which did not previously cause an 
excitation was applied. tVhen each of the peptides v:as tested at t.he 
initial concentration, 14 (25%) of the units were not affected by any of 
the peptides and 8 (15%) of the units were excited by all three peptices. 
The number of cells sensitive to one peptide and not the other two was as 
·follows: 
11 cells were sensitive only to substance P, 
7 cells were sensitive only to neurotensin 
and 1 cell was sensitive only to VIP. 
The number of cells which were sensitive to two pep tides but· not to t.he 
third was as follows: 
7 cells were sensitive to substance P and neurotensinbut not VIP, 
3 cells were sensitive to neurotensin and VIP but not substanceP 
and 2 cells were sensitive to substance P and VIP but not neuro-
tensin. 
The existence of cells which respond to one of the three excitatory pep-
tides studied and not the other two strongly suggests that there are pop-
ulations of cells Hhich are specifically excited by one of these peptides. 
There is also considerable overlap in the sensitivity to the three p2p-
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tides between cells of the myenteric plexus. 
Figure 36. Effects of two or more excitatory peptides on each of three 
myenteric neurons. Ordinate: spike frequency (10 s epochs). 
Abscissa: time. (a) This experiment was done in calcium-
free Krebs which contained EGTA (l mM) • During the periods 
indi~ated by·the open, vertically hatched and solid bars, 
the perfusing solution was changed to one which contained 
·neurotensin (NT, 1 nM), VIP (1-10 pM) and substance P (SP, 
1-10 nM) . All three peptides caused an increase in spike 
frequency. This unit had about a tenfold greater sensitivity 
·to neurotensin than to substance P. VIP had a clear effect 
at a concentration 1,000 times less than substm1ce P. (o) 
The solid bars indicate the period during which the bathing 
solution contained neurotensin (NT, 1 nM}, VIP (1 nN} or 
subtstance P (SP, 1 nM}. Neurotensin and substance P were 
about equally effective in causing an increase in spike freq-
uency while VIP was without effect. (c) Solutions of sub-
stance P (SP, 1 nM} and neurotensin (NT, 1 nN} were perfused 
during the periods indicated by the solid bars. The spike 
frequency of this unit was markedly increased by substance P 
(1 nM) and only slightly affected by neurotensin (1 nM} . 
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4. DISCUSSION 
4 .1. EXTRACELLULAR RECORDING FROM THE HYENTEHI C PLEXUS 
Extracellular recording in vitro offers many advantages over re-
cording in vivo. Known concentrations of agonists a~d antagonists can be 
added to the bath, the effects of changing ion concentrations in the bath-
ing fluid can be studied and the distinction can be made between direct 
actions of the drug on t.he cell and those mediated t.ranssynaptically. 
However, there are some limi·tations which are common to both extracellu·· 
lar recording in vitro and in vivo. First 1 investigation of ionic mech-· 
anisms with solutions of altered ionic compositions are difficult to in-
terpret because changes in firing rate are only a rough measure of t.he 
action of the agent tmd8r study. A cha.r>go in firing rate can be as a 
result of many possible factors including membrane poc.:en tial, membrane 
resistance, a change in the threshold or sodium inactivation or potassiu:n 
activation. h'hen studying the change in firing rat.e produced by a given 
dr-u.g, the experiment is limited to changes in firing rate which vary be-
tween complete in!-1ibi tion caused by an inhibitory substance and depolar-
ization block caused by an excitatory substance. To investigate ionic 
mechanisms, it must be possible to measure changes in the propert.ios of 
the neuron which are not bcu.'1dcd by the limits which determine \vhether 
the neuron will or \dll not give an action :9otent.ial. Properties such as 
membrane potential, input resistance 1 threshold and n:.:versal potentials 
of drugs in normal Krebs solutions and in solutic-ns cf ult.ered ion con-
centrations are much more useful in determination of U:e ionic mechanism 
by which a drug acts. Second, us_ing extraceLlular recording, it. is net 
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possible to study changes in synaptic potentials. Third, in the present 
study, special attention must be paid to possible changes in firing rate 
produced by movement of the underlying smooth muscle when recording from 
myenteric neurons. All movement of the smooth muscle was eliminated in 
the present experiments by careful pinning of a single ganglion, or by 
using solutions which were calcium-free or contained cobalt {1 mM). 
The primary difference between results from intracellular and 
extracellular recording of neurons from the guinea pig myenteric plexus 
is that spontaneous activity was recorded with extracellular electrodes 
and no spontaneous activity was found when intracellular recordings were 
made. The site of origin of the extracellular activity could acco1mt for 
this difference between the two techniques. That is t.o soy, intracellu-
J.ar electrodes record activity in the cell soma, whereas ""xtraceL~ular 
electrodes may record activity from other sites, such as the C8ll pro--
cesses or terminals. It is difficult to identify the source of the ex-
tracellular activity definitively; however, all indications suggest it .... " 
the cell soma. (1) The strongest such indication is that spontaneous 
action potentials or evoked ali-or-nothing potentials were record(:~d only 
from the surface of the ganglia and were never recorded from the inter-
connecting strands. (2) The only activity which was recorded from the 
interconn2cting stra..1ds was electrically evoked, graded with the inten-
sity of stimulation and had a multiphasic waveform. Because few cell 
bodies are found in these strands, it is likely that the graded, short 
latency, evoked po'L~entials \-rhich were recorded, v1ere from cell processes. 
(3) The waveform and time course of the spontaneous extracellular spikes 
recorded from the ganglion surface also suggest that the source of the 
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activity is somatic. The time course of the action pote~tial corresponds 
to the first time differential of that recorded >vith intracellular elec-
trodes (Nishi and North, l973a). The monophasic or sligl:tly biphasic 
waveform of the potential is usually considered to be somatic (De Valois 
and Pease, 1973). This waveform indicates that there is a good resistive 
seal around the electrode. If the resistive seal was smaller, two changes 
in the extracellular spike would result. First, the amplitude of thespike 
would become much smaller due to an increased a..--nount of e:!.ec·trical shlmt-
ing between the recording and indifferent electrodes·. Second, one might 
expect to record the field potentials from the cell w--:tich 2-.re set up hy 
the membrane currents during the action potential. The fielJ potePtials 
would result in a triphasic waveform which is proportional to the second 
differential of the change in cell potential vli th respect to time (Hubbard, 
Llinus and Quastel, 1969). 
The resistive seal around the electrode is sufficiently go(x1 that 
the extracellular potential is coupled to the intracellular potenLi:1l by 
the capacitance of the cell mernbra!'1e. Under these conditions the extra-
cellular spike should be in the opposite polarity to the intracellular 
spike and the wavefoxnt would be proportional to t.he first differential of 
the change in potential with respect to time (Hubbard et al., 1969). In 
p:r·actice the polarity and waveforra of the extracellular spikes usually 
conformed to this prediction; however, spikes of opposite polarity and of 
varied waveform (syrt,;r.etrically biphasic rat.her than monophasic) \·mre re-
corded occasionally. These spikes were more often seen ,.;hen using large 
recording electrodes (> 70 ].!n). There are at least b·:o explanations which 
may accoUl'1t for the variation in spike polarity and \·?a.veform. (1) The 
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resistive seal around the electrode is not perfect. ~·;:Cen recording extra-
cellularly using ·the sucrose gap method, the resistance betwec:n the re-
cording and indifferent electrodes was reported to be usually nore thm1 5 
Mst (Nishi and Koketsu, 1968). Using this method the extracellular poten-
tials are opposite in polarity but s~~ilar in wavefo~n and amplitud~ to 
the intracellular potentials. Because a sucrose gap involves the resis-
tance of a population of cells over a fairly large (1 mm) gap, it is dif-
ficult to compare the resistance seen using sucrose gap .,.,ith the resis-
tance observed with a suction electrode. However, tl:ere is at least a 
tenfold difference between the resistance measured by tl-:e tv.·o methods, 
and this may account in part for the differences in spike polarity, atnpli-
tude and waveform seen using the suction electrodes. (2) An e:1tire cell 
body is not always covered by the suction elec:t.roCl.:'. ;;h:;,n a large <:::lee-
trode (> 70 f.Jffi) is used, one might expect that parts e;f. several eel} bod-
ies would be covered. If a large part of the cell bod.y ,,;ere not co'.'ered. 
by the electrode, the membra.-'1e current produced durir:g a:1 action potential 
by this part of the cell may result in a large local field potential. 
These field potentials, and not others, are recorded b2ca~se of the prox-· 
imity of the electrode to the source and the relativel~· la.rge size of t:he 
source (cell body as opposed to cell process). If a largs p3rt of the 
cell body is outside the e~ectrode, then the polarity of the E:piJ:e shoulcl 
be opposite (posi·tive) to that which is recorded when the cell is mostly 
beneath the electrode. 1[ half of the cell '.Yas cover•;;ci b'J the electrode, 
then the waveform might be expected to be symrnetrical~.y biphasic. 
The small size of the clectracellular potentials recorded r<~ight 
i.ndic'J.te that their source is '.:\ smaller st.ructure tha.;1 the cell so:na. 
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Ho·..rever, the use of a large, lovr resistance electrode may result in atten-
uation of extracellular potentials. In fact, on theoretical grounds, the 
size of the potential can be predicted (appendix 1). Even if the elec-
trade made a perfect resistive seal around a cell 1 such that all the cur-
rent generated by the cell resulted in a potential difference recorded at 
the electrode,-the potential would be only 1-5 mV. If the recording was 
from a cell process, the maximt~ potential would be only 50-150 ~V. These 
considerations therefore suggest that the extracellular electrodes are in 
fact recording potentials which are derived from the· s~~a spike. 
Another possible consideration which may explain the origin of 
the spontaneous extracellular act.i vity is that under the conditions of 
extrc:tcellular recording, tlw n ~urons "·ere S:f'11dl'tically d:river:., and tha.t 
synaptic activity v1as nbse:nt in the intracellular record::.ng e);.perirc.2nts. 
'I'his f'OSSibility \•TaS test.ed in bvO ways: (1) By the use of c.':llciu:n-·-:':::::ce 
solutions and (2) by the use of cobalt. Calcium-free solution blocked 
synaptic 1:·L"an.s;nissicn (Dingledine and Goldstein, 1976), b11t had a. de::;,ol-
arizing effect on its O\vn (Nishi and North, l973a) . The depolarization 
of cells in calcium-free solutions may then substitute for the decline 
in any ongoing synaptic influences such that the firing rate was main-
tained. Solutions which contc..in cobalt (1 nH) also block the e.p.s.p. 
and have no effect or a ver-J sn;o.ll depolarizing effe~t on membrane paten-
tied (Kat.ayama and North, nnpulJlishcd results). In the present study, 
the firing rate, of myent,:-r.ic neurons \·;as not affected by solutions which 
contained l rn~ cobal1~ (n=G). 
It appears that U1c exi~racellular electrodes are recordin'] from 
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t!-le cell soma of myenteric neurons and that the sponta:r,e:ms activity is 
not due to ongoing synaptic activity. The neuronal o.ctivity recorded 
with extracellular electrodes is thought to be induced by the large suc-
tion electrodes based on the following observations. First, no spontan-
eous activity was recorded with suction electrodes having a tip diameter 
less than 30 ~. but electrically evoked activity could be recorded with 
these 5mall suction electrodes. Second, the firing rate of some units 
could be increased or decreased by using greater or lesser amounts of 
suction. Third, sometimes when the electrode was placed on the ganglion 
with suction and no activity was recorded, excitatory agents adder'! to the 
bath would cause a ur'li t to begin firing. Likewise, units other than the 
one being recorded v10uld sometimes begi:'l to fin" wh'=n ezci t::atcry ag8nt.s 
were added to the bat.h. 
Although the single spike and burst type firir.g patterns pre-
viously described may represent different function::;.l t:,:pes of neurons 
within the myenteric plexus, little physiological significance can be 
ascribed to this activity since it is thought to be artificially induced 
by the suct.ion electrode. As a model to study the action of various 
agents on neuronal firing, it is in some respects analgous to artificial 
induction of fi.rin~ in many studies by iontophoretically applied gluta-
mate. The use of me.chanical irritation of the cell to in::luce firing may 
be, in some respects, <:m improvcnent over the use of excitatory amino 
acids because it eliminates possible interact io:1s {or pro::::>osed inter-
act: ions) betw.:,en t~e agent being studied and the exci tato:cy agent used 
to stimulate the cells. 
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Nechanical irritation of the myenteric n""urons b~· t'!"'.e su-:::tion 
electrode may also be closer to a physiological stimulus ::ha.:-1 cne migh·t 
expect since the gut \vall is subjected to chc>..nges in pressure and marked 
changes in diameter during the passage of luminal contents through the 
gastroi.ntestinal tract. The ganglia of the myenteric plexus undergo 
clear changes in size with the amount of stretch which is put on the 
longitudinal muscle when pinning out the tissue. Similar changes in size 
and shape of the ganglia are observed in tissues where the longitudinal 
smooth muscle is spontaneously active. The movements of peristalsis must 
also result in mechanical deformations of the ganglia in vivo. It. lS pos--
sible that application of a suction electrode simulates so~e stage of dis-
tension which is present during peristalsis a.'1d this results in the fir-
ing of myenteric neurons. 
The sensitivity to various agents, both exci ta~ory and inhihi tory, 
varied among units. One explanation is that the myenteric pleX'.1E" L, a 
heterogeneous population of cells and that certain cells are much more 
sensitive to some agents than are other cells (see sections 3.4.1. cmd 
3.4.5.). Another possibility is that the intensity of st.L"":lulatior: p:co-
duced by the suction electrode could alter the response of a cell to any 
given agent. The c:.rnount of suction does alter the firing rate of some 
neurons. It i.s possible that the degree of inhibition or excitation pro-
duced by a giv2n agent could be altered by the amount of suction in the 
elect1~ode. Thr~ sensitivity of units to inhibitory agents also seemed to 
vary vrith the size of the suction electrode; units roco.::-ded v:ith large 
(70-90 )JTII) electrodes being less sensitive than those recorded vlith smaller 
electrodes. Presumab.l~', a larger electrode or an increased a.r:tount of sue-
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tion offered a greater source of stimulation such ttat: it took a greater 
concentration of inhibitory substctnce to overcome the sti.:im1ation. This 
explanation may account for the variability in the degree of i~:hibition 
or excitation produced by inhibitory or excitatory agents among popula-
tions of sensitive units. 
4. 2. THE ACTION OF OPIA'l'ES AND ENDOGENO'JS OPICID P:SPTIDES 
Morphine has been shown to inhibit the firing rate in 90% of 
myenteric neurons tested (Dingledine, Goldstein and Kendig, 1974; Dingle-
dine and Goldstein, 1975; 1976). This inhibition was found to be media-
ted via opiate receptors located on the cell being studied and not medi-
ated through a synaptic mechanism (Dingledine and Goldstein, 1975; 1976). 
The present results confirm these findings and extend the observations to 
the endogenous opioid peptides. In addition, the action of morpi1ine \O:as 
test.ed in solutions o-: altered ionic composition. Z·!orp!"linG appeared to 
be equally effective in solutions containing high pot.assi'lEn, low potas-
siurn and low chloride. These results cannot bo taken as definitiv<: e'!i-
de nee against the involvement of these ions in the act ion o£ raur!_):hinc~ ,. 
since neuronal firing could still be inhibited by morphine even if the 
ionic mechanism of its action involved one of these i.cns. The driving 
force for a potential change caused by morphine rr.ay bs shifted markedly 
by changing the extracellular concentration of potassiu .. :n or chloride. If 
the firing rate was dependent only on the potential of the cell, the ef-
fect produced by morphine on the firing rate might also be changed by 
changing the driving force of the ion or ions involved. Since t.hc" firing 
frequency is not dependent only on potential, a change in the driving 
force produced by changing extracellular ion concentration3 may not alter 
the effect of morphine. For example, it is possible that norphine causes 
a large increase in conductance, which results in block<1de of propagation 
of the action.potential by shunting the current through the nembranP. 
The fall in membrane resistance would still occur in solu'c.ions 11hich 
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markedly alter the driving force of the ion or ions invol·,red in the ac-
tLon of morphine. 
The endogenous opioid peptides, met- and leu-enkephalin and 8-
endorphin all inhibited neuronal firing in the myenteric plexus. These 
inhibitions are considered to be opiate receptor mediated for the follow-
ing reasons. First, the effective concentration of agonists were low. 
Second, the inhibition was blocked or prevented by lo, .. ;er concentrations 
of the opiate antagonist naloxone. Third, the active benzomorphan anta-
gonist Mr-2267 was effective in blocking the inhibition produced by these 
peptides whereas an equal concentration of the inactive isc:ner Hr-2265 
was ineffective. The inhibition produced by the opioid peptides was not 
blocked by phenoxybenzamine, propranolol or by solutions ir: which synap·-
tic transmission was assumed to be blocked. 
Met-enkephalin was found ·to inhibit the firing rate of my,~ntcric 
neurons at. lower concentrations (about 10 times) than morphine and no:c-
morphine. However, morphine, met-enkephalin and B-endorphin were equally 
effective in inhibiting the electrically induced contraction of t.he guineo:t 
pig ileum myenteric plexus-longitudinal muscle preparatio:-1 {Lord, t·later-· 
field, Hughes and Kosterlitz, 1977). The metabolism of net-enkephalin is 
one explanation for the differences found between the results obtained 
using the contractile response and those obtained using extracellular re-
cordings. The effects of metabolism were studied on the cont:::-actile re-
sponse using enkephalin analogs which were more resista:1t to metabolic 
degradation. The analogs were up to 6 times more effective than met-
enkephalin in inhibi tL'lg the contraction and yet coillpared to r.-tet-enkephalin 
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there was little change in the ability of the analogs to displace naloxone 
from opiate binding sites (Lord et al., 1977). Thus, it appears that in 
that preparation,metabolism of met-enkephalin does decrease its effective-
ness. The effect of metabolism on the inhibition in firing of myznteric 
neurons under the conditions of the present experiment are limited. The 
size of the tissue is small, so that the ail'.ount of metabolism is limited 
by the relative lack of peptidases. The tissue is continuously perfused 
with fresh Krebs solution, and during the period of peptide application, 
fresh peptide solution continuously perfuscs the tissue. Under the condi-
tions .used for extracellular recording, the ganglia of the myenteric plex-
us are laid out flat such that they are directly exposed to the peptide 
containing solutions. 
It is also possible that the inhibition in fi:ring rate is mediated 
by a different type of opiate receptor from the one whic~ decreases the 
release of acetylcholine from the nerve terminals. There is mounting evi-
dence that the myenteric plexus contains a heterogeneous population of 
opiate receptors (Lord et al., 1977). Demonstration of separate popula-
tions of receptors using extracellular recording requires qua..'1titative 
studies such as determination of p~ values of antagonists and precise 
determination of relative potencies of a series of agonists. Such quanti-
tative experiments are rendered impossible because there is ~oo much var-
iability inherent in the method of recording with extracellular suct.ion 
electrodes (see 4.1.). 
There is a large amount of variability among uni t.s in the response 
to a given concentration cf a single 0piate or opioid peptide such that 
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only general qualitative statements can be made about the relative potency 
of a series of agonists. 
A membrane stabilization of hyperpolarization was proposed as 
being a possible mechanism of action (Dingledine and Goldstein, 1976). 
SUbsequently, morphine \'las found to hyperpolarize a population of neurons 
(North, 1976; North and Tonini, 1977). However, the proportion of units 
in which the firing rate is decreased is much larger than the population 
of neurons in which a hyperpolarization was found. O:l.e possible explana-
tion is that extracellular recording selects specifically the population 
of neurons which have opiate receptors. The cells •. ,hich ' . ..;ere r:.ost often 
sensitive to the narcotics using intracellular electrodes '\·•ere the type 
I cells (North apd Tonini, 1977). These cells are nore excitable t.han 
type II cells (Nishi and North, 1973~, and it is likely that these cells 
would fire more readily when stimulated by a large suction electrode. 
Another explanation may be that extracellular electrodes record paten-
tials which are only rarely recorded at the soma with intracellular elec-
trades. There is now evidence from experiments using iontophoret.ic ap-
plication of enkephalin that the hyperpolarization in the soma originates 
in the processes (North, Katayama and Williams, 1979). It is possible 
that the firing recorded extracellularly originates from irritation of a 
cell process close to the soma (the extracellular electrodes were usually 
30-70 1Jffi in tip diameter) and that the hyperpolarization produced by opi-
ates at this site acts to inhibit the firing. 
Another difference between the results obtained fron intracellular 
and extracellular techniques is the occurrence of tac!1y;::hylaxis to the 
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hyperpolarizing effect of the opiate and opioid peptides. If the hyper-
polarization recorded at the cell soma was solely responsible for the in-
hibition in firing rate recorded extracellularly, then why is there little 
sign of tachyphylaxis to the inhibition in firing rate produced by the 
opiates or opioid peptides? One possible explanation may be that impale-
ment of a neuron with an intracellular electrcde renders the cell unable 
to respond to the opiates over an extended period of time. Such a change 
in the cell may be rela-ted to leakage of chloride ions from the microelec-
trode (North and Tonini, 1977). It is also possible that impalement of 
the neuron results in a slow change in the dendritic-soma conductance 
ratio, such that potential and resistance changes Hhich originate in the 
prOCf:!Sses may be progressively attenuated when recording at the cell soma. 
A swelling of the cell soma following impaleme:1t has been noted and could 
result in changes in the dendritic-soma conductance ratio. It is also 
possible that another mechanism other than hyperpol::1rizat.ion causes tbe 
inhibition in firing rate. As previously discussed, one possible mech-
anism is a marked increase in conductance to some ion such as chlo::::ide or 
potassium which results in blockade in propagation of an action potential 
down a process at some point. A decrease in resistance was seen in al~ut 
one half of the myenteric neurons which were hyperpolarized ru1d a measure-
ment of input resistance was made (North, Katayama and \·lilliams, 1979) . 
No change in resistance was ever noted in neurons which v1ere not hyper-
polarized by opiates or opioid peptides. This was taken as evidence indi-
cating that the opioid peptides act at a site a\.;ay fro::n the cell soma. 
The occurrence of a hyperpolarization with a decrease in input resistance 
in some cells and not others was perhaps due to variations from cell to 
cell in the dendritic-soma conductance ratios. The fact that a change in 
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conduc:tance was never seen in the absence of a hyperpolarization may be 
interpret.ed in at least two ways. First, these cells are not sensitive 
to the opiates of opioid peptides. Second, these cells are sensitive but 
have a ve1·y low dendritic-soma conductance ratio such that potentials in 
the processes cannot be recorded in the soma. The fact that an increase 
in conductance-was never observed in the absence of a hyperpolarization 
strongly suggests that the hyperpolarization is at least one mechani::;m 
v1hich decreases neuronal excitability and an increase in conductance is a 
second possible mechanism -v:hich is less often recorded in the cell soma. 
Studies on the ionic mechanism of action of the opiates and opioid 
peptides using extracellular recording techniques have been limi·ted as 
previously described. 'I'he same studies using intracellular rE:cording 
te::hniques have been limited by the number of cells which give reproducibl0 
responsesi hm.,ever, a few isolated experiments have been done \vhich verify 
the results obtained with extracellular recordings. In one cell, the 
hyperpola.ri:>:ation produced by met-enkephalin (300 nH) was not altered in 
a solution containing low chloride (10 nM) and in two other neurons the 
action of met-enkephalin {300 nM) was still present in solutions >vhich 
were calcium-free (did not contain EGTA) {North and Williams, unpublished 
results). Further experiments in solutions of altered ionic composition 
are required to elucidate the ionic mechanism of the action of the opiates 
and opioid peptides. 
The inhibitions caused by the enkephalins and B-endorphin are 
mediated through an action directly on the cell under study rJCcause they 
persi~;t in calciwn·-fxee solutions. These experiments also indicate tha'...: 
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calcium ions are not required for this action of opiates. SL~ilar re-
sults were obtained for the inhibition of firing produced by morphine 
(DingledL~e and Goldstein, 1975; 1976). The proportion of units sensi-
tive to enkephalin was reduced in calcium-free solutions as was reported 
when studying the action of morphine (Dingledine and Goldstein, 1976). 
Although it is not possible to distinguish absolutely different types 
of units using extracellular recording, the appearance of morphine and 
enkephalin insensitive units in calcium~free solutions strongly suggests 
that the insr='nsi tive cells are the type II cells of the intracellular 
classi-fication. First, the excitability of type II cells has been shown 
to increase in calcil.®-free solutions due to the removai of the calcium-
dependent slow after hyperpolarization follu.ving the spike (Nis!-'.i and 
North, 1973; North, 1973). Second, ty-pe II cells have been shown to b2 
less sensitive to the hyperpolarizing action of morphine when studie-::1 
using in·tracellular techniques (Nort.h and Tonini, 1977) . 
Increasing the calcium ion concentration (10 rr::.!) always dec1:eased 
the firing rate of myenteric neurons. This inhibition •.·;as not mediated 
byopiate receptors but through a stabilizing effect of the calcium ions 
on the cell membrane. There are at least two mechanisms by which calcium 
can st.abilize the neuronal membrane to inhibit spike firing: first, by 
suppressing sodium activation (Koketsu, l9G5) and, second, by increasing 
the int.racellular calcium concentration which increased potassiurn conduc-
tance (Krnjevic and Lisiewicz, 1972; North, 1973}. The role of calcium 
ions in the action of opiates at other sites is some>vha'l~ conflicting. 
Elevating the extracellular calcium ion concentration in. vivo has been 
folU1d to overcome the action of mo:r:phine (Takemori, 1952; Yakunaga, 
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Kancto and Hano, 1966). On the other hand, decreasing calcium levels 
with EGTA or lanthanum resulted in a potentiation of the antinociceptive 
effect of morphine in rat (Harris, Loh and Nay, 1975). The release of 
transmitter substances from in vitro preparations which are sensitive to 
the opiates is decreased by morphine (Paton, 1957; Schaumann, 1975; Hen-
derson and Hughes, 1974). Increasing the extracellular calcium ion con-
centration increases the release of transmitter from the nerve terminals 
which are sensitive to opiates (Henderson and Hughes, 1974). However, 
this effect of calcium is common to all neurotransmission sites, not only 
those-which are sensitive to opiates. The action of calcium probably has 
a much greater effect on the release of transmitter substances ir:. viYb 
a'1d in vitro than on the stabilization of neuronal exci tn~ility and inhi-
bition of firing which was studied in the present expcrLnsnts. 
The physiological significance of the effects produced !Jy E',nJ~e-
phalin and S-endorphin remains to be determined. Concentrations c£ s-
endorphin as low as 3 nM were found to inhibit some myenteric nr:;uro'1s. 
This concentration is about the same as that which was fou:r1d in the pla2ma 
of rats after stressful stimulation (Guillemin et al., 1977). Stress-
induced release of S-endorphin has not been measured in t.he guinea pig. 
It seems unlikely that the myenteric plexus is a target orsan for hlood 
borne B-endorphin since only a small proportion of myenteric neurons were 
inhibited by concentrations in the 1-3 nN range. Concentrations of met·· 
enkephalin of 3 nM were much more effective in producing an inhibition of 
firing in the myenteric plexus. Enkephalin has been sho·w~n to be contained 
within the neurons of the myenteric plexus, and in view of its actions 
upon single neurons, it seems possible that electrophysiological evidence 
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for its release by electrical stimulation could be obtained, Hm.,rever, 
repetitive stimulation (0.1-10 Hz) for up to l min only rarely caused 
any inhibition of neuronal firing and this was never affected by naloxone. 
Repetitive stimulation more often caused .a longer lasting excitation. It 
is possible that naloxone-reversible inhibitions may have been occluded 
by concomitant release of other transmitters. The longer lasting excita-
tory response was not studied in detail. It is possible that this exci-
tation is produced by release of one or another of t:he excitatory neuro-
pcptides. 
4. 3. THE ACTION OF SOHATOSTATH; 
Somatostatin is found in cell bodies and nerve terminals of the 
myenteric plexus (Costa et al., 1977) and the present study shows that 
it causes an inhibition in firing rate of single ~yenteric neurons. In-
hibitions of firing rate were produced by soillatostatin in the sa~e con-
centration range as the effective concentrations of met-enkephalin. Sorr.e 
units were also inhibited by concentrations of so:-:~atostatin which \•lere 
found. to inhibit growth hormone release ( 3 ni<!) (Brazeau et a~. , 1973) • 
These results may be taken as evidence in support of a physiological role 
for somatostatin in the myenteric plexus. The action of somatost.:..tin \vas 
probably not mediated through an opiate receptor nechanism for two rea-· 
sons: first, naloxone never altered the inhibition in firing rate pro--
duced by somatostatin and, second, some cells which were not senc:;itj_vc 
to high concentrations of enkephalin were found to be sensitive to lov7 
concen·trations of somatostatin. 'rhe inhibition in firing produced by 
somatostatin was not blocked by phenoxybenzamine or propra11olol and per-
sisted in solutions which were calcium-free, indicating the action was not 
due to release of an inhibitory transmitter and \-.'as not dependent en the 
presence of extracellular calcium. 
A population of neurons exhibited tachyphylaxis to the effects 
of somatostatin. This was more apparent at highAr concentrations. How-
ever, even at higher concentrations, if the interval between applications 
was extended, reproducible responses could be obtained. The occurrence 
of tachyphylaxis to somatostatin contrasts \·:.ith the effect.:s produced by 
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enkephalin which prQduced little or no sign of desensitization. Similar 
results were obtained with the electrically induced contraction of the 
myente!.-ic plexus longitudinal muscle preparaticm (Guillemin 1 1976). 
Somatostatin inhibitedthe contractile response and marked tachyphylaxis 
to thiE inhibitory effect was noted. The concentrations of somatostatin 
(700 nM - 2 .1 ~M) used to inhibit the contractile response were much 
higher than those effective in decreasing the firing rate of myenteric 
neurons. The inhibition of the contractile response to electrical sti-
rnulation by somatostatin was not affected by naloxor).e. Furthermore, 
during the periods Hhen the response to sornatostatin ''as desensitized, 
the effect of B-endorphin was unchanged, which also indicates that soma-
tostatin does n0t act via opiate receptors • 
.:i:ontophoretic applicatiou of somatostatin (curre;·,ts up to 30 nA) 
decreased the firing rat.e of cerebellar, cortical and hypothal::L<•.i~ neu-
rons of 1.·at (Renaud et al., 1975) a..'1d neurons from la-rti::-~a I-III of the 
spinal cord from cat Cr1iletic et al., 1977 i Randic and :-Iiletic 1 1978) • 
The inhibition in firing rate produced by sornatostatin a·:: these sites, 
as well as myenteric neurons 1 may be due to a membrane sta'>)ilization or 
hyperpolarization. Hmvever, in the in_ vivo studies, an indirect action 
c2.nnot as yet be ruled out. Using the sucrose gap method 0::1 the isolated 
frog spinal cord, somatostatin was found t:o cause a hyperpolarization 
recorded from the dorsal roots in solutions where synnptic transmission 
was blocked (Padjen 1 1977). However, the hype:r.polarization in frog spi-
nal cord required 100-1 1 000 times the concentrat.ion than that ,,;hich pro-
duced an inhibition in firing of myenteric neurons. It r..ay be that the 
frog spinal cord preparation is nn1ch less sensitive than myenteric neu-
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rons or, possibly, the inhibition in firing is due to so~e other mech-
anism and hyperp.).larizations are seen only at higher concentrations. 
Iontophoresis of. somatostatin at other sites has caused an in-
crease in neuronal excitability (Dodd and Kelly, 1978; ~offe, Havicek, 
Friesen and Chernick, 1978). A depolarization and increased excitability 
in response to somatostatin was found with intracellular recordings from 
CAl and CA2 cells from slices of rat hippocampus (Dodd and Kelly, 1978). 
An increase in firing rate \vas also seen in response to somatostatin in 
s0nsorimotor neurons from rabbits record<.:!d in vivo (Iof:f:e et al, 1978). 
In the study by Dodd and Kelly (1978), the iontophoresis electrode vms 
filled with somatostatin (3 nK) dissolved in sodium acetate (5 nll·l, pH'"' 
7.0), ar1d a negative curren·t (196 nA) was used to eject the peptl.d:c;. In 
the other study, the iontophoresis electrode was fillec \·lith somatosL:~tin 
(5 nl-1) in distilled water (pH not indicated) and the peptice was ~d ect.ed 
as a cation (l0-50 nA). In no study was the a1nount of sonatos~at:in 
ejected from the electrode measured. It is possible that the pH of th= 
solution in the electrodes may account for the different polarities of 
current used in these studies. 
The excitatory effects of somatostatin may be due to an indirect 
action of somatostatin. It is difficult to demonstrate a direct action 
using iontophoretic application of somatostatin or any other peptide 
using an in vivo system, and indirect effects were no::. c:onsidered in the 
study using hippocampal slices (Dodd and Kelly, 1978). 
4.4. EXCITATORY PEPTIDES 
4.4.1. Substance P 
Substance P caused an increase in firing rate in the majority of 
myenteric neurons. The excitation produced by substa11ce P was notal ten~d 
by calcium-free solutions, solutions which contained nicotinic and mus-
carinic antagonists or solutions in which all sr.1ooth ::mscle movenents 
were eliminated. These results indicate that the action of substance P 
is directly on the neurons from which recordings -;·;ere nade. The effec--
tive concentration range (300 pH - 30 nM) in this preparation is cor:lpClr-
a.ble with other in vitro preparations (e.g. contraction of the gui;:wa 
pig .:..:.€.;.1..-:-,- ?..osell, Bja.::::-:croth, Chang, Yar:1aguchi, ~·Jans;, rta.ckar, Fishe.r 
and Folkers, 1977 and contraction of the guinea pig va;_; de£erer:::; - Zet:ler, 
1977), and with the Kd (3 nM) for binding sites in brain ho:nogen2.tcs 
using tritiated substance P (Nakata et al., 1978). These corr0lations 
may be taken as partial proof that the increase in firing rate produced 
by substance P on myenteric neurons is mediated by a sii'lilar receptor. 
It is difficult to compare the concentrations used in iontophoretic stu-
dies on single neurons in vivo with the concentrations of substance P 
used in the present study. However, substance P caused a depolarization 
of motor neurons in the isolated spinal cord of frog (Konishi and Otsuka, 
1974~) and newborn rat (Konishi and Otsuka, 1974£) which required 30-100 
times the concentration of substance P which · .. ras effective on the myen-
teric neurons. 
There was some tachyphylaxis to the effects of substance P on 
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myenteric neurons. Desensi tizat.ion and variable responses to iontophor-
etic application of substance P on central neurons has also been reported 
(Krnjevic and Horris, 1974; Henry, Krnjevic and :-!orris, 1975; Davies and 
Dray, 1976; Le Gall La Salle and Ben-Ari, 1977; Sastry, 1978a). It is 
difficult to determine, using extracellular recording techniques, the 
mechanism of this apparent desensitization. It is possible, for example, 
that depolarization block may account for decreasing effects of substance 
P. 
The specificity of the action of substance P was tested TH:L th two 
analogs (penta-substance P (7-ll) and substance P free acid). Studies of 
structure activity relationships of substance P on the depolarization of 
newbora rat spinal mot:or neurons have demonstrated that even smal1 ch;mges 
in the amino terminus of the substance P molecule drastic2lly alt.?rs the 
biological activity (Otsuka and Konishi, 1977). Removal of the firs'c 5 
amino acid residues from the carboxy terminus did not alter the :hio1_ogical 
potency significantly. However, the activity dropped off markedly witn 
further elimination of carboxy residues. The penta-substa,ce P (7-ll) 
analog was at least 50 times less potent than substance P on the rat spi-
nal motor neurons (Otsuka and Konishi, 1977). In the present. study, the 
pentapeptide analog was about 30 times less active than substance P. The 
substance P free acid analog has not been studied in other preparations. 
However, removal of the terminal methionine residue decreased the biolog-
ical potency by 2,000 fold, as measured on the rat spinal motor neurons 
(Otsuka and Konishi, 1977). These results, &'1d those of the present study, 
are consistent with the observation that small changes in the amino end 
of the substance P molecule can markedly change its biological potency. 
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Baclofen, a proposed substance P antagonist (Saito et al., 1975), 
was ineffective on the substance P response in myenteric neurons and had 
no effect on its own. The action of baclofen at other sites has been re-
ported to be GABA-like (J<rnjevic, 1977). Baclofen decreases the firing 
rate of spontaneously firing neurons and blocks excitations produced by 
acetylcholine and glutamate as.well as substance Pin the substantia 
nigra (Davies and Dray, 1976), spinal neurons (Henry and Ben-Ari, 1976) 
and. interpeduncular neurons (Sastry, 1978a). It appears that baclofen 
only antagonizes substance P effects when baclofen itself has a depress-
ant action. 
The present results show that substance P is effective in low 
concentrations and these are similar to those L'1 which it binds to rat 
brain homDgenates (Nakata et al., 1978). These results are not inconsis-
tent v!ith a neurotransmitter or neuromodulator role of substance I' in thE: 
myent.eric plexus. Further study on the action of substance I' using int:L2.-
cellular techniques may provide more conclusive evidence on the role of 
substance P in the my2nteric plexus (see 4.5.). 
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4.4.2. Neurotensin 
Neurotensin produced an increase in the firing rate of myenteric 
neurons similar to that caused by substance P. The effective concentra-
tion range and the time course of action of neurotensin \•:ere both about 
the same as for substance P. The increase in the firing rate was not 
affected by calciuin-free solutions or the presence of cholinergic a:.1tago-
nists. There vlere some notable differences between the effects of neuro-
tensin. and substance P. First, since the longitudinal smooth r:mscle was 
not stimulated by neurotensin directly, higher concentrations could be 
studied. Second, t::1e increase in firing rate produced by neurotensin was 
roo:::::e reproducible and did not exhibit tachyphylaxis as did the excitations 
causecl. by substance P. Finally, the population of cells which were sen-
sitive to ne•1rotensin ':.>as not the same as that for substFLnce P: tha·t is 
to say, there were cells which were affected by substance n but not by 
neurotensin and vice versa. 
An increase in firing rate in response to neurot.ensin a.}_Ji_)lied by 
iontophoresis has been repo1.-ted at several sites in the central nervous 
system (frontal cortex, hippocampus, striatum and lateral thalamus) 
(Zieglga'1sberger, Siggins, Brmvn, Vale a..'1d Bloom, 19 78) . It is not pos-
sible to correlate the concentrations used in the present study with stud-
ies .,,hich used iontop~oretic application. Hm1ever, the effective concen-
tration rang·e in the pYC:!sent study is in the sarne range (l-100 nH) as 
that \-:hich contracts the guinea pig ilemn (Seqawa, Hosoka\·:a, Kitagn.wa and 
Yajirna, 1977; Kitab<Ji and Freyc:tet- 1 1978). 
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The physiological significance of the increase in firing rate 
produced by neurotensin in myenteric neurons is not k..11::Y:m because the 
peptide is not found in neurons of the plexus. Neurote:-~sin is found in 
high concentrations in endocrine-like cells of the ile~~ (Sundler, Alu-
mets, Hakanson, Carraway and Leeman, 1977; Sundler, Hakanson, Hammer, 
Alumets, Carraway, Leeman and Zimmermru1, 1977). It is possible that the 
neurotensin released from these cells in response to local distension may 
act as a local hormone which alters neuronal excitability. 
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4.4.3. VIP 
VIP caused an increase in the firing rate of a population of my-
enteric neurons in a concentration range of 1 p:·I to 10 nH. Th.e use of 
higher concentrations was prohibited because the peptide was obtained in 
small quantities (100 ng) which were lyophiled from a solution containing 
0.02% BSA. This excitation was a direct action on the neuron under study 
since VIP was equally effective in solutions which were calcium-free and 
in solutions which contained cobalt (1 mM). 
Excitation of cortical neurons has been reported using ic·n·:::.ophor-
etic application of VIP (Phillis, Kirkpatrick a.'1d Said, 1978). Also, in 
this study, VIP and substance P were applied by superfusion to the iso-
lated toad spinal cord preparation: VIP was 2-3 times :aore potent ·than 
substance P in depolarizing both the dorsal and ventra~ roots. However, 
the effective concentrations of VIP and substance P were very high (VIP, 
3-6 J.ll>l; substance P, 6-20 lJ..T\1) • It was implied that the increase in fir-
ing rate of ~ortical neurons was a result of a depolarizing action of VIP 
similar to that on the toad dorsal and ventral roots. 
The results from the iontophoretic experiments suggest that the 
neurons were very sensitive to VIP since low concent-rations of VIP {300 
l.IJ'.1 in 100 mM NaCl) vlere used in the iontophoresis electrodes. The trans-
port number of VIP under those conditio:1s must be very lor.·l. The increase 
in firing rate produced by iontophoretically applied VIP often decreased 
with repeated applications. The results from the present study on myen-
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teric neurons indicate that VIP was effective at concentrations 100 fold 
less than the effective concentration of substance P, although the popu--
lation of myenteric neurons which were sensitive to VIP '~Tas much smaller 
than the population sensitive to substance P. The increase in firing 
rate of myenteric neurons produced uy VI~ added to the perfusing solution 
tended to decline with repeated applica·tions of VIP as did the increase 
in firing of cortical neurons produced by repeated iontophoretic applica-
tions. 
VIP is an important peptide in the gut, in terms of the large 
quantities which are contained within the nerve processes and cell somata 
(Larsson et ~1:.·, 1976; Fux, Hokfelt, Said and t-lutt, 1977). Its action on 
the firing rate of rr,yenteric neurons may support a possible neurotrans-
mitter or neuromodulator role in the plexus. Hmvever, further study with 
pure VIP is required to demonstrate clearly its possible physiolog:l.caJ. 
significance. 
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4.4.4. The Action of All Three Excitatory Peptides 0::1 the Same Unit 
The action of all of the excitatory peptides '.·:ere studied on the 
same unit in order to determine if different populations of neurons could 
be distinguished by their sensitivity to one or another of the excitatory 
peptides (substance P, neurotensin, VIP). The results indicate that there 
are cells which have different sensitivity to these peptides. There is a 
large population of cells which are sensitive to more tha~ one peptide. 
HO'ivever, there is a significant proportion of cells which are sensiti•1e 
to only one of the three peptides. The number of cells sensitive to only 
VIP v1as very small and this may be due to the use of only 10'.·1 concentra-
tions of VIP. Cells which were sensitive to v:tP were a1.so nore likely tc 
be sensitive to substance P and/or neurotensin. Units whic:-1 weYe sensi·-
tive to substance P only, were found most ofte-:1, follc'.·:ed l:;y t.ho.::;e sensi-
tive to only neurotensin. Of the units sensitive to either substa.!1C:e P 
or neurotensin, 33% were found to be sensitive to both peptiues. 
The results indicate that there are popula'cions of neurons in the 
myenteric plexus with varying sensitivity to the excitatory peptides. 
This variation in sensitivity to the excitatory peptides ca'1not be as a 
result of differences in the amount of suction used in the recording elec-
trode or the size of the electrode since all three excitatory peptides 
were tested on the same cell. The demonstration of different populations 
of cells which are sensitive to each of the excitatory pP.ptides may be 
taken to indicate that these peptides have different fu::1ctional roles in 
the myenteric plexus. Clear demonstration that these peptides in fact 
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have functionill roles in the myentE:~ric plexus a'dai ts t!1e development of 
specific antagonists. 
Demonstration of different populations of myenteric neuronsbased 
on their sensi"tivity to the excitatory peptides also suggests that the 
effects of these peptides are specific. If the increase in firing rate 
was produced by a non-specific mechanism, one might e;.,:pect that a cell 
which was excited by substance P would also be excited by a peptide of 
similar molecular weight such as neurotensin. This type of study is not 
possible when using iontophoretic application of pepi:ides since the trans--
port number for most of these peptides is not knm·m. In the case cf suh·-
stance P where transport number has been studied, there is ma:t·ked v.:uia-
tion in transport number from one electrode to the next (j(i:njevic, Henry 
and ::or::is, 1974,). If the transport nwllber of the ot:J.er peptid9s is just 
as variable, then comparisons of the sensitivity of units t:o a variety 
of peptides administered by iont.ophoresis is impossible:: to interpre·t. 
4. 5. PEPTIDES IN THE l'1YENTERIC pu:;x·_;s 
Iontophoretic application of the neuropept:i.des on to single neu-
rons in the central nervous system has yielded cle~r effects on firing 
rates in cells from various locations which contain tne specific peptide 
under study. Host of the effects produced by the peptides used in the 
present study on single neurons in the myenteric plexus are the s~~e 
qualitatively as those which have been found in the central nervous sys-
tem. -The action of endorphins has been studied at several sites in the 
central nervous system and, in most of these studies, the action of t.he 
opioid peptide was determined to, be mediated by ~. opiate receptor be-
cause the inhibitions in firing are reversed or preve:--,teCi by a SJ?eciflc 
antagonist such as naloxone. With this exception, sp2<:ific a"ltagonlsts 
for the ncuropeptides have not been described. As a result, it is dif-
:=icult to resolve which putative neurotransmitt•2r could be involved in a 
postsynaptic action in response to presynaptic sti::nulation, especially 
when the mechanism of action of two substances is the sa~e. Experiments 
using cross desensitization is one possible method by • ..;:,ich to overcome 
this problem. Another possible approach is to use agents ~·Thich deplete 
specific neurotransmitters (such as p-chlorophenyl alanine in the case 
of 5-HT, and capsaicin for substance P). 
Problems with the specificity of neurop~ptide action in the ab-
sertce of specific antag:::mists can be eliminated in isolated preparations 
by using structurally related analogs. Iontop:-10re~..:.ic studies with ana-
logs, however, cannot be used quantitatively. At the present time, the 
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action of neuropeptides has been described in several sites. However, 
the neurophysiological roles of these peptides in the central and peri-
pheral nervous systems remains to be determined. 
The presence of many of the neuropeptides in the gut may seem 
odd at first. However, demonstration of the presence of these peptides 
in nerves and also in endocrine-like cells of the gut has supported the 
theory that endocrine-like cells are the most primitive form of nervous 
tissue (Pearse, 1978). The endocrine-like cells in t::e gut share a num-
ber of cytochemical and ultrastructural properties >vi t:h cells which are 
considered to be neuroendocrine (hypothalamus, pituita~? ~~d adrenal 
medulla) (Pearse, 1968). Pearse (1968) referred to t!-lese cells as APUD 
(amine precursor uptake and decarboxylation) cells based on their ability 
to take up and decarboxylate amine precursors (5-hydroxyt:c']ptophan). 
Some nerve cells also have this ability. The embryolog.ical origin of 
these cells has been shown, in some cases, to be from neuroectoderm 
(Pearse and Polak, 1971~,£_). Several of the neuropeptides have b0~..:n 
found in vesicles contained in APUD cells, neuroendocrine cells and in 
nerves of the peripheral and central nervous systems. In this way, the 
neuropeptides appear to be another common link between the endocrine n.nd 
nervo·us systems. 
The endocrine effects of the hypothalamic peptides such as vaso-
pressin, oxytocin and the releasing factors and possibly somatostatin 
have been described, as have the actions of ma."1y of the gastrointestinal 
peptide hormones such as gastrin, cholecystokinin, insulin and glucagon. 
The physiological significance of the peptides contained within the ter-
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minals and varicosities of nerves remains to be dete~ined. It is pas-
sible that the neuropeptides are merely embDJological re~ants whichhave 
no physiological role in later life. On the other ha1d, studies of neu-
ropeptides may help to resolve questions concerning t~e nature of neuro-
transmitters at some sites (for example, the nature of the nonadrenergic 
inhibitory transmitter responsible for the relaxation of the smooth mus-
cle in various locations of the gastrointestinal tract). In the presence 
of atropine, the smooth muscle of the taenia coli relaxes (with a hyper-
polarization) in response to nerve stimulation (Burns"':o::k, Cru;lpbell, 
Bennett and Holman, 1963). This hyperpolarization is abolished by tetro-
dotoxin and is m1changed by guanethedine or sympathetic dener~ation 
(Furness, 1969~,£_). There is some evidence that the ::raDs:nitter may be 
a purine nucleotide. Adenosine triphosphate (ATP) h::/.?2::C::..:Jolarizes the 
smooth muscle and is contained in nerve terminals of t::-:e taenia coli 
(see review by Burnstock, 1972). The identity of t!!e tra11smitter, how-
ever, has not been determined. Since many of the neuropeptides are also 
contained in the nerve terminals of the gut, and so::-:1e :1europept.ides are 
kno,.ln to have actions directly on the smooth muscle (su}:)stance .P and neu-
rotensin), it is reasonable to think that a neuropeptide could be the 
inhibitory neurotransmitter. 
Another example where a neuropeptide may act as a net:rotransmi tter 
or neuromodulator is in the myenteric plexus. Substa1ce P has been sug-
gested to mediate a slow excitatory synaptic poter1tial seen in some myen-
teric neurons (Katayama and North, 1978). A depolarization of myenteric 
neurons associated with a decrease in potassium conduc-f:ance ·:;as found 
with superfusion of substance P (3-100 nM). Iontophoretic application 
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also caused a slow depolarization (duration 10-100 s) in some neurons. 
Stimulation of the nerves (10 Hz for 1 s) also caused a slo1v depolariza-
tion 1·1ith a similar time course. The <lepolarization produced by nerve 
stimula-c.ion was abolished in calcium-free, high magnesium (5 mH) Krebs 
solution such that a synaptic mechanism was indicated, but was notaltered 
by atropine (1 11M) or hexamethonium (100 ].1M) • The slo-.-1 synaptic poten-
tial was also associated with an increase in resistance which probably 
is due to a decrease in po·tassium conductance. It is not possible to 
say with complete certainty, but this evidence is suggestive that sub-
stance P is the transmitter at this site. Other possible endogenous sub-
stances which may also be involved are VIP and 5-H'J.'. Studies such as 
these may ~elp to determine the physiological significance of other neu-
ropeptides in the central as well as the peripheral nervous systems. 
4. 6. PROPOSALS FOR FUTU::<.E IW?.::C 
The neuropeptides, met- and leu-enkephalin, 3-endorphin, somata-
statin, neurotensin, substance P and VIP, had clear effects on the fir-
ing rate on neurons of the myenteric plexus. 
1. Since the neuropeptides are not di?t:!:'ibuted equally in various 
areas of the gastrointestinal tract, studies of t::.eir !?o·tencies and of 
the proportion of cells sensitive to the neuropsptides in different areas 
of th~ gut may answer questions about their physiological roles. 'I'his 
study may also include extrinsic denervation si:1ce so::c2 of the peptides 
(somatostatin, enkephalin and substance P) ma:z origi:~5.~:e L-1 cells out.<-:ide 
the gut. 
2. T'ne action of these peptides on mer:0r~~e ~r:operties and syn-
aptic potentials of myenteric neurons s'cud.ied ·.d t.'-1 ir-.tra.:::ellular. elec-
trades would enable the ionic mechanisms of actio:1 to be studied in de-
tail. Hith this method, iontophoretic application o: the pept.ides on to 
various regions of the cell can be studied and the effE.cts produced by 
this means of application can be compared to bath o.pplications of knaNn 
concentrations of the peptides. 
3. In order to propose a neurotransmitter or neuromodulator 
role for any of the neuropeptides in the myenteric plexus, several of 
the required criteria have yet to be studied. Yne3e are outlined in 
Table 13. Somatostatin, substance P, enkerhalin and VIP have been found 
in nerves of the myenteric plexm;. Eelease of e:-1:-:e;:;::alin from the rayen-
teric plexus by electrical stimulation has been studied with limited suc-
cess. Eel ease of substance P, somatostatin and ~::::P fro:::\ the myenteric 
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plexus has not been reported. Yne synthesis of enke?halin has b~en 
studied in the myenteric plexus but again, the synthesis of any of the 
other neuropeptides at this site has not. A mechanis:c. by ~·:hich the ncu--
ropeptides are inactivated or removed from the effector site has not 
been described for any of the endogenous neuro?eptides in the myenteric 
plexus. Finally, the action of each of the neuro?eptides must be mim-
icked by nerve stimulation. This type of experiment is aided by specific 
antagonists to compare the antagonism of the effect produced by an exog-
enously applied agent with the antagonism of the effect produced by nerve 
stimulation. Unfortunately, the only available a."l.tag:J.:-:ists to any of ·the 
neuropeptides in the myenteric plexus are those -...ffiich act on the opiate 
receptor to block the action of the opioid peptides. Identification of 
possible neurotransmitters is aided by cross-aesensit.i?.a.t:i.on c.xperi;;~ent:s 
between exogenously applied agents and the nerve mediateC: response. 
Drugs vvhich deplete specific neurotransmit.ters from tl-,e nerve te:rrr.inals 
are also useful. This type of experiment can be done using extracellular 
techniques. H::::>wever, interpretation of the results can be difficnlt~. 
Intracellular recording offers em additional method b1 'h'hich to idz:ntify 
neurotransmitter substances. Using intracellular recordings, the ionic 
mechanism of action of an exogenously applied agent can be compared t:o 
the action and mechanism which results from nerve stimulation. Even in 
·the absence of a specific antagonist, the evidence provit1sd by intra-
cellular recordings may strongly support or refute the neurotrail.smitter 
role of Lhe neuropeptides in the myenteric plexus. 
0 
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Table 13. The present state of . .... . cr~ ... er~a which must be satisfied to prove a neuro·transmi t ter role for 
some neuropeptides in the myenteric 
Presence in Release by 
?cptidc Nerve Terminals Stimulation 
Enkcphalin yes ., l 
G·-endorphin ns .ns 
Substance p yes ns 
Neurotensin no ns 
VIP yes ns 
Somatostatin yes ns 
abbreviations: yes - shov.-n to be present 
no - not present 
Nerve 
plexus. 
Synthetic 
W:.z,chincry 
yes 
ns 
ns 
ns 
n·-
. "" 
ns 
? - studied but still not clear 
ns - not studied 
E extracellular recording 
I - intracellular recording 
:-1echanism Action Mimicked by 
of ~~omoval Action Nerve Stimulation 
llS E inhibition not found 
of firing 
I hyperpolari- not l'ound 
zation 
ns E inhibition ns 
of fir in 
ns E increase in ? 
firing rate 
I depolarization ? 
ns E increase in ns 
firing rate 
ns E increase in ? 
firing rate 
ns E inhibition n:::; 
of firing: 
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SUf!.HARY 
Extracellular recordings from single myenteric neurons '\·lere mad.e 
with large suction electrodes. The origin and nature of the spontaneous 
neuronal activity was thought to be somatic and induced by irritation of 
the cell b~;l the large electrode. This conclusion is based on the follo·,.r-
ing observations. First, spontaneous acti vit:z· was only recorded frocn the 
ganglia and not from the interconnecting strands Hhere there are few cell 
bodies. Second, no spontaneous activity was recorc1ed ',·;i th small suction 
electrodes or large electrodes without suction. Third, cells which ex-
hibi ted a decreasing firing rate t-;ith increasing spike aJ.Ttplitude could be 
induced to fire by increasing the suction or addinq excitator~z asents t.o 
the tissue bath. Spontaneously firing cells we:re rout.::inely recorded for 
l-2 hr and sometimes for periods up to 6 hr. Pre·;ious '.-;or.kers hi-ld shown 
that mo.:::phine inhibited the firing rate in a stereosre:::ific naloxinc re-
versible manner, indicating this preparation as a usefl!l model to study 
pharmacological agents. 
A number of neuropeptides have been fmmd in nc.r:ves of the my;.;m-
teric plexus, including enkephalin, somatostatin, substance P and VIP. 
The action of these peptides and neurotensin '.vas tested. on the firing 
rate of myenteric neurons. These peptides were tested in known concen·-
trations, in solut:.i:ms vrhich completely blocked synaptic transmission, 
and in solutions containing various specific and non-specific pharmaco-
logical ant.agorlists. The endorphins (met- and leu-enkei)lv~lin and 13-
endorphin) :r-eversibly decreased the firing rate b:l a:-~ • .L oplaL.e recertor 
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mechanism, at concentrations sirnilar to those which in:-tibi t the nerve-
mediated contraction of the longitudinal muscle (3-300 nl·l) . The time 
course of the inhibition was immediate with the entry of the p2ptide into 
the bath and washed out quickly with remov-al of the peptide from the bath. 
In the same concentration range, somatostatin decreased the firing of 
myenteric neurons. The inhibition was of the s~ne time course as enke-
phalin, but in some Q~its there were signs of tachyphylaxis. The inhi-
bition produced by somatostatin was not affected by opiate or adrenergic 
antagonists. 
Substa."1ce P and neurotensin produced marked increases in firing 
in myenteric neurons. The concentration range which produced an excita-· 
tory effect (100 p:1 - 100 nl-1) was in the same concentrations :r:ange as 
that required to contract the guinea pig ileum. There were so:ne signs of 
desensitization to substance P with repeated applications \·;hereas the ex-
citations produced by neuroter"sin were less likely to exhibit desensi ti-
zation. The excitations produced by substance P and neurotensin \.Jere 
thought to be relatively specific based on two studies. First, two sub-
stance P analogs (substance P pentapeptide and substance P free acid) were 
both markedly less active than substance P on myenteric neurons. The bio-
logical activity of these analogs was also less than that of substance P 
when tested on smooth muscle and spinal cord preparations. Second, sub-
stance P and neurotensin affected separate populations of myenteric neu-
rons. That is to say, there were cells that were exquisitely sensitive 
to substance P and relatively insensitive to neurote~'1sin and vice versa. 
VIP also produced a."1 increase in firing of myenteric neurons but at con-
cent.rations 100-1,000 fold less than the effective concentrations of sub-
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st.r>..nce P and neurotensin. Repeated applications of '.'IP often resulte<l 
in diminution of the response, implying some tachyp:!:l:t•lc:xis. The popula-
tion of net:rons which is sensitive to VIP is also sensitive to substance 
P and/or neurotensin: fe>·l cells were excited by VIP a:1d not by substance 
P or neurotensin. 
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APPENDIX A 
Determination of spike amplitude recorded Hith large suction electrodes 
on theoretical grounds. 
(1) Recording from the cell soma. The follmving assumptions 
are made: 
(a) 'I'he cell diameter is 50 llffi. 
(b) A 50 ~ electrode is placed on the cell such that 
it completely covers the cell. 
(c) A perfect resistive seal is formed around the out-
side of the electrode. 
(d) 'l'he action potential of the ce 11 is 70 mV with a 
rise time of 1 ms. 
(e) Capacitive current only is measured. 
(f) l'Rmbrane capacitance-== lj.:Fjcm2. 
The sur:!:ace area for capacitive current. 
2 -6 2 
A= nr· = 19.4 x 10 em 
Total capacitance. 
C membrane caracitance x surface area 
C 1 ]JP/cm2 x 19.4 x 10-6 cm2 = 19.4 x lQ-6 ]JI' 
'l'otal charge. 
Q = C XV= 19.4 X l0-l2 (P) X 7 X 10-2 (V) 
Q == 1.36 x lo-12 coulombs 
O.:rr~nt. generat~,d during rising phase of action :potential. 
I~ Q/dt = 1.4 X lO-l2 (C)/l0-3 = 1.4 X 10-9 A 
Pot:er1tial drop across an electrode (resistance 1 !'-1r2) • 
-9 6 V = I X R = 1.4 X 10 X 1 X 10 = 1.4 mV 
Under the given conditions, the potential measured dnring an 
action potential would be L 4 mV. The conditions in rracti~~e are much 
different. There is not a perfect resistive seal arounc1 the electrode: 
in fact, it. is only 200-500 krl. 'l'his resistance is produced by t.he suc-
tion and. appears to be important because no activity (spontaneous or 
evoked) ca.n be recorded without suction. Increasing the amount of suc-
tion increases the sealing resistance and also increases the size of the 
spike recorded. Consideri.:1g that the resistive seal arou.r:td the electrode 
is not peL[ect, it seems rea~;onable to assume that the spike amplitude 
measured in practice must be smaller than the predicted value of 1.4 mV. 
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(2) Recording from a process. 'l'he follov1ing assu."!lpt5.ons a::-_·e 
made: 
(a) Cell process is 1 ~ in di~"!leter and 50 ~ long. 
(b) The cell process spikes all along its length at 
the same time. 
(c) The spike is 70 mV and has a rise ti~e of l ms. 
(d) A perfect resistive seal is made around the elec-
trode. 
(e) Capacitive current only is measured. 
(f) Hembrance capacitance = lfJ}'/cm2. 
The surface area for capacitive current. 
A= TirL = 3.1 X 0.5 X 10-4 X 50 X 10-4 = 77.5 X 10-B cm2 
Total capacitance. 
2 -8 C = 1 ~/em x 77.5 x 10 = 7.75 X lO-l3 F 
Total-charge. 
~3 ~ ~4 Q = C XV= 7.75 X 10 X 7 X 10 = 5.4 X 10 C 
Current generated during rising phase of action pot<~ntial. 
I = Q/dt = 5.4 X lO-l4/l0-3 = 5.4 X 10-ll A 
Po"te:-:.'::i.al d~op across an electrode (resistance: 1 :-:-.~). 
V = I X R = 5.4 X 10-ll X 1 X 106 = 5.4 X 10-S V 
Under the asusmptions listed above, the anplitude of the spike 
measured during an action potential in a process vrould be 54 )JV. Since 
the resistive seal. around the electrode is not perfect (see appendix A-1), 
a smaller potential is expected. In addition, the entire length of nerve 
(SO pm) is not depolarized simultaneously, such that the estimated current 
is actually smaller than that predicted. Since the ~":!plj_tude of spontan-
eous potentials ranged from SO pV (just over the noise level) to 500 )JV, 
it is unlikely that these potentials originated from single cell pro-
cesses but probably correspond to the action potential in somata. 
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